10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)
☒	ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended January 1, 2022
or
☐	TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to

Commission File No. 001-33346

SUMMER INFANT, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation)	20-1994619 (I.R.S. Employer Identification No.)
1275 Park East Drive, Woonsocket, Rhode Island (Address of principal executive offices)	02895 (Zip Code)

(401) 671-6550

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, Par Value $0.0001	SUMR	Nasdaq Capital Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐   No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No ☒

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒
​ Smaller reporting company ☒
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.   ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐   No ☒

The aggregate market value of the registrant’s voting and non-voting common equity held by non-affiliates as of July 2, 2021, was $10.9 million. For purposes of this computation, all officers, directors, and 10% beneficial owners of the registrant are deemed to be affiliates. Such determination should not be deemed to be an admission that such officers, directors, or 10% beneficial owners are, in fact, affiliates of the registrant.

The number of shares issued and outstanding of the registrant’s common stock as of March 11, 2022 was 2,164,708.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s Proxy Statement for its 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.

INDEX TO FORM 10-K

FOR THE FISCAL YEAR ENDED JANUARY 1, 2022

		PAGE
	PART I
ITEM 1.	Business	3
ITEM 1A.	Risk Factors	7
ITEM 1B.	Unresolved Staff Comments	17
ITEM 2.	Properties	17
ITEM 3.	Legal Proceedings	17
ITEM 4.	Mine Safety Disclosures	17
	PART II
ITEM 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	17
ITEM 6.	[Reserved]	18
ITEM 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
ITEM 7A.	Quantitative and Qualitative Disclosures About Market Risk	29
ITEM 8.	Financial Statements and Supplementary Data	29
ITEM 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	29
ITEM 9A.	Controls and Procedures	29
ITEM 9B.	Other Information	30
ITEM 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	30
	PART III
ITEM 10.	Directors, Executive Officers and Corporate Governance	31
ITEM 11.	Executive Compensation	31
ITEM 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	31
ITEM 13.	Certain Relationships and Related Transactions, and Director Independence	31
ITEM 14.	Principal Accountant Fees and Services	31
	PART IV
ITEM 15.	Exhibits and Financial Statement Schedules	32
ITEM 16.	Form 10-K Summary	32
SIGNATURES		35

2

PART I

When used in this report, the terms “Summer,” the “Company,” “we,” “us,” and “our” mean Summer Infant, Inc. and its subsidiaries. Note that all dollar amounts in Part I are in thousands of U.S. dollars unless otherwise noted.

Proposed Merger with Kids2, Inc.

On March 16, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Kids2, Inc., a Georgia corporation (“Parent”), and Project Abacus Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides, subject to its terms and conditions, for the acquisition of the Company by Parent through the merger of Merger Sub with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Parent (the “Proposed Merger”).

Under the terms of the Proposed Merger, each share of common stock of the Company issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (other than shares of common stock (i) owned by Parent, Merger Sub, the Company or any subsidiary of Parent, Merger Sub or Company, or (ii) held by a stockholder who is entitled to, and who has perfected, appraisal rights for such shares under Delaware law) automatically will be converted into the right to receive cash in an amount of $12.00 per share (the “Merger Consideration”), without interest, subject to any required withholding of taxes.

The completion of the Proposed Merger is subject to closing conditions, including: (i) the approval of the Merger Agreement by the Company’s stockholders; (ii) the absence of any laws or court orders making the Proposed Merger illegal or otherwise prohibiting the Proposed Merger; (iii) other customary closing conditions, including the accuracy of the representations and warranties of each party (subject to certain materiality exceptions) and material compliance by each party with its covenants under the Merger Agreement; and (iv) the closing of a debt financing by Parent to fund the Merger Consideration. The parties expect the transaction to close in the second quarter of 2022, subject to the satisfaction or waiver of the closing conditions. For a detailed description of the Merger Agreement and the Proposed Merger, please see Item 1.01 of the Current Report on Form 8-K that will be filed with the Securities and Exchange Commission (“SEC”) on or about March 16, 2022, and a copy of the Merger Agreement filed as Exhibit 2.1 therewith.

The Company’s board of directors (the “Board”) has unanimously resolved to recommend that the Company’s stockholders adopt the Merger Agreement (the “Company Board Recommendation”).
​

Item 1. Business

Overview

We are an infant and juvenile products company doing business under the name SUMR Brands. We are a recognized authority in the juvenile product industry, providing parents and caregivers a full range of innovative, high-quality, and high-value products to care for babies and toddlers. We seek to improve the quality of life of parents, caregivers, babies and toddlers through our product offerings, while at the same time maximizing shareholder value over the long term.

We operate in one principal industry segment across geographically diverse marketplaces, selling our products globally to large, national retailers as well as independent retailers, on our partner’s websites, and our own direct to consumer website. In North America, our customers include Amazon.com, Wal-Mart, Target, Buy Buy Baby, Home Depot, and Lowe’s. Our largest European-based customer is Smyths Toys. We also sell through international distributors and representatives in geographic locations where we do not have a direct sales presence and directly to select international retail customers. Our company was originally founded in 1985 and has publicly traded on the Nasdaq Stock Market since 2007 under the symbol “SUMR”.

We aim to become a globally recognized leader in the juvenile product industry by creating products that families everywhere need, want, love and depend on. To support future growth, we will continue to seek to develop and launch new juvenile products based on consumer demand, while also strengthening our core product offerings. In addition to organic growth, we will consider acquisitions of products or businesses. We have strong partnerships with our suppliers in the U.S., Mexico, and Asia. We believe that our ability to develop products that are preferred by consumers gives us a competitive advantage in meeting our customer demands. We have long-standing relationships with our brick and mortar and e-commerce retail customers in the U.S. and will continue to focus on strengthening them to increase our presence in stores and online. We intend to continue managing our operational costs through ongoing SKU reductions and rationalization, warehouse labor reductions, leasehold rationalization and the subletting of

3

excess space where applicable. Additionally, we plan on continuing to increase our direct import business and to shift manufacturing to areas where container and other transportation costs are more cost efficient.

Leveraging our strength in product development, global sourcing and sales to national retailers, independent retailers, international distributors and ecommerce (pureplay and omni-channel), we are launching a new brand into the pet space, Ozzy & Kazoo ™, in 2022. Our focus is on creating products that complement our juvenile development and sourcing strategy, as well as a well-rounded product offering to highlight our brand in this new category, such as gates, pet beds and other pet supplies. By providing high quality, innovative pet products, our goal is to establish SUMR Brands as an authority in pet products, similar to our position as a recognized authority in the juvenile products industry. Initial products are anticipated to launch during the second quarter of 2022. In 2021, we began selling certain of our current products, primarily gates, under the brand name “Summer” in pet channels, including Chewy, Inc., though sales in 2021 were not material. We believe our entry into the pet products is an opportunity for incremental growth.

Products

We currently market our juvenile products in several product categories, including gates, potty, bath, entertainers, specialty blankets, strollers, car seats and travel systems. We are a North American market leader in the bath and potty categories. We market our core products under our Summer™ and SwaddleMe^® brand names.

Within gates, we offer a product range of more than 30 products. Our line of gates offers versatility that covers use in home, ease of installation, and aesthetically pleasing designs. We continue to receive positive feedback from retailers as we expand our portfolio with consumer preferred features and styling.

We first entered the infant bathing category in 2002, and we have continued to create useful and safe solutions for bathing. Our innovative bath product, My Bath Seat™, continues to be extremely popular with consumers. We have an established roadmap for developing products in the three subcategories of bathing (bathers, bathtubs, and bath seats) to address consumer needs as baby grows, and to create loyalty to our brands.

We are a North American market leader in potties, and 2021 was a strong year in potty. We launched four new products, the My Travel™ Potty, the 3-in-1 Sit ‘N Play, My Size ® Lights & Songs and My Size ® Lights & Songs Transitions, further growing our breadth and depth of assortment that supports different consumer needs and various price points.

We are a North American market leader in the convenience segment of strollers. Our 3Dlite^® Convenience Stroller continues to be a favorite among parents. We have continued to expand our range of convenience stroller platforms to appeal to the experienced parent. In addition, in 2020, we launched the Myria modular travel system and the Affirm 335 infant car seat that attract first time expectant parents to our products.

Our specialty blankets include SwaddleMe^® specialty blankets as well as our expanded line of Slumber Buddy soothers. Acquired in 2008, SwaddleMe^® continues to be a trusted brand synonymous with infant safe sleep. In 2021, we added a new stage 3 Night Sack and introduced our Velboa soft touch fabrics which have been well received in the market.

We currently also offer audio and video monitors under the Summer™ brand. Our monitors feature high quality components, intended to fulfill the desire for consumers to connect with baby at any time or place.

In 2021, we began selling certain of our current products primarily gates, under the brand name “Summer” in pet channels, including Chewy, Inc., and, as noted above, in 2022, we will launch a new brand into the pet space, Ozzy & Kazoo ^™, with an initial assortment of pet care products, including gates, pet beds and other pet supplies.

Product Development and Design

A thorough understanding of our consumer, the competition, and our customer retail partners drives our product development. Developing and marketing innovative solutions are a critical element of our strategy. We strive to produce proprietary products that offer distinctive benefits, are visually appealing, and provide safe, thoughtful solutions.

We conduct market analyses in our geographic regions of priority, evaluate identified opportunities, and design products accordingly. The majority of our products are currently designed at our Rhode Island headquarters. When appropriate, we also partner

4

with manufacturers in Asia on product development. In addition to new product development, we continuously look for ways to improve upon existing products based on consumer insights with a strong focus on the end-user experience.

Suppliers and Manufacturing

We source our products globally from a variety of suppliers and manufacturers, including from China, Vietnam, Mexico and the United States. We are not dependent on any one supplier as we use many different manufacturers and presently own the majority of tooling and molds used for our products. Our Hong Kong subsidiary provides us with an Asian sourcing presence and the ability to oversee quality, electronic engineering and other issues that may arise during production. Generally, we buy finished goods from manufacturers, and thus do not directly procure raw materials for product manufacturing. Historically, we have not experienced any significant disruption of supply as a result of raw material shortage, but there is the possibility that shortages could occur in the future based on a variety of factors beyond our control. We have seen increases in the cost of certain raw materials, including cotton, steel and resin and negotiate with our suppliers as to adjustments in pricing due to such increased costs.

Asian-made goods are shipped on the water to our warehouses, which currently takes approximately six to eight weeks due to ongoing global supply chain challenges as compared to three to four weeks a year ago. We also utilize a direct import program, to reduce costs and shipping time to certain customers. We maintain inventory in warehouses located in the United States and Canada as well as a third-party logistics warehouse in China. Most of our customers pick up their goods at our warehouses. We also deliver shipments direct to customers for sales from our own website and our consumer replacements program as well as for other smaller retail partners that request such arrangements.

Sales and Marketing

Our products are largely marketed and sold through our own direct sales force. We also have certain sales representatives in North America and distributors that service customers internationally. We seek to expand our direct-to-consumer sales, which we believe will also increase overall brand awareness. Sales are recognized upon transfer of title to our customers and are made utilizing standard credit terms of approximately 60 days. We generally accept returns only for defective merchandise. We maintain a U.S.-based internal customer service department that responds to customer inquiries, investigates and resolves issues, and is available to assist customers and consumers during business hours.

Marketing, promotion and consumer engagement are key elements in the juvenile industry. Historically, a significant percentage of our promotional spending has been structured in coordination with large retail partners. We continue to focus our marketing efforts on growing brand awareness among our target consumer demographic, optimizing marketing investments, and executing an integrated marketing strategy. We believe an important component of our future growth is based on speaking to the right customer, with the right content, in the right channel, at the right time. We have implemented online marketing, social media, and digital analytics tools, which allow us to better measure the performance of our marketing activities, learn from our consumers, and receive valuable insights into industry and competitor activities.

Competition

The juvenile product industry has many participants, none of which has dominant market share, though certain companies may have disproportionate strength in specific product categories. We compete with a number of different companies in a variety of categories, although there is no single company that competes with us across all of our product categories. Our largest direct competitors are Tomy Company, Ltd., Dorel Industries, Inc., Regalo Baby^®, Munchkin^®, GB^® (Goodbaby International Holdings, Ltd.), Graco^® (a subsidiary of Newell Rubbermaid), Chicco^®, Fisher-Price^® (a subsidiary of Mattel, Inc.), and Aden & Anais^®.

The primary method of competition in the industry consists of brand positioning, product innovation, quality, price, and timely distribution. Our competitive strengths include our ability to develop innovative new products, breadth of assortment, high consumer star ratings, our relationships with national retailers, and the quality and pricing of our products.

Intellectual Property

We rely on a combination of trademarks, patents, and trade secrets to protect our intellectual property. Our current U.S. patents include various design features related to safety gates, playards, bath seats, bathers, and monitors with several other patents under review by the United States Patent and Trademark Office (USPTO). The issued U.S. patents expire at various times depending on the date of issuance during the next 18 years. In certain circumstances, we will partner with third parties to develop proprietary

5

products. The duration of our trademark registrations varies from country to country. However, trademarks are generally valid and may be renewed indefinitely as long as they are in use and/or their registrations are properly maintained.

Customers

Sales to the Company’s top seven customers together comprised approximately 88% of our sales in fiscal 2021 and 87% of our sales in fiscal 2020. Of these customers, three generated more than 10% of sales for fiscal 2021: Amazon.com (38%), Walmart (24%), and Target (18%). In fiscal 2020, three customers generated more than 10% of sales: Amazon.com (33%), Walmart (28%), and Target (17%).

We have no long-term contracts with these customers, and as a result, our success depends heavily on our customers’ willingness to purchase and provide shelf space for our products.

Seasonality

We do experience some variations in seasonal demand for our products in our second and third quarters of each year. However, we expect to generate higher than average volumes for the initial shipment of new products which typically includes enough inventory to fill each store plus additional amounts to be kept at the customer’s distribution center. The timing of these initial shipments varies by customer depending on when they finalize store layouts for the upcoming year and whether there are any mid-year product introductions.

Regulatory Matters

Each of our products is designed to comply with all applicable mandatory and voluntary safety standards. In the United States, these safety standards are promulgated by federal, state and independent agencies such as the US Consumer Product Safety Commission, ASTM, the Federal Communications Commission, the Food and Drug Administration, the Federal Trade Commission, and various states Attorney Generals and state regulatory agencies. All of our products are independently tested by third party laboratories accepted by the Consumer Product Safety Commission to verify compliance to applicable safety standards. A similar approach is used to design and test products sold internationally.

Insurance

We carry product liability insurance that provides us with $15,000 coverage with a minimal deductible. We consult with our insurers to ascertain appropriate liability coverage for our product mix. We believe our current coverage is adequate for our existing business and will continue to evaluate our coverage in the future in line with our expanding sales and product breadth.

Employees

We believe that the development, attraction and retention of employees is an important factor to our Company’s success. We offer our employees a wide range of benefits, and to support the advancement of our employees, we offer training and development programs encouraging advancement from within. As of January 1, 2022, we had 112 employees, 107 of whom were full time employees and 55 of whom worked in our Rhode Island headquarters. We also utilize temporary labor at our main leased warehouse and distribution center located in California.

Available Information

The Company is incorporated under the laws of the State of Delaware. Our principal executive offices are located at 1275 Park East Drive, Woonsocket, Rhode Island 02895, and our telephone number is (401) 671-6550. We maintain our corporate website at www.sumrbrands.com.

We file reports with the Securities and Exchange Commission (“SEC”), including an annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports that we file with, or furnish to, the SEC. The SEC maintains an Internet website, www.sec.gov, that contains reports, proxy and information statements and other information that we file electronically with the SEC. Our website also includes corporate governance information, including our Code of Ethics and our Board committee charters. The information contained on our website does not constitute a part of this report.

6

Item 1A. Risk Factors

An investment in our securities involves a high degree of risk. You should carefully consider the material risk factors described below before making an investment decision. If any of the events or circumstances described in the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected, and the trading price of our common stock could decline.

Business Operations and Financial Risks

There is substantial doubt about our ability to continue as a going concern. If we are unable to continue as a going concern, our securities will have little or no value.

Our independent registered public accounting firm has issued a report on our financial statements at January 1, 2022 that includes an explanatory paragraph referring to our recent losses from operations and negative operating cash flows, which raises substantial doubt about our ability to continue as a going concern for the twelve months from the issuance date of those financial statements if we are unable to meet our operating plan or take such actions to increase revenues or reduce expenses to maintain compliance with the financial covenants under our loan agreements or obtain additional financing. As of January 1, 2022 we had $535 of cash, $40,572 of outstanding indebtedness, and borrowing availability of $2,949 under our asset-based loan agreement. We can give no assurances that our losses will not continue in the future or that we will be profitable in the future. Our prior losses have had, and potential losses could have, an adverse effect on our financial condition. We have developed plans to extend our liquidity to support working capital requirements, including among other things: explore price increases where possible, enhance certain supply chain processes and related costs, reduce product costs through re-engineering certain products, reduce discretionary marketing spend to the extent it does not impact revenue performance, obtain additional financing and/or consider strategic alternatives.

Our ongoing operations may require us to obtain amendments from our lenders under our existing loan agreements or to raise additional funds, and there are no assurances that our lenders will agree to any amendments or that such additional financing will be available on terms acceptable to us, or at all. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty. While we have entered into a definitive agreement with Kids2, Inc. to acquire the Company, the transaction is subject to closing conditions and other risks as described further below. If we are unable to meet our operating plan, obtain necessary amendments to our existing loan agreements if we cannot meet our financial covenants, obtain additional financing, or complete our transactions with Kids2, Inc., and as a result are unable to continue as a going concern, our stockholders would likely lose most or all of their investment in the Company.

The concentration of our business with certain retail customers means that changes in the purchasing policies of these customers could have a significant impact on our business and operating results.

In fiscal 2021, sales to our top three customers (Amazon.com, Wal-Mart, and Target) accounted for approximately 80% of our total sales, and sales to our top seven customers in fiscal 2021 accounted for approximately 88% of our total sales. We do not have long-term commitments or contracts with any of our retail customers, and retailers make purchases by delivering one-time purchase orders. Therefore, any customer could potentially renegotiate the terms of our business relationship at any time, which could include reducing overall purchases of our products, altering pricing, reducing the number and variety of our products carried and the shelf space allotted for our products, and reducing cooperative advertising or marketing support. Because of the current concentration of our business with these retail customers, a change in our relationship with any of these customers could adversely affect our results of operations and financial condition.

If we do not appropriately manage our supply chain or maintain sufficient inventory levels, and we are unable to deliver our products to our customers in sufficient quantities or on a timely basis, our operating results will be adversely affected.

Our business places stringent demands on our inventory forecasting and production planning processes. This inventory management approach may be particularly challenging when combined with “just-in-time” inventory management systems commonly used by customers to minimize their inventory levels. If we fail to meet tight shipping schedules, we could damage our relationships with customers, incur additional fees charged by our customers and cause sales opportunities to be delayed or lost. In order to meet these deadlines, we may incur additional shipping costs.

7

Most of our customers receive our product at our distribution center located in California. To deliver products to these customers on a timely basis, we need to maintain adequate inventory levels of the desired products. Disruptions in our supply chain result in delays in our receipt of inventory, therefore impacting our ability to meet customer demand. We currently face logistical challenges related to the lack of availability of truckers, containers and shippers. These challenges result in significant increases in transportation costs in order to maintain sufficient inventory and directly impact our cost of goods and therefore our margins. These supply chain disruptions have increased as a result of the COVID-19 pandemic and we expect them to continue in 2022.

Conversely, at the time we place factory orders, we may not have firm orders from customers or a complete understanding of what consumer demand for those products will be. If our inventory forecasting processes are not accurate, it may result in inventory levels in excess of the levels forecasted and we may not have sufficient space at our distribution center to accommodate excess inventory. As a result, we could be required to record inventory write-downs for excess and obsolete inventory or incur additional expense for storage of excess inventory, which would adversely affect our operating results.

Covenants in our loan agreements may affect our liquidity or limit our ability to complete acquisitions, incur debt, make investments, sell assets, merge or complete other significant transactions. Deviations from expected results of operations and expected cash requirements could result in a failure to meet financial covenants, which would adversely affect our financial condition and results of operations.

We fund our operations and working capital needs through operating cash flow and borrowing under on our asset-based loan agreement with Bank of America and a term loan agreement with Wynnefield Capital. Because a majority of our suppliers are based in Asia, we generally are paying for product a short time after it has been received in the United States, but we have not generally yet received payment from customers. If our working capital needs exceed our cash flows from operations, we rely on the credit facilities under our loan agreements to satisfy those needs.

Our loan agreements include certain covenants that place limitations on or restrict a number of our activities, including our ability to incur additional debt, create liens on our assets or make guarantees, make certain investments or loans, pay dividends or make distributions, dispose of or sell assets, or enter into a merger or similar transaction. These restrictive covenants may limit our ability to engage in acts that may be in our best long-term interests. Any significant deviation in actual results from our expected results of operations, or in the timing of material expenditures from current estimates, any significant business or product acquisitions, or other significant unanticipated expenses could result in us not meeting applicable financial covenants.

Non-compliance with the covenants in our loan agreement could result in us being unable to utilize borrowings under our credit facilities, a circumstance which potentially could occur when operating shortfalls would most require supplementary borrowings to enable us to continue to fund our operations. If access to our credit facilities is limited or terminated, our liquidity would be constrained, affecting our operations and growth prospects, and we would need to seek amendments to our loan agreements or obtain additional equity or debt financing or face default. There is no assurance that such financing would be available on acceptable terms or at all. Furthermore, any equity financing may result in dilution to existing stockholders and any debt financing may include restrictive covenants that could impede our ability to effectively operate and grow our business in the future.

We face risks related to the widespread COVID-19 pandemic that impacted our business in 2020 and 2021 and may continue to impact our business and financial performance and our ability to continue as a going concern.

In 2020 and 2021, the global COVID-19 pandemic and the actions taken by governments, businesses, and individuals in response to it resulted in significant disruption of the global economy and global supply chains. Such disruption has impacted the market in which we, our employees, customers, suppliers and manufacturers operate and has had and will likely continue to have a negative impact on our business and financial performance. These risks and impacts include:

● increased operational risks, including continued global supply chain challenges related to closure of facilities, quarantines and governmental actions; and

● increased customer-related risks, including risks of accounts receivable collection, insolvency of retail customers, and delays in payment;

8

In addition to the specific risks to our business noted above, we will also be subject to the long-term effects the COVID-19 pandemic may have on the U.S. economy as a whole. Continued uncertainty regarding the extent the COVID-19 pandemic and the governmental response will likely continue to impact consumer discretionary spending, and therefore demand for our products. In addition to the risks specifically described above, the impact of COVID-19 is likely to implicate and exacerbate other risks disclosed in this Item 1A. The continued uncertainty of the impact of COVID-19 on our business and the global economy may continue to impact our business and financial performance and our ability to continue as a going concern.

Our ability to grow and compete will be harmed if we do not successfully satisfy consumer preferences, enhance existing products, develop and introduce new products, and successfully market and achieve acceptance of our products.

Our business and operating results depend largely upon providing our customers with products that appeal to the end consumer. Consumer preferences are constantly changing, particularly among parents who are often the end purchasers of our products. Our success largely depends on our ability to identify emerging trends in the infant and juvenile health, safety and wellness marketplace, and to design quality products that address consumer preferences and prove safe and cost effective.

Our ability to maintain and increase our current market share will depend upon our ability to anticipate changes in consumer preferences and satisfy these preferences, enhance existing products, develop and introduce new products, grow existing distribution channels and seek additional distribution channels for these products, successfully market the products and, ultimately, achieve consumer acceptance of these products. A failure to achieve market acceptance of our products could harm our ability to grow our business.

An inability to develop and introduce planned new products or product lines in a timely and cost-effective manner may damage our business.

In developing new products and product lines, we have anticipated dates for associated product introductions. When we state that we will introduce, or anticipate introducing, a particular product or product line at a certain time in the future, those expectations are based on completing the associated development, implementation, marketing work, and manufacturing in accordance with our currently anticipated development schedule. Unforeseen delays or difficulties in the development process, significant increases in the planned cost of development, changes in anticipated consumer demand for our products, and delays in the manufacturing process may cause the introduction date for products to be later than anticipated or, in some situations, may cause a product introduction to be discontinued. The risk is also heightened as we look at new alternatives to engineer product functions outside of our core competencies in an effort to provide greater innovation and product differentiation. If we are unable to manufacture, source and ship new products in a timely manner and on a cost-effective basis, it could have an adverse effect on our business and operating results.

The intense competition in our market could reduce our net sales and profitability.

We operate in a highly competitive market and compete with several large domestic and foreign companies and with smaller producers of infant and juvenile products. Many of our competitors have longer operating histories, greater brand recognition, and greater financial, technical, marketing and other resources than us, or have greater e-commerce and social media presence than us. We experience price competition for our products and competition for shelf space at retailers, all of which may increase in the future. In addition, with the acceleration in consumers purchasing online, there is a low barrier to entry into our market for newer, smaller companies that solely operate an e-commerce business. If we cannot adjust to changes in our market and compete successfully in the future, our net sales and profitability will likely decline.

Liquidity problems or bankruptcy of our key retail customers could have a significant adverse effect on our business, financial condition, and results of operations.

A significant portion of our revenue is with key retail customers. Due to the current pressure on traditional brick-and-mortar retailers, there is increased risk that retailers may suffer material losses or file for a petition for bankruptcy. Sales to retail customers are typically made on credit without collateral. If a customer files for bankruptcy, our pre-petition accounts receivable may not be realized and post-petition orders reduced or cancelled. The bankruptcy laws may severely limit our ability to collect pre-petition accounts receivable. If key customers cease doing business as a result of bankruptcy or significantly reduce the number of stores operated and therefore the amount of products ordered from us, it could have an adverse effect on our business, financial condition, and results of operations, including our ability to access availability under our credit facility.

9

Because we rely on foreign suppliers and we sell our products in foreign markets, we are subject to numerous risks associated with international business that could increase our costs or disrupt the supply of our products, resulting in a negative impact on our business and financial condition.

While most of our sales continue to be in North America, we operate facilities and sell products in countries outside the United States. Additionally, as we discuss below, we utilize third-party suppliers and manufacturers located in Asia to produce a majority of our products. These sales and manufacturing operations, including operations in emerging markets that we have entered, may enter, or may increase our presence in, are subject to the risks associated with international operations, including:

● economic and political instability;

● restrictive actions by foreign governments;

● greater difficulty enforcing intellectual property rights and weaker laws protecting intellectual property rights;

● trade restrictions;

● work stoppages or other changes in labor conditions, including due to the COVID-19 pandemic;

● reduction in business activity in some parts of the world;

● currency fluctuations and devaluations;

● changes in import duties or import or export restrictions;

● compliance with anti-bribery and anti-corruption regulations;

● untimely shipping of product and unloading of product through West Coast ports;

● complications in complying with the laws and policies of the United States affecting the importation of goods, including duties, quotas, and taxes;

● limitations on repatriation of foreign earnings; and

● complications in complying with foreign tax laws.

Future changes to the U.S. tariff and import/export regulations could have a negative effect on our results of operations. Due to our reliance on manufacturers located in China, from which we currently import a majority of our products, the occurrence of such trade reforms or restrictions could impact our business in an adverse manner.

As a result of our international operations, we are subject to the U.S. Foreign Corrupt Practices Act and similar foreign anti-corruption and anti-bribery laws. Recent years have seen a substantial increase in the global enforcement of anti-corruption laws, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by both the U.S. Department of Justice and the SEC resulting in record fines and penalties, increased enforcement activity by non-U.S. regulators, and increases in criminal and civil proceedings brought against companies and individuals. Our failure to successfully comply with any such legal requirements could subject us to monetary liabilities and other sanctions that could harm our business and financial condition.

Also, because we generate some of our revenue outside the United States but report our financial results in U.S. dollars, our financial results are impacted by fluctuations in foreign currency exchange rates. If the U.S. dollar is strong against foreign currencies, our translation of foreign currency denominated revenue or expense could result in lower U.S. dollar denominated net revenue and expense.

10

Geopolitical risks, such as those associated with Russia’s recent invasion of Ukraine, could result in increased market volatility and uncertainty, which could negatively impact the Company’s business, financial condition, and results of operations.

The uncertain nature, magnitude, and duration of hostilities stemming from Russia’s recent military invasion of Ukraine, including the potential effects of sanctions limitations, retaliatory cyber-attacks on the world economy and markets, and potential shipping delays, have contributed to increased market volatility and uncertainty, which could have an adverse impact on macroeconomic factors that affect the Company’s business and could amplify the existing supply chain challenges faced by the Company. As a result of Russia’s invasion of Ukraine, the United States, the United Kingdom and the European Union governments, among others, have developed coordinated economic and financial sanctions packages. As the invasion of Ukraine continues, there can be no certainty regarding whether such governments or other governments will impose additional sanctions, or other economic or military measures against Russia. The impact the invasion of Ukraine, including economic sanctions or additional war or military conflict, as well as potential responses to them by Russia, is currently unknown and they could adversely affect the Company’s business, supply chain, suppliers, customers and potential consumer demand for our products. It is not possible to predict the broader consequences of this conflict, which could include further sanctions, embargoes, regional instability, geopolitical shifts and adverse effects on macroeconomic conditions, the availability and cost of raw materials, supplies, freight and labor, currency exchange rates and financial markets, all of which could impact the Company’s business, financial condition and results of operations.

Any adverse change in our relationship with our suppliers could harm our business.

We rely on numerous third-party suppliers located in Asia for the manufacture of most of our products. While we believe that alternative suppliers could be located if required, our product sourcing could be affected if any of these suppliers do not continue to manufacture our products in required quantities or at all, or with the required levels of quality, and we would incur additional costs if we change suppliers. We may also decide to change suppliers from time to time, which could result in disruption of supply due to the transition of suppliers and other costs associated with terminating supplier relationships. We do not have any long-term supply contracts with our foreign suppliers; rather, we enter into purchase orders with these suppliers. In addition, difficulties encountered by these suppliers in the countries where they operate, such as fire, accident, natural disasters, outbreaks of contagious diseases, or political unrest, could halt or disrupt production at the affected locations, resulting in delay or cancellation of orders. For instance, COVID outbreaks in China may result in delays in manufacturing of our products due to closure of factories and delays in shipping products to the U.S., which could impact our sale forecasts and inventory levels. Any of these events could result in delayed deliveries by us of our products, causing reduced sales and harm to our reputation and brand name.

Increases in the cost of materials or labor used to manufacture our products could decrease our profitability and therefore negatively impact our business and financial condition.

Because our products are manufactured by third-party suppliers, we do not directly purchase the materials used in the manufacture of our products. However, the prices paid by us to these suppliers could increase if raw materials, labor, or other costs increase. If we cannot pass these increases along to our customers, our profitability will be adversely affected.

Increased tariffs, additional tariffs or other import or export taxes on our products could have an adverse impact on the cost of our products, the demand for our products and our business, financial condition and results of operations.

The United States and other countries have levied tariffs and taxes on certain goods, including products imported into the United States from China. The majority of our products are manufactured outside the United States, mainly in China, and imported for sale in the United States. Tariffs enacted in 2019 impacted our 2019 and 2020 results and caused market disruption amongst our major customers in 2019. In addition, while exclusions from tariffs were granted for certain of our products in 2019 and 2020, these exclusions have now expired, and while we have applied for further exclusions, there are no assurances they will be granted.

While we have taken actions to mitigate the impact of these tariffs and are exploring alternative sources of supply outside of China, if existing tariffs are increased or if additional tariffs or trade restrictions are implemented by the United States, China or other countries, the cost of our products manufactured in China or other countries and imported into the United States would increase substantially, which would force us to increase the prices of the affected products.

There is no assurance that we would be successful in mitigating the impact of increased or additional tariffs, and any increase in pricing to allow us to maintain reasonable margins could adversely affect the demand for those products and may result in decreased profitability and lower sales, thereby having an adverse effect on our business, results of operations and financial condition.

11

Earthquakes, floods, fire, epidemics or other catastrophic events out of our control may damage or impact the operations of our primary distribution facility and harm our results of operations.

Our main leased warehouse and distribution center is located in Riverside, California, near major earthquake faults. A catastrophic event, such as an earthquake, flood, fire, or other natural or manmade disaster, could impact operations at this facility. In addition, operations at our distribution facility could be disrupted or required to close if there are any employees who are diagnosed with the coronavirus or there is a governmentally-imposed quarantine or other geographic limitations imposed on companies doing business in California. Any of these events could impair distribution of our products, damage inventory, interrupt critical functions, or otherwise affect our business negatively, harming our results of operations.

We may have exposure to greater than anticipated tax liabilities that, if not identified, could negatively affect our consolidated operating results and net worth.

Our provision for income taxes is subject to volatility and could be adversely affected by nondeductible equity-based compensation, earnings being lower than anticipated in jurisdictions where we have lower statutory rates and being higher than anticipated in jurisdictions where we have higher statutory rates, transfer pricing adjustments, not meeting the terms and conditions of tax holidays or incentives, changes in the valuation of our deferred tax assets and liabilities, changes in actual results versus our estimates, or changes in tax laws, regulations, accounting principles or interpretations thereof, and taxes relating to deemed dividends resulting from foreign guarantees made by certain of our foreign subsidiaries. For example, in fiscal 2021 we recorded a $1,512 valuation allowance against US deferred tax assets that may not be utilized. In making such determination, we considered all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. In addition, like other companies, we may be subject to examination of our income tax returns by the U.S. Internal Revenue Service and other tax authorities. While we regularly assess the likelihood of adverse outcomes from such examinations and the adequacy of our provision for income taxes, there can be no assurance that such provision is sufficient and that a determination by a tax authority will not have an adverse effect on our results of operations.

We could suffer adverse tax and other financial consequences if taxing authorities do not agree with our tax positions, or we are unable to utilize our net operating losses.

We are periodically subject to a number of tax examinations by taxing authorities in the states and countries where we do business. We also have significant deferred tax assets related to our net operating losses (NOLs) in U.S. federal and state taxing jurisdictions. Generally, for U.S. federal and state tax purposes, NOLs can be carried forward and used for up to twenty years, and all of our tax years will remain subject to examination until three years after our NOLs are used or expire.

In addition, U.S. federal, state and local tax laws, are extremely complex and subject to varying interpretations. We recognize tax benefits of uncertain tax positions when we believe the positions are more likely than not of being sustained upon a challenge by the relevant tax authority. In fiscal 2020, we took a tax deduction related to a worthless stock loss in connection with the dissolution of one of our subsidiaries, Born Free Holdings Limited. However, because of the uncertainty as to whether this position may be challenged by the U.S. tax authorities, we have determined this tax benefit to be an uncertain tax position and have fully reserved for the tax benefit associated with the deduction. If there are tax benefits, including, but not limited to, the worthless stock loss deduction or our use of NOLs, or other tax attributes, that are challenged successfully by a taxing authority, we may be required to pay additional taxes or we may seek to enter into settlements with the taxing authorities, which could require significant payments or otherwise have an adverse effect on our business, results of operations and financial condition.

In addition, we may be limited in our ability to utilize our NOLs to offset future taxable income and thereby reduce our otherwise payable income taxes. Our ability to utilize our NOLs is also dependent, in part, upon us having sufficient future earnings to utilize our NOLs before they expire. If market conditions change materially and we determine that we will be unable to generate sufficient taxable income in the future to utilize our NOLs, we could be required to record an additional valuation allowance. Our NOLs are also subject to review and potential disallowance upon audit by the taxing authorities of the jurisdictions where the NOLs were incurred, and future changes in tax laws or interpretations of such tax laws could limit materially our ability to utilize our NOLs. If we are unable to use our NOLs or use of our NOLs is limited, we may have to make significant payments or otherwise record charges or reduce our deferred tax assets, which could have an adverse effect on our business, results of operations and financial condition.

12

A material impairment in the carrying value of other intangible assets could negatively affect our consolidated results of operations and net worth.

A portion of our assets are intangible, which are reviewed on an annual basis and/or whenever events and changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the carrying value of these assets exceeds the current fair value, the asset is considered impaired and is reduced to fair value, resulting in a non-cash charge to earnings during the period in which any impairment is determined. If we make changes in our business strategy, our future operating performance was to fall significantly below forecast levels or if external conditions adversely affect our business operations, we may be required to record an impairment charge for intangibles, which would lead to decreased assets and reduced net operating results and net worth.

Legal and Regulatory Risks

We may be unable to adequately protect our information systems from cyberattacks, which could result in the disclosure of confidential or proprietary information, including personal data, damage our reputation, disrupt our operations and subject us to significant financial and legal exposure.

We rely on information technology systems, including systems managed by third parties, across our operations, including for management of our supply chain, sale and delivery of our products, and various other processes and transactions, including credit card processing for online sales. In the course of our operations, we may collect and use confidential customer data and a variety of personal data. A successful cyberattack could result in the theft or destruction of intellectual property, data, or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations. Cyberattacks are increasing in their frequency, sophistication and intensity, including wrongful conduct by hostile foreign governments, industrial espionage, wire fraud and other forms of cyber fraud, the deployment of harmful malware, denial-of-service and social engineering fraud. Cyberattacks have become increasingly difficult to detect, and a successful cyberattack could cause serious negative consequences for us, including the disruption of operations and the misappropriation of confidential business information or personal data. Although we devote resources to protect our information systems, we realize that cyberattacks are a threat, and there can be no assurance that our efforts will prevent information security breaches that would result in business, legal, financial or reputational harm to us, or would have an adverse effect on our results of operations and financial condition. Any failure to prevent or mitigate security breaches or improper access to, use of, or disclosure of personal data could result in significant liability under state, federal and international laws regarding data privacy, and may cause an adverse impact to our reputation and potentially disrupt our business.

Intellectual property claims relating to our products could increase our costs and adversely affect our business.

We receive, from time to time, claims of alleged infringement of patents relating to certain of our products, and we may face similar claims in the future. The defense of intellectual property claims can be costly and time consuming, even in circumstances where the claim is without merit. We may be required to pay substantial damages or settlement costs in order to resolve these types of claims. In addition, these claims could materially harm our brand name, reputation and operations.

As a manufacturer of consumer products, we are subject to various government regulations and may be subject to additional regulations in the future, violation of which could subject us to sanctions or otherwise harm our business. In addition, we could be the subject of future product liability suits, product recalls, and other claims relating to the use of our products, which could harm our business.

Because we produce infant and juvenile health, safety and wellness consumer products, we are subject to significant government regulation and face product liability risks relating to consumer use of our products. We must comply with a variety of state and federal product safety and product testing regulations. In particular, our products are subject to the Consumer Product Safety Act, the Federal Hazardous Substances Act (“FHSA”) and the Consumer Product Safety Improvement Act (“CPSIA”), which empower the Consumer Product Safety Commission (the “CPSC”), to take action against hazards presented by consumer products. With expanded authority under the CPSIA, the CPSC has and continues to adopt new regulations for safety and products testing that apply to our products. These regulations have or likely will significantly increase the regulatory requirements governing the manufacture and sale of children’s products and increase the potential penalties for noncompliance with applicable regulations. The CPSC has the authority to exclude from the market and recall certain consumer products that are found to be potentially hazardous. Consumer product safety laws also exist in some states and cities within the United States and in Canada and Europe, as well as certain other countries. If we fail to comply with these laws and regulations, or if we face product liability claims, we may be subject to damage awards or settlement costs that exceed any available insurance coverage, and we may incur significant costs in complying with recall requirements.

13

We maintain a quality control program to help ensure compliance with applicable product safety requirements. Nonetheless, we have experienced, and may in the future experience, issues in products that may lead to product liability, personal injury or property damage claims, recalls, withdrawals, replacements of products, or regulatory actions by governmental authorities. A product recall could have an adverse effect on our results of operations and financial condition, depending on the product affected by the recall and the extent of the recall efforts required. A product recall could also negatively affect our reputation and the sales of other products. Furthermore, concerns about potential liability may lead us to voluntarily recall selected products. Complying with existing or new regulations or requirements could impose increased costs on our business operations, decrease sales, increase legal fees and other costs, and put us at a competitive disadvantage compared to other manufacturers not affected by similar issues with products, any of which could have an adverse effect on our financial condition. Similarly, increased penalties for non-compliance could subject us to greater expense if our products were found to not comply with such regulations.

In addition to product liability risks relating to the use by consumers of our products, we also must comply with a variety of state and federal laws and regulations which prohibit unfair or deceptive trade practices, including dissemination of false or misleading advertising. While we take steps that we believe are necessary to comply with these laws and regulations, there can be no assurance that we will always be in compliance. Compliance with these various laws and regulations could impose significant costs on our business if we fail to comply and could result in monetary liabilities and other penalties and lead to significant negative media attention and consumer dissatisfaction, which could have an adverse effect on our business, financial condition and results of operations.

Risks Related to an Investment in Our Securities

Our stock price has been and may continue to be volatile.

The market price of our common stock has been, and is likely to continue to be, volatile. When we or our competitors announce new products, experience quarterly fluctuations in operating results, announce strategic relationships, acquisitions or dispositions, change earnings estimates, publish financial results or other material news, our stock price is often affected. The volatility of our stock price may be accentuated during periods of low volume trading, which may require a stockholder wishing to sell a large number of shares to do so in increments over time to mitigate any adverse impact of the sales on the market price of our stock.

Our largest stockholder controls a significant percentage of our common stock, and its interests may conflict with those of our other stockholders.

Wynnefield Capital, through its affiliates, beneficially owns approximately 35% of our outstanding common stock. In addition, a member of the Company’s Board of Directors is an employee of Wynnefield Capital, and in January 2022 the Company entered into a loan and security agreement with Wynnefield Capital. As a result, Wynnefield can exercise significant influence over the Company and over matters requiring stockholder approval, including the election of directors, changes to our organizational documents and significant corporate transactions. This concentration of ownership and relationship with Wynnefield makes it more difficult for any other holder or group of holders of our common stock to be able to affect the way we are managed or the direction of our business. The interests of Wynnefield Capital with respect to matters potentially or actually involving or affecting us, such as acquisitions, financings and other corporate opportunities, and attempts to acquire us, may conflict with the interests of our other stockholders. Wynnefield Capital has also entered into a voting agreement with Parent pursuant to which they agreed to vote their beneficially owned shares of common stock in favor of the Merger.

We may be unable to maintain compliance with the continued listing requirements of the Nasdaq Capital Market which could cause our common stock to be delisted and result in the lack of a market for our common stock, cause a decrease in the value of our common stock, and adversely affect our business, financial condition and results of operations.

We may be unable to meet the continued listing requirements of the Nasdaq Capital Market for the listing of our common stock, notably, the stockholders’ equity minimum requirement. If we fail to meet the Nasdaq Capital Market’s continued listing requirements, our common stock could be delisted. If our common stock is delisted, we expect prices for our common stock to be quoted on one of the OTC Markets or the OTC Bulletin Board. Under such circumstances, our stockholders may find it more difficult to sell, or to obtain accurate quotations, for our common stock, and our common stock would become substantially less attractive to certain purchasers such as financial institutions, hedge funds and other similar investors. There is no assurance, however, that prices for our common stock would be quoted on one of these other trading systems or that an active trading market for our common stock would thereafter exist, which would materially and adversely impact the market value of our common stock and our stockholders’ ability to sell our common stock.

14

Anti-takeover provisions in our organizational documents and Delaware law may limit the ability of our stockholders to control our policies and effect a change of control of our Company and may prevent attempts by our stockholders to replace or remove our current management, which may not be in your best interests.

There are provisions in our certificate of incorporation and bylaws that may discourage a third party from making a proposal to acquire us, even if some of our stockholders might consider the proposal to be in their best interests and may prevent attempts by our stockholders to replace or remove our current management. These provisions in our certificate of incorporation include authorization for our Board of Directors to issue shares of preferred stock without stockholder approval and to establish the preferences and rights of any preferred stock issued, and to issue one or more classes or series of preferred stock that could discourage or delay a tender offer or change in control. Our bylaws require advance written notice of stockholder proposals and director nominations.

Additionally, we are subject to Section 203 of the Delaware General Corporation Law, which, in general, imposes restrictions upon acquirers of 15% or more of our stock. Finally, the Board of Directors may in the future adopt other protective measures, such as a stockholder rights plan, which could delay, deter or prevent a change of control.

Risks Related to the Proposed Merger with Kids2. Inc.

The Company will be subject to business uncertainties and contractual restrictions while the Proposed Merger is pending.

Uncertainty about the effect of the Merger on employees and third parties (including customers and suppliers) may have an adverse effect on the business, financial condition and results of operations of the Company. These uncertainties may impair the Company’s ability to retain and motivate key personnel pending the consummation of the Proposed Merger, as such personnel may experience uncertainty about their future roles and relationships following the consummation of the Proposed Merger. Additionally, these uncertainties could cause customers, suppliers, vendors and others who deal with the Company to seek to change existing business relationships with the Company or fail to extend or maintain existing relationships with the Company.

The pursuit of the Proposed Merger and the preparation for the integration of the Company’s business with Parent’s business may place a burden on the Company’s management and internal resources. Any significant diversion of management attention away from ongoing business concerns and any difficulties encountered in the transition and integration process could have an adverse effect on the Company’s business, financial condition and results of operations. In addition, the Merger Agreement restricts the Company from taking certain actions without Parent’s consent while the Proposed Merger is pending. These restrictions could have an adverse effect on the Company’s business, financial condition and results of operations.

The Proposed Merger is subject to conditions to closing that may not be satisfied or waived, including that Parent may not obtain the necessary debt financing set forth in the commitment letters received by Parent in connection with the Merger.

The respective obligations of the Company and Parent to complete the Proposed Merger are subject to a number of conditions that must be fulfilled in order to complete the Proposed Merger, including (i) the approval of the Company’s stockholders, (ii) the absence of any governmental order preventing or prohibiting consummation of the Merger or any other transactions contemplated in the Merger Agreement, (iii) the accuracy of the representations and warranties of the parties at closing, and (iv) the concurrent closing of a debt financing by Parent to fund the merger consideration. If these conditions are not satisfied or waived, the Merger may not be completed. Parent has entered into debt commitment letters providing for (i) an asset-based credit facility and (ii) a term loan, a portion of the proceeds of which will fund Parent’s obligation to pay the merger consideration at the closing of the Merger. The obligations of the lenders under the debt commitment letters are subject to a number of conditions, including the receipt of executed loan documentation, accuracy of certain specified representations and warranties, and certain pro forma financial conditions. If these conditions are not satisfied or waived, the lenders will not be obligated to satisfy their commitment. While Parent is obligated pursuant to the Merger Agreement to use commercially reasonable efforts to obtain alternative financing if the current commitments are terminated or not available, there is no assurance that Parent would be able to secure alternative financing.

15

Failure of the Proposed Merger to be completed, the termination of the Merger Agreement or a significant delay in the consummation of the Proposed Merger could negatively impact the Company.

The merger agreement is subject to a number of conditions which must be fulfilled in order to complete the Proposed Merger. These conditions to the consummation of the Proposed Merger may not be fulfilled and, accordingly, the Proposed Merger may not be completed. In addition, if the merger is not completed by June 30, 2022, either the Company or Parent may choose to terminate the Merger Agreement if the failure to consummate the transactions contemplated by the Merger Agreement by such date is not caused by any breach of the Merger Agreement by the party electing to terminate the Merger Agreement, before or after approval of the Proposed Merger by the Company’s stockholders.

If the Proposed Merger is not consummated, the ongoing business, financial condition and results of operations of the Company may be adversely affected and the market price of the Company’s common stock may decline significantly, particularly to the extent that the market price reflects a market assumption that the Proposed Merger will be consummated. If the consummation of the Proposed Merger is delayed for any reason, including by the receipt of a competing acquisition proposal, the business, financial condition and results of operations of the Company’s may be adversely affected.

In addition, the Company has incurred and will incur substantial expenses in connection with the negotiation and completion of the Proposed Merger, as well as the costs and expenses of filing, printing and mailing a proxy statement. Any of the foregoing, or other risks arising in connection with the failure of or delay in consummating the Proposed Merger, including the diversion of management attention from pursuing other opportunities and the constraints in the Merger Agreement on the ability to make significant changes to the Company’s ongoing business during the pendency of the Proposed Merger, could have an adverse effect on the Company’s business, financial condition and results of operations.

The Merger Agreement may be terminated under various circumstances, and the Company has and will continue to incur fees and expenses in connection with such termination.

The Merger Agreement may be terminated under various circumstances by either the Company or Parent if the failure to consummate the transactions contemplated by the Merger Agreement is not caused by any breach of the Merger Agreement by the party electing to terminate the Merger Agreement. For example, the Merger Agreement may be terminated if the Merger is not completed by June 30, 2022, or in connection with a change in the Company Board Recommendation in the event the Board determines that the Company has received an acquisition proposal from a third party which the Board determines constitutes a Superior Proposal, as defined in the Merger Agreement. If the Board makes a change in the Company Board Recommendation, the Company will be required to pay Parent a termination fee of approximately $2.3 million.

The Merger Agreement contains provisions that may discourage other parties from pursuing, announcing or submitting an acquisition proposal to the Company that might result in greater value to Company stockholders.

The Merger Agreement contains provisions that may discourage a third party from pursuing, announcing or submitting a competing acquisition proposal to the Company that might result in greater value to Company stockholders than the Proposed Merger. These provisions include a general prohibition on the Company from soliciting or entering into discussions with any third party regarding any acquisition proposal or offers for competing transactions, subject to limited exceptions.

In connection with entering into the Merger Agreement, Company stockholders holding shares of common stock constituting approximately 53% of the Company’s issued and outstanding common stock have entered into voting agreements with Parent pursuant to which they agreed to vote their beneficially owned shares of common stock in favor of the Merger. The vote of such shares in favor of the Merger would be sufficient to approve the Merger Agreement by the Company’s stockholders under the provisions of Delaware law and the Company’s Certificate of Incorporation.

16

Litigation against the Company or the members of the Company’s board of directors could result in significant costs, management distraction, and/or a delay of or injunction against the Proposed Merger.

Many proposed merger transactions are the subject of shareholder litigation. While the Company believes that any claims that may be asserted by purported shareholder plaintiffs related to the Proposed Merger would be without merit, the results of any such potential legal proceedings are difficult to predict and could delay or prevent the Proposed Merger from being competed in a timely manner. The existence of litigation related to the Proposed Merger could affect the likelihood of obtaining the required approval from Company stockholders. Moreover, any litigation could be time consuming and expensive, could divert management’s attention away from their regular business and, any lawsuit adversely resolved against the Company or members of the Company’s board of directors, could have an adverse effect on the Company’s business, financial condition and results of operations.

If the actions remain unresolved, they could prevent or delay the completion of the Proposed Merger. One of the conditions to the consummation of the Proposed Merger is the absence of any law or order (whether temporary, preliminary or permanent) by any court or regulatory authority of competent jurisdiction prohibiting, restricting or making illegal consummation of the transactions contemplated by the Merger Agreement (including the Proposed Merger). Consequently, if a settlement or other resolution is not reached in any lawsuit that is filed or any regulatory proceeding and a claimant secures injunctive or other relief or a regulatory authority issues an order or other directive prohibiting, restricting or making illegal consummation of the transactions contemplated by the Merger Agreement (including the Proposed Merger), then such injunctive or other relief may prevent the Proposed Merger from becoming effective in a timely manner or at all.

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

We are headquartered in a 20,200 square foot facility in Woonsocket, Rhode Island. We have a lease on this facility, which will expire in 2025. We also lease small offices in Canada, the United Kingdom and Hong Kong.

We maintain inventory at our main leased warehouse and distribution center in California (approximately 460,000 square feet) as well as in Canada (approximately 61,000 square feet). These leases expire at various times through 2026.

Item 3. Legal Proceedings

The Company is a party to routine litigation and administrative complaints incidental to its business. The Company does not believe that the resolution of any or all of such current routine litigation and administrative complaints is likely to have a material adverse effect on the Company’s financial condition or results of operations.

Item 4. Mine Safety Disclosures

Not applicable.

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock is traded on the Nasdaq Capital Market under the symbol “SUMR”.

Holders of Common Stock

As of March 11, 2022, there were approximately 34 holders of record of our common stock. Because shares of our common stock are held by depositaries, brokers and other nominees, the number of beneficial holders of our shares is substantially larger than the number of record holders.

17

Issuer Repurchases of Equity Securities

None.

Recent Sales of Unregistered Securities

Not applicable.

Item 6. [RESERVED]

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion is intended to assist in the assessment of significant changes and trends related to our results of operations and financial condition. The information contained in this section has been derived from our consolidated financial statements and should be read together with our consolidated financial statements and related notes included elsewhere in this report. Readers should also review and consider our disclosures under the heading “Special Note Regarding Forward-Looking Statements” describing various factors that could affect our business and the disclosures under the heading “Risk Factors” in this report.

Note that all dollar amounts in this Item 7 are in thousands of U.S. dollars, except share and per share data.

Overview

We are an infant and juvenile products company doing business under the name SUMR Brands. We are a recognized authority in the juvenile product industry, providing parents and caregivers a full range of innovative, high-quality, and high-value products to care for babies and toddlers. We seek to improve the quality of life of parents, caregivers, and babies through our product offerings, while at the same time maximizing shareholder value over the long term.

We operate in one principal industry segment across geographically diverse marketplaces, selling our products globally to large, national retailers as well as independent retailers, on our partner’s websites, and our own direct to consumer website. In North America, our customers include Amazon.com, Wal-Mart, Target, Buy Baby, Home Depot, and Lowe’s. Our largest European-based customer is Smyths Toys. We also sell through international distributors, representatives, and to select international retail customers in geographic locations where we do not have a direct sales presence.

Leveraging our strength in product development, global sourcing and sales to national retailers, independent retailers, distributors and ecommerce (pureplay and omni-channel), we are launching a new brand into the pet space, Ozzie & Kazoo(TM), in 2022. Our focus is on creating products that complement our juvenile development and sourcing strategy, as well as a well-rounded product offering to highlight our brand in this new category, such as gates, pet beds and other pet supplies. Initial products are anticipated to launch during the second quarter of 2022. In 2021, we began selling certain of our current products, primarily gates, under the brand name “Summer” in pet channels, including Chewy, Inc., though sales in 2021 were not material. We believe our entry into the pet products is an opportunity for incremental growth.

Net sales in the fourth quarter of 2021 decreased by 2.0% from the previous year quarter, and net sales for the full year decreased 7.5% from the prior year. Net sales for the fourth quarter and the full year in 2021 declined primarily as a result of limited inventory availability due to global supply chain challenges including increased transit times to receive our product into our warehouse from Asia due to limited availability of containers and port congestion, that resulted in our making significant sales order cuts to our customers as we were not able to satisfy demand.

In the fourth quarter, net loss was $4,764 in 2021 compared to a net loss of $3,389 in the fourth quarter of 2020. The loss in 2021 was primarily a result of elevated container rates and associated transportation and logistical expenses that impacted our cost of goods sold. For example, in order to meet demand, we arranged air freight shipments for high priority items because of the increased transit times on water from Asia, and we incurred significant demurrage charges due to the shortage of truckers and overall congestion at ports. The net loss in 2021 also included a $1,512 valuation allowance against US deferred tax assets recorded in the fourth quarter. The net loss in fiscal 2020 was primarily a result of a $1,800 loss on the early extinguishment of debt and a $676 write-off of intangible assets related to the Company’s decision to dissolve its Born Free Holdings entity. For the full year 2021, net loss was $2,898 compared to a net loss of $1,102 in 2020 driven largely by the same factors that impacted fourth quarter 2021 results.

18

General and administrative expenses declined by $698 in the full year, primarily attributable to a reduction in salaries and other employee related compensation as a result of restructuring initiatives implemented in 2020 partially offset by an increase in customer chargebacks related to significant order cuts due to supply chain challenges. We ended fiscal 2021 with a net loss of $1.35 per share compared to a net loss of $0.52 per share in fiscal 2020.

In the fourth quarter of 2020, we announced the completion of a debt refinancing with Bank of America, which reduced interest expense by $154 in the fourth quarter of 2021 and $2,692 for the full year 2021 as compared to prior year periods.

As further described below, subsequent to year end 2021, we entered into a second-lien, subordinated term loan in the amount up to $5,000, with requests for the funding of tranches limited to every 30 days. At the time of a funding request, availability (as defined in our existing loan agreement with Bank of America) must be either (i) equal to or less than $6,000 in the 30 days immediately preceding the request date or (ii) on the date of the request and on the date of borrowing, equal to or less than $3,000. We requested and received an initial funding of $2,000 at closing of the new loan. This term loan will give us additional flexibility to manage current supply chain challenges including elevated container rates, increased demurrage charges as well as carrying higher than normal inventory on the water due to extended transit times due to port congestion.

Proposed Merger with Kids2, Inc.

On March 16, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Kids2, Inc., a Georgia corporation (“Parent”), and Project Abacus Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides, subject to its terms and conditions, for the acquisition of the Company by Parent through the merger of Merger Sub with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Parent (the “Proposed Merger”).

Under the terms of the Proposed Merger, each share of common stock of the Company issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (other than shares of common stock (i) owned by Parent, Merger Sub, the Company or any subsidiary of Parent, Merger Sub or Company, or (ii) held by a stockholder who is entitled to, and who has perfected, appraisal rights for such shares under Delaware law) automatically will be converted into the right to receive cash in an amount of $12.00 per share (the “Merger Consideration”), without interest, subject to any required withholding of taxes.

The completion of the Proposed Merger is subject to closing conditions, including: (i) the approval of the Merger Agreement by the Company’s stockholders; (ii) the absence of any laws or court orders making the Proposed Merger illegal or otherwise prohibiting the Proposed Merger; (iii) other customary closing conditions, including the accuracy of the representations and warranties of each party (subject to certain materiality exceptions) and material compliance by each party with its covenants under the Merger Agreement; and (iv) the closing of a debt financing by Parent to fund the Merger Consideration. The parties expect the transaction to close in the second quarter of 2022, subject to the satisfaction or waiver of the closing conditions. For a detailed description of the Merger Agreement and the Proposed Merger, please see Item 1.01 of the Current Report on Form 8-K that will be filed with the Securities and Exchange Commission (“SEC”) on or about March 16, 2022, and a copy of the Merger Agreement filed as Exhibit 2.1 therewith.

COVID-19 Impact and Ongoing Supply Chain Challenges

As previously disclosed, the COVID-19 pandemic impacted our business in fiscal 2020 and 2021. Early in the pandemic in 2020, we began to see customers that have retail stores reduce orders as they experienced or anticipated closures of those stores. While we did see an uptick in sales to those customers with significant e-commerce capabilities, it did not offset the reduced orders from our mid-size and smaller customers. We believe that customers with e-commerce capabilities will continue to have increased demand. However, given the unpredictability of the COVID-19 pandemic, it is possible that some stores will remain closed or will have to close should there be a resurgence of COVID-19 outbreaks or that these customers will close or reduce the number of stores that they operate in response to the COVID-19 pandemic. In addition, our suppliers that are located in China and elsewhere may be subject to closure should there be a resurgence of COVID-19 outbreaks in those locations.

The COVID-19 pandemic continued to impact our business in 2021, as we experienced challenges in our shipping and distribution channels throughout our global supply chain. As noted above, in order to meet demand, we incurred increased costs to air freight certain products to meet demands of some of our key retail partners and saw elevated container rates, increased demurrage charges and other associated transportation and logistical costs that materially impacted our gross profit and our margins in the fourth quarter and the full year.

19

We have been successful and are continuing to implement price increases with customers to mitigate some of these cost challenges. We also have been successful and continue to work to shift sales to direct import, which enables product to be delivered more quickly and profitably to our customers. Direct import sales increased 64.6% in fiscal 2021 as compared to fiscal 2020, with direct import sales representing approximately 20.2% of total sales in fiscal 2021.

If and to the extent these supply chain challenges continue, we may not be able to meet demand. We also expect costs associated with these matters to remain elevated, as well as costs associated with our main leased warehouse and distribution center, with new lease terms that became effective in the fourth quarter of 2021 that will increase our lease costs. To the extent we do not meet our financial projections or are unable to mitigate the impact of these challenges, our business, financial position, results of operations and cash flows would be adversely affected.

We will continue to assess the impact of the COVID-19 pandemic on the supply chain, consumer demand and overall business operations throughout 2022. We believe COVID-19 in the United States and in other countries has added greater uncertainty and unpredictable economic consequences in the coming months, and therefore we cannot currently predict how it will impact our business in the long term.

Summary of Critical Accounting Policies and Estimates

The following summary of our critical accounting policies is presented to assist in understanding our consolidated financial statements. The consolidated financial statements and notes are representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the consolidated financial statements. Additional information about our accounting policies and estimates may be found in Note 1 to our consolidated financial statements included in this report.

We make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses. The accounting policies described below are those we consider critical in preparing our financial statements. Some of these policies include significant estimates made by management using information available at the time the estimates were made. However, these estimates could change materially if different information or assumptions were used.

Revenue Recognition

We recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what we expect to receive in exchange for the goods or services. Our principal activity from which we generate revenue is product sales. Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation in a contract by transferring control over a product to a customer when product delivery occurs. A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for the Company is a transfer of its products to its customers. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation.

A transaction price is the amount of consideration the Company expects to receive under the arrangement. The Company is required to estimate variable consideration (if any) and to factor that estimation into the determination of the transaction price. The Company conducts its business with customers through valid purchase or sales orders each of which is considered a separate contract because individual orders are not interdependent on one another. Product transaction prices on a purchase or sale order are discrete and stand-alone. Purchase or sales orders may be issued under either a customer master service agreement or a reseller allowance agreement. Purchase or sales orders, master service agreements, and reseller allowance agreements which are specific and unique to each customer, may include product price discounts, markdown allowances, return allowances, and/or volume rebates which reduce the consideration due from customers. Variable consideration is estimated using the most likely amount method, which is based on our historical experience as well as current information such as sales forecasts.

Contracts may also include cooperative advertising arrangements where the Company allows a discount from invoiced product amounts in exchange for customer purchased advertising that features the Company’s products. These allowances are generally based upon product purchases or specific advertising campaigns. Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct benefit and fair value and are accounted for as direct selling expenses.

20

Trade Receivables

Trade receivables are carried at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The allowance for doubtful accounts represents adjustments to customer trade accounts receivable for amounts deemed uncollectible. The allowance for doubtful accounts reduces gross trade receivables to their estimated net realizable value. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based upon historical experience and management’s evaluation of outstanding accounts receivable.

Inventory Valuation

Inventory is comprised of finished goods and is stated at the lower of cost, inclusive of freight and duty using the first-in, first-out (FIFO) method or net realizable value. Our warehousing costs are charged to expense as incurred. We regularly review slow-moving and excess inventory and write-down inventories as appropriate. Management uses estimates to record write-downs based on its review of inventory by product category including length of time on hand and estimates of future orders for each product. Changes in consumer preferences, as well as demand for products, customer buying patterns and inventory management could impact the inventory valuation.

Long-Lived Assets with Finite Lives

We review long-lived assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered to be impaired when its carrying amount exceeds both the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition and the asset’s fair value. Long-lived assets include property and equipment and finite-lived intangible assets. The amount of impairment loss, if any, is charged by us to current operations.

Indefinite-Lived Intangible Assets

We account for indefinite-lived intangible assets in accordance with accounting guidance that requires indefinite-lived intangible assets be tested annually for impairment and more frequently if events or changes in circumstances indicate that the asset might be impaired. Our annual impairment testing is conducted in the fourth quarter of every year.

We test indefinite-lived intangible assets for impairment by comparing the asset’s fair value to its carrying amount. If the fair value is less than the carrying amount, the excess of the carrying amount over fair value is recognized as an impairment charge and the adjusted carrying amount becomes the asset’s new accounting basis.

Management also evaluates the remaining useful life of an intangible asset that is not being amortized each reporting period to determine whether events and circumstances continue to support an indefinite useful life. If an intangible asset that is not being amortized is subsequently determined to have a finite useful life, it is amortized prospectively over its estimated remaining useful life.

Income Taxes

Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carry forwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence, it is more likely than not that such benefit will be realized. In making such a determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations.

We recognize interest and penalties, if any, related to uncertain tax positions in interest expense. On a global basis, the open tax years subject to examination by major taxing jurisdictions in which we operate is between 2014 and 2021.

21

Results of Operations

The following table presents selected consolidated financial information for our Company for the fiscal years ended January 1, 2022 (“fiscal 2021”) and January 2, 2021 (“fiscal 2020”).

	Year ended				Year Ended
	January 1, 2022				January 2, 2021
Net sales	$	143,665	100.0	%	$	155,299	100.0	%
Cost of goods sold		104,286	72.6	%		104,448	67.3	%
Gross profit		39,379	27.4	%		50,851	32.7	%
General and administrative expenses		28,662	20.0	%		29,360	18.9	%
Selling expenses		10,785	7.5	%		12,574	8.1	%
Depreciation and amortization		2,239	1.6	%		3,348	2.2	%
Impairment of intangible asset		—	0.0	%		676	0.4	%
(Loss) income from operations		(2,307)	(1.6)	%		4,893	3.1	%
Interest expense, net		1,386	1.0	%		4,078	2.6	%
(Gain) loss from extinguishment of debt		(1,972)	(1.4)	%		1,800	1.2	%
Loss before provision for income taxes		(1,721)	(1.1)	%		(985)	(0.7)	%
Provision for income taxes		1,177	(0.1)	%		117	(0.1)	%
Net loss	$	(2,898)	(2.0)	%	$	(1,102)	(0.8)	%

Fiscal 2021 Compared with Fiscal 2020

Net sales decreased 7.5% to $143,665 for fiscal 2021 from $155,299 for fiscal 2020 due primarily to limited inventory availability, a direct impact of supply chain disruption due to on-going effects of COVID-19, including securing containers in Asia and increased transit time to receive goods into our warehouses. For fiscal 2021, sales to our top customers were significantly impacted because of these inventory challenges, and we were not able to fully meet our customer and consumer demand. We continue to be successful in shifting business to direct import, which suppresses top line results, but is more profitable in the current environment, to mitigate current supply chain issues. While direct import sales increased in fiscal 2021 as compared to fiscal 2020, the increase did not offset the loss of sales due to limited inventory availability.

Cost of goods sold includes the cost of the finished product from suppliers, duties and tariffs on certain imported items, freight-in from suppliers, and miscellaneous charges. The components of cost of goods sold remained substantially the same for fiscal 2021 as compared to fiscal 2020. In fiscal 2021, we experienced a significant increase in container and other supply chain costs as compared to fiscal 2020, which resulted in cost of goods staying elevated despite lower sales, impacting our gross profit.

Gross profit decreased 22.6% to $39,379 for fiscal 2021 from $50,851 for fiscal 2020. Gross margin decreased in fiscal 2021 to 27.4% from fiscal 2020 at 32.7%. Gross profit dollars decreased primarily due to lower sales and elevated freight costs reflected in cost of goods sold. Additionally, we utilized air freight to keep inventory in stock for high priority, in-demand products, which also suppressed our gross margin in the fourth quarter and impacted full year results. Gross profit in 2020 included a $2,483 benefit from tariff exclusions on certain gate, bath, and bedrail products that became effective between December 2019 and May 2020. Tariff exclusions received since December 2019 expired in August 2020.

General and administrative expenses declined 2.4% to $28,662 for fiscal 2021 compared to $29,360 for fiscal 2020 but increased as a percent of sales to 20.0% for fiscal 2021 from 18.9% for fiscal 2020. The increase as a percent of sales was attributable to lower net sales. While the Company continues to benefit from the full year run-rate of its restructuring initiatives implemented in the first quarter of 2020, the savings did not significantly offset the lower net sales and we did experience increased expenses for labor at our main leased warehouse and distribution center.

Selling expenses decreased by 14.2% to $10,785 for fiscal 2021 from $12,574 for fiscal 2020 and improved as a percent of sales to 7.5% for fiscal 2021 from 8.1% for fiscal 2020. The decrease in selling expense dollars was primarily due to lower net sales. Selling expense as a percent of net sales decreased as a result of lower cooperative advertising due to the increase in direct import sales, and the expiration of all royalty expense in the first half of 2021.

22

Depreciation and amortization decreased to $2,239 for fiscal 2021 from $3,348 in fiscal 2020 as many of our tools have fully depreciated. Capital expenditures were substantially the same year over year, decreasing slightly in fiscal 2021 to $1,160 from $1,258 in fiscal 2020. In the fourth quarter of 2020, the Company recorded an asset impairment charge of $676, representing the remaining unamortized balance of the definite-lived asset related to our Born Free Holding Limited (BFH) trademarks. This intangible asset was determined to have a carrying value that was non-recoverable. The determination resulted from the Company’s decision to dissolve the BFH entity which was completed in December 2020. The Company also considered whether other long-lived assets in other asset groups were impaired and concluded that they were not. No other impairment was recorded in fiscal 2020 or fiscal 2021.

Net interest expense decreased 66.0% to $1,386 for fiscal 2021 from $4,078 in fiscal 2020 primarily as a result of lower average debt balances and reduced interest rates due to the amended and restated loan agreement entered into in the fourth quarter of 2020. Additionally, fiscal 2020 included the write-off of $266 of previously unamortized financing fees associated with the reduction in the total revolver commitments under our credit facility in March 2020.

For fiscal 2021, we recorded a $1,177 tax provision on $1,721 of pretax loss for the period. The tax provision for fiscal 2021 was primarily the result of a $1,512 increase in valuation allowance against US deferred tax assets that may not be utilized.

For fiscal 2020, we recorded a $117 tax provision on $985 of pretax loss for the period. The pretax loss included a $1,800 loss from the extinguishment of debt. The tax provision for fiscal 2020 included a $7,435 federal benefit for the worthless stock loss of BFH, as well as a net $236 decrease in valuation allowance for nondeductible interest expense, a $273 decrease in valuation allowance against our state research and development tax credit deferred tax asset, and a $253 valuation allowance against foreign subsidiary net operating loss deferred tax assets, offset by a $7,543 provision for uncertain tax positions The uncertain tax position provision related to the worthless stock loss benefit recorded on the 2020 tax return on the liquidation of a foreign subsidiary. Due to the uncertain nature of worthless stock deductions, we determined the associated tax benefit to be an uncertain tax position and accordingly, we have fully reserved for the tax benefit. This tax position may be subject to audit and future adjustment by the IRS, which could result in a reversal of none, part, or all of the income tax benefit or could result in a benefit higher than the net amount recorded. If the IRS rejects or reduces the amount of the income tax benefit related to the worthless stock loss, we may have to pay additional cash income taxes, which could adversely affect our results of operations, financial condition, and cash flows. We cannot guarantee what the ultimate outcome or amount of the benefit we receive, if any, will be.

Liquidity and Capital Resources

Cash Flows

We fund our operations and working capital needs through cash generated from operations and borrowings under our credit facilities.

In our typical operational cash flow cycle, inventory is purchased in U.S. dollars to meet expected demand plus a safety stock. The majority of our suppliers are based in Asia and such inventory currently takes approximately six to eight weeks to arrive at the various distribution points we maintain in the United States and Canada, an increase from three to four weeks a year ago. Payment terms for these vendors are approximately 30-75 days from the date the product ships from Asia and therefore we are generally paying for the product a short time after it is physically received in the United States, and in some cases before it is physically received into our warehouses. In turn, sales to customers generally have payment terms of 60 days, however, direct import sales with certain customers are paid beyond 60 day terms resulting in an accounts receivable and increasing the amount of cash required to fund working capital. To bridge the gap between paying our suppliers and receiving payment from our customers for goods sold, we rely on our credit facilities.

The majority of our capital expenditures are for tools and molds related primarily to new product introductions. We receive indications from retailers near the middle of each year as to what products they will be taking into their product lines for the upcoming year. Based on these indications, we will then acquire the tools and molds required to build and produce the products. In most cases, the payments for the tools are spread out over a three to four month period.

23

For fiscal 2021, net cash used in operating activities was approximately $8,391 driven primarily by an increase in accounts receivable, an increase in inventory and lower net sales. Inventory includes inventory on the water and as a result of supply chain disruption, inventory time on water was significantly extended resulting in a lack of available inventory in our warehouses. Inventory on the water accounted for approximately 46.5% of our total inventory at fiscal year end 2021, an increase of 76.9% as compared to 2020 fiscal year end. The increase in accounts receivable was due primarily to an increase in direct import sales for which customers take longer to pay than on domestic sales. For fiscal 2020, net cash provided by operating activities was approximately $17,607 generated primarily from operating performance and improved working capital efficiency.

For fiscal 2021, net cash used in investing activities was approximately $1,247. For fiscal 2020, net cash used in investing activities was approximately $1,278.

For fiscal 2021, net cash provided by financing activities was approximately $9,653 driven primarily by working capital needs from increases in accounts receivable and inventory. For fiscal 2020, net cash used in financing activities was approximately $16,644, representing a significant net paydown of funded debt.

Based primarily on the above factors, net cash increased for fiscal 2021 by $25, resulting in a cash balance of approximately $535 at fiscal year end.

The following table summarizes our significant contractual commitments at fiscal 2021 year-end:

			Payment Due by Fiscal Period
									2027 and
Contractual Obligations	Total		2022		2023	2024	2025	2026	beyond
Revolving Facility	$	33,228		—	—	—	33,228	—	—
Term Loan Facility		5,625		1,125	1,500	1,500	1,500	—	—
FILO Loan		1,719		469	625	625	—	—	—
Estimated future interest payments on Revolving Facility		3,234		951	951	951	381	—	—
Estimated future interest payments on Term Loan Facility		427		189	136	87	15	—	—
Estimated future interest payments on FILO Loan Facility		99		54	34	11	—	—	—
Operating leases		16,393		3,592	3,498	3,347	3,284	2,672	—
Total contractual cash obligations	$	60,725		6,380	6,744	6,521	38,408	2,672	—

Estimated future interest payments on our Revolving Facility and Term Loan Facility are based upon the interest rates in effect at January 1, 2022. The above does not reflect obligations under our new subordinated term loan described below that was entered into in late January 2022.

Capital Resources

In addition to operating cash flow, we also rely primarily on our asset-based revolving credit facility and FILO loan with Bank of America, N.A. to meet our financing requirements, which are subject to changes in our inventory and account receivable levels. We regularly evaluate market conditions, our liquidity profile, and various financing alternatives for opportunities to enhance our capital structure, and in January 2022 we entered into a second lien, subordinated term loan in an amount up to $5,000 with Wynnefield Capital, Inc., as agent, as further described below.

Going Concern

The consolidated financial statements included elsewhere in this report have been prepared on a going concern basis, which assumes that we will continue to operate as a going concern and which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

As described below, the Company’s asset-based loan agreement with Bank of America and subordinated term loan agreement with Wynnefield Capital do not expire until October 15, 2025, both agreements have adjusted EBITDA and liquidity covenants. While these covenants provide room for us to conduct our business in the ordinary course, we currently face a challenging supply chain environment that impacts our ability to execute on our operating plan and consequently, we amended our loan agreements on March 16, 2022 to reset our financial covenants to adjust for expected ongoing challenges to our operating plan in the near term.

24

Due to continuing losses, our financial position and the challenging supply chain environment, there is no assurance that we will be able to maintain compliance with our financial covenants under our loan agreements, which would impair our ability to meet our financial obligations as they become due without future amendments to our loan agreements. In addition, the COVID-19 pandemic has significantly increased economic and demand uncertainty across the globe, and while demand for our products has remained steady, if these challenges continue, we may not be able to meet demands of our customers which could result in lost or cancelled orders from our customers and could materially and adversely affect our business, financial condition, and results of operations.

Based on our known cash needs as of March 16, 2022, and the anticipated availability under our loan agreements, we have developed plans to extend our liquidity to support our working capital requirements and our ability to meet our financial obligations. Our plans with regard to these matters include the following: (1) continuing to explore price increases where possible, (2) enhancing certain supply chain processes to obtain lower cost containers for its products and reduce demurrage and detention charges through additional new procedures, (3) reducing warehouse costs through new processes as it relates to pallets, (4) reducing product costs through re-engineering of certain products, (5) reducing discretionary marketing to the extent that it does not impact revenue performance, and (6) considering additional financing and/or strategic alternatives.

However, there can be no assurance that our plans will be achieved and that we will be able to meet our financial obligations without obtaining additional financing or sources of capital. Therefore, in accordance with applicable accounting guidance, and based on the Company’s current financial condition and availability of funds, there is substantial doubt about our ability to continue as a going concern through twelve months from the date these financial statements were issued.

If we are unable to meet our current operating plan, do not adequately control expenses, or adjust our operations accordingly, we may experience constraints on our liquidity and may not meet the financial and other covenants under our loan agreements, which could impact our availability. There is no assurance that we will meet all of our financial or other covenants in the future, or that our lenders will grant waivers or agree to amend the terms of our agreements with them if there are covenant violations. In such case, we may be required to seek to raise additional funds through debt or equity financings, restructure our existing debt, engage in strategic collaborations, and/or a strategic transaction that is in the best interest of our stockholders. Any such financing or strategic transaction could result in significant dilution to our existing stockholders, depending on the terms of the transaction. If we are unable to identify a strategic transaction, raise additional funds, and/or restructure our existing debt, our operations could be limited and we may not be able to meet all of our obligations under our existing loan agreements.

Loan Agreement with BofA

We and our wholly owned subsidiary, Summer Infant (USA), Inc., are parties to a Third Amended and Restated Loan and Security Agreement (as amended the “BofA Loan Agreement”) with Bank of America, N.A., as agent (“BofA”), that provides for (i) a $40,000 asset-based revolving credit facility, with a $5,000 unused letter of credit sub-line facility as of January 1, 2022, (ii) a $7,500 term loan and (iii) a $2,500 FILO (first-in, last-out) loan. The BofA Loan Agreement replaced our prior credit facility with BofA and term loan with Pathlight Capital. As of January 1, 2022, the outstanding revolving credit facility, FILO and term loan balances were $33,228, $1,719 and $5,625, respectively.

On January 28, 2022, we entered into an amendment to the BofA Loan Agreement to permit the new second-lien term loan described below (the “New Term Loan”) and to modify certain covenants to provide us with additional flexibility in light of ongoing supply chain challenges. The amendment, among other things, (1) revised the definition of EBITDA to allow the add-back of costs and expenses associated with the New Term Loan, (2) modified the fixed charge coverage ratio covenant to provide that the ratio shall be at least 1.00 to 1.00 as of the last day of each fiscal month commencing December 31, 2022, (3) reflected temporary increase through April 2, 2022 in (i) the maximum percentage of accounts owing from Amazon that may be included as eligible accounts in the borrowing based from 45% to 55%, and (ii) the maximum portion of the borrowing base that is attributable to eligible in-transit inventory from $7,000 to $11,000, (4) removed references to LIBOR and replaces them with the Bloomberg Short-Term Bank Yield (“BSBY”) Index rate administered by Bloomberg, (5) added a new minimum availability requirement of $3,000 at all times, and (6) added a new minimum EBITDA requirement to be maintained on a rolling monthly basis beginning on April 2, 2022. The description below reflects the terms of the BofA Loan Agreement as amended.

On March 16, 2022, we entered into a second amendment to the BofA Loan Agreement that (i) increased the minimum availability requirement to $3,500, (ii) modified the fixed charge coverage ratio to provide for a ratio of at least 1.00 to 1.00 as of the last day of each fiscal month commencing January 28, 2023, (iii) adjusted the minimum EBITDA covenant thresholds and (iv) permits the Company to addback of costs of legal advisors and independent consultants incurred during the period from January 1, 2022 through July 2, 2022 in an aggregate amount not to exceed $1,000. The lender also waived the requirement that the Company’s audit and certification with respect to its fiscal year 2021 financial statements be without qualification.

25

Pursuant to the BofA Loan Agreement, total borrowing capacity under the revolving credit facility is based on a borrowing base, which is generally defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory (subject to certain limitations) or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of the loans under the revolving credit facility is October 15, 2025 (subject to customary early termination provisions). Loans under the revolving credit facility provided prior to January 28, 2022 bear interest, at our option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability, and loans provided after January 28, 2022 bear interest, at our option, at a base rate or at the Bloomberg Short-Term Bank Yield Index (“BSBY”) rate administered by Bloomberg. Interest payments are due monthly, payable in arrears. We are also required to pay an annual non-use fee on unused amounts under the revolving credit facility, as well as other customary fees as are set forth in the Loan Agreement. As of January 1, 2022, the interest rate on LIBOR based revolver loans and on base rate revolver loans was 2.625% and 4.500%, respectively.

The principal of the term loan is to be repaid, on a quarterly basis, in installments of $375, until paid in full on termination and subject to mandatory repayment in certain circumstances. The scheduled maturity date of the term loan is October 15, 2025, or earlier, if the revolving credit facility is terminated. Prior to January 28, 2022, the term loan bore interest, at our option, at a base rate or at LIBOR, plus applicable margins, and after January 28, 2022 bears interest, at our option, at a base rate or at the BSBY rate. Interest payments on the term loan are due monthly, in arrears. As of January 1, 2022, the interest rate on LIBOR based term loans and on base rate term loans was 3.875% and 5.75%, respectively.

The total borrowing capacity under the FILO loan is the lesser of (i) the then applicable aggregate FILO commitment amount and (ii) a borrowing base, generally defined as a specific percentage of the value of eligible accounts, plus a specified percentage of the value of eligible inventory. The aggregate FILO commitment amount will be proportionately reduced each quarter until the FILO loan is terminated at maturity on October 15, 2024. There can be no voluntary repayment on the FILO loan as long as there are loans outstanding under the revolving credit facility, unless (i) there is an overadvance under the FILO loan, or (ii) such prepayment is accompanied by a permanent dollar for dollar reduction in the aggregate FILO commitment amount such that, after giving effect to such prepayment and reduction, the outstanding principal amount of the FILO loan is equal to but does not exceed the lesser of (A) the aggregate FILO commitment amount and (B) the FILO borrowing base. Prior to January 28. 2022, the FILO loan bore interest, at our option, at a base rate or at LIBOR, plus applicable margins, and after January 28, 2022 bear interest, at our option, at a base rate or at the BSBY rate. Interest payments on the FILO loan are due monthly, in arrears. As of January 1, 2022, the interest rate on LIBOR based FILO loans and on base rate FILO loans was 3.625% and 5.50%, respectively.

All obligations under the BofA Loan Agreement are secured by substantially all the assets of the Company, and our subsidiaries, Summer Infant Canada Limited and Summer Infant Europe Limited, are guarantors under the BofA Loan Agreement. The BofA Loan Agreement contains customary affirmative and negative covenants. Among other restrictions, we are restricted in our ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. Under the terms of the BofA Loan Agreement prior to the 2022 amendments, until the term loan and FILO loan have been repaid in full, we were required to maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.00 to 1.00 for the twelve-month period then ended and after the term loan and FILO loan have been repaid in full, we will be required to maintain the fixed charge coverage ratio if availability falls below $5,000. Under the March 2022 amendment, we will be required to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the last day of each month commencing January 28, 2023. As of January 1, 2022, we complied with the fixed charge coverage ratio covenant.

Under the terms of the BofA Loan Agreement as amended in January and March 2022, until the term loan and FILO loan have been repaid in full, we are required to have (i) availability under the BofA Loan Agreement of $3,500 at all times and (ii) to meet a specified minimum EBITDA requirement on a rolling monthly basis beginning on April 2, 2022.

The BofA Loan Agreement also contains customary events of default, including if the Company fails to comply with any required financial covenants and upon the occurrence of a change of control without consent of the lender. In the event of a default, all of the obligations under the BofA Loan Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations become due and payable.

For additional information on the BofA Loan Agreement, please see Note 5 and Note 13 to our consolidated financial statements included in this Annual Report on Form 10-K.

26

Second-Lien, Subordinated Term Loan

On January 28, 2022, we and our subsidiary, Summer Infant (USA), Inc., as borrowers, entered into a Loan and Security Agreement with certain financial institutions as lenders, and Wynnefield Capital, Inc., as agent for the lenders, which was amended on March 16, 2022 (as amended, the “New Term Loan Agreement”). The lenders, Wynnefield Partners Small Cap Value, L.P. and Wynnefield Partners Small Cap Value, L.P. I, are existing stockholders of the Company and, together with affiliates, beneficially own approximately 35% of our outstanding common stock, and an employee of Wynnefield Capital, Inc., Stephen Zelkowicz, serves on the Company’s Board of Directors (the “Board”). Because the New Term Loan Agreement is a related party transaction, it was reviewed and approved by the Audit Committee of our Board.

The New Term Loan Agreement provides for a second lien, subordinated term loan in an amount up to $5,000, with requests for the funding of tranches limited to every 30 days (the “New Term Loan”). At the time of a funding request, availability (as defined in the BofA Loan Agreement) must be either (i) equal or less than $6,000 in the 30 days immediately preceding the request date or (ii) on the date of request and on the date of borrowing, equal or less than $3,000. The initial funding tranche may be in an amount of up to $2,000, and subsequent tranches may not exceed $1,000.

Borrowings under the New Term Loan Agreement bear interest at a rate of 5.0% per annum until January 27, 2024, and thereafter at a rate of 9.0% per annum, payable in arrears on a quarterly basis. The principal amount of any borrowing will be repaid quarterly in installments equal to 2.5% of the highest amount of borrowings outstanding under the New Term Loan Agreement during the applicable quarter, commencing on July 1, 2022 and continuing until the maturity date of April 19, 2026. In addition, we will be required to make prepayments on any outstanding borrowings under the New Term Loan Agreement in an amount equal to 50% of the average excess amount of availability (as defined in the BofA Loan Agreement) for the prior 30 days in excess of $10,000 and so long as (i) before and after giving effect to such mandatory prepayment, no default or event of default has occurred or will occur as a result of the payment, and (ii) before and after giving effect to the payment there is at least $10,000 of availability (as defined in the BofA Loan Agreement).

Borrowings under the New Term Loan Agreement are secured by a second lien on substantially all of the assets of the Company and are subordinated to the Company’s obligations under the BofA Agreement. The New Term Loan Agreement contains customary affirmative and negative covenants and events of default substantially the same as the BofA Agreement.

For additional information on the New Term Loan Agreement, please see Note 13 to our consolidated financial statements included in this Annual Report on Form 10-K.

PPP Loan

On August 3, 2020, the Company received loan proceeds of $1,956 (the “PPP Loan”) pursuant to the Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration (“SBA”) under the U.S. CARES Act. The PPP Loan, which was in the form of a promissory note (the “PPP Note”), between the Company and BofA, as the lender, had a maturity date of July 27, 2025, and would bear interest at a fixed rate of 1% per annum. Monthly principal and interest payments were deferred until (i) the date on which the amount of forgiveness was remitted to the Company’s lender, (ii) the date on which the Company’s lender provided notice that the Company was not entitled to loan forgiveness, and (iii) if a borrower did not apply for loan forgiveness, 10 months after the date of the loan forgiveness covered period. The Company was permitted to voluntarily prepay the borrowings in full with no associated penalty or premium. Under the terms of the PPP, the principal and interest could be forgiven if the PPP Loan proceeds were used for qualifying expenses, including payroll costs, rent and utility costs. The PPP Note contained customary representations, warranties, and covenants for this type of transaction, including customary events of default relating to, among other things, payment defaults and breaches of representations and warranties or other provisions of the PPP Note. The occurrence of an event of default could have resulted in, among other things, the Company becoming obligated to repay all amounts outstanding under the PPP Note. On February 18, 2021, the Company applied for full forgiveness of the PPP loan through Bank of America. In May 2021, the SBA determined that the PPP Loan was fully approved for forgiveness and on May 23, 2021, the PPP Loan was repaid in full by the SBA to BofA. The forgiveness amount remitted was $1,956 in principal and $16 in interest.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and a subsequent amendment to the initial guidance, ASU 2018-19 Codification Improvements to Topic 325, Financial Instruments-Credit Losses (collectively, Topic 326). Topic 326 requires measurement and recognition of expected credit losses for financial assets held, which include, but are not limited to, trade and other receivables. The new standard is

27

effective for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Special Note Regarding Forward Looking Statements

This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements concern management’s current assumptions, estimates, beliefs, plans, strategies and expectations and anticipated events or trends and similar expressions concerning matters that are not historical facts. Such forward-looking information may be identified by terms such as “expect,” “anticipate,” “believe,” “outlook,” “may,” “estimate,” “should,” “predict” and similar terms or variations thereof, and includes statements regarding our expectations with respect to our ability to meet our operating plan and obtain additional financing or other sources of capital in order to continue as a going concern, our strategic priorities, our efforts to mitigate the increases in raw material costs and impacts from the current global supply chain crisis, the benefits of and savings from our restructuring initiatives, the ongoing impact of the COVID-19 pandemic on our business as well as the US and global economies, our ability to develop and launch new products and to strengthen our customer relationships, our ability to manage operational costs, increases in our direct import business to reduce transportation costs, the success of our entry into the pet channel, and expected trends and product offerings in 2022, and the expected closing of the proposed merger with Kids2, Inc. These statements are based on a series of expectations, assumptions, estimates and projections about our Company, are not guarantees of future results or performance, and involve significant risks, uncertainties and other factors, including assumptions and projections, for all forward periods. Our actual results may differ materially from any future results expressed or implied by such forward-looking statements. Such factors include, among others, the following:

● our ability to continue as a going concern;

● the concentration of our business with certain retail customers who may change their purchasing policies or suffer liquidity problems or bankruptcy;

● our ability to manage our supply chain and mitigate ongoing supply chain challenges;

● our ability to manage and maintain sufficient inventory to meet customer demand;

● our ability to maintain sufficient availability under and to comply with financial and other covenants in our loan agreements;

● our ability to complete the Proposed Merger with Kids2 in a timely manner or at all;

● the widespread nature of the COVID-19 pandemic;

● our ability to compete by introducing new products or enhancing existing products that satisfy consumer preferences;

● our ability to develop and introduce new products in a timely and cost-effective manner;

● our ability to compete effectively with larger and smaller companies that have more financial resources and greater e-commerce presence than us;

● our reliance on foreign suppliers and potential disruption in foreign markets in which we operate;

● our ability to achieve the expected long-term benefits and savings of our restructuring initiatives;

● increases in the cost of raw materials used to manufacture our products;

● our ability to protect our intellectual property;

● compliance with safety and testing regulations for our products;

28

● product liability claims arising from use of our products;

● potential exposure to greater than anticipated tax liabilities;

● a material impairment of other intangible assets;

● our ability to maintain the listing of our common stock on and to comply with the continued listing requirements of the Nasdaq Capital Market; and

● any failure, inadequacy or interruption of our information technology systems resulting from cyberattacks or other failures that may disrupt our operations and lead to disclosure of confidential or proprietary data.

The foregoing list of important factors does not include all such factors, nor necessarily present them in order of importance. In addition, please refer to the “Risk Factors” section of this report for additional information regarding factors that could affect our results of operations, financial condition and liquidity.

We intend our forward-looking statements to speak only as of the time of such statements and do not undertake or plan to update or revise them as more information becomes available or to reflect changes in expectations, assumptions or results. We cannot give any assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties referred to in this report or included in our other periodic reports filed with the SEC could materially and adversely impact our operations and our future financial results.

Any public statements or disclosures by us following this report that modify or impact any of the forward-looking statements contained in or accompanying this report will be deemed to modify or supersede such outlook or other forward-looking statements in or accompanying this report.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Not required.

Item 8. Financial Statements and Supplementary Data

The financial statements required by this item are attached to this Annual Report on Form 10-K beginning on Page F-1.

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

  None.

Item 9A. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15 under the Securities Exchange Act of 1934, as of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and our Interim Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of January 1, 2022. Our principal executive officer and principal financial officer have concluded, based on their evaluation, that our disclosure controls and procedures were effective as of January 1, 2022.

29

(b) Management’s Report on Internal Control over Financial Reporting

Management of our Company is responsible for establishing and maintaining adequate internal control over financial reporting. As defined in Rule 13a-15(f) under the Exchange Act, internal control over financial reporting is a process designed by, or under the supervision of, a company’s principal executive and principal financial officers and effected by a company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. It includes those policies and procedures that:

1)Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of a company;

2)Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of a company are being made only in accordance with authorizations of management and the board of directors of the company; and

3)Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on its financial statements.

Because of the inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

The Company’s management has used the criteria established in the 2013 “Internal Control—Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO Framework”) to evaluate the effectiveness of the Company’s internal control over financial reporting.

Management of the Company conducted an evaluation of the effectiveness, as of January 1, 2022, of the Company’s internal control over financial reporting and based on its evaluation under the COSO Framework, management has concluded that the Company’s internal control over financial reporting was effective as of January 1, 2022.

(c) Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ended January 1, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information

On December 15, 2021, the Company, Summer Infant (USA), Inc., as borrowers, and certain subsidiaries of the Company as guarantors, entered into a letter agreement with BofA with respect to the Loan Agreement pursuant to which (i) the maximum percentage of accounts owing from the Amazon Companies that may be included in eligible accounts under the Loan Agreement shall not exceed 55% effective through April 2, 2022, and thereafter will be reduced back to 45% and (ii) the maximum portion of the revolver borrowing base under the Loan Agreement attributable to Eligible In-Transit Inventory (after giving effect to the Inventory Formula Amount) shall not exceed $11,000 effective through April 2, 2022, and thereafter will be reduced back to $7,000. A copy of the letter agreement is filed herewith as Exhibit 10.7 and is incorporated herein by reference.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

30

PART III

Pursuant to Paragraph G(3) of the General Instructions to Form 10-K, the information required by Part III is being incorporated by reference herein from our definitive proxy statement (or an amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022.

Item 10. Directors, Executive Officers and Corporate Governance

The information relating to directors, director nominees and executive officers of the Company is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

The information relating to Section 16(a) beneficial ownership reporting compliance is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

We have adopted a Code of Ethics that applies to all of our directors, officers and employees. The Code of Ethics is publicly available in the Investor Relations section of our website at www.sumrbrands.com. Amendments to the Code of Ethics and any grant of a waiver from a provision of the Code of Ethics requiring disclosure under applicable SEC and Nasdaq rules will be disclosed on our website.

The information relating to the Company’s Audit Committee and its designated audit committee financial expert is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

The information concerning procedures by which stockholders may recommend director nominees is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

Item 11. Executive Compensation

The information relating to executive compensation and the Company’s Compensation Committee is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information relating to security ownership of management, certain beneficial owners, and the Company’s equity plans is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information relating to certain relationships and related party transactions and director independence is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services

The information relating to the independent registered public accounting firm fees and services and the Company’s pre-approval policies and procedures for audit and non-audit services provided by such accounting firm is set forth in our definitive proxy statement (or amendment to this Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended January 1, 2022 and is incorporated herein by reference.

31

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)(1)Financial Statements

The list of consolidated financial statements and notes required by this Item 15(a)(1) is set forth in the “Index to Financial Statements” on page F-1 of this Annual Report on Form 10-K.

(2)Financial Statement Schedules

All schedules have been omitted because the required information is included in the financial statements or notes thereto.

(3)Exhibits

The exhibits required by Item 601 of Regulation S-K and Item 15(b) are listed in the “Index to Exhibits” below.

(b)Exhibits

The exhibits listed in the “Index to Exhibits” below are filed as part of this Annual Report on Form 10-K.

Item 16. Form 10-K Summary

Not applicable.

Index to Exhibits

Exhibit No.	Description
2.1	Agreement and Plans of Reorganization, dated as of September 1, 2006, by and among KBL Healthcare Acquisition Corp. II, and its wholly owned subsidiary, SII Acquisition Inc., and Summer Infant, Inc., Summer Infant Europe Limited, Summer Infant Asia, Ltd. and their respective stockholders (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on September 5, 2006)
2.2	Purchase and Sale Agreement, dated March 24, 2009, between Summer Infant (USA), Inc. and Faith Realty II, LLC (Incorporated by reference to Exhibit 2.1 to the Registrant’s Quarterly Report on Form 10-Q/A filed on August 18, 2009)
2.3	Lease Agreement, dated March 24, 2009, between Summer Infant (USA), Inc. and Faith Realty II, LLC (Incorporated by reference to Exhibit 2.2 to the Registrant’s Quarterly Report on Form 10-Q/A filed on August 18, 2009)
2.4	Stock Purchase Agreement, dated as of March 24, 2011, by and among the Registrant, Summer Infant (USA), Inc., Born Free Holdings Ltd., and each stockholder of Born Free Holdings Ltd. (Incorporated by reference to Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on March 28, 2011)
3.1	Amended and Restated Certificate of Incorporation, as amended (Incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K filed on March 18, 2020)
3.2	Amended and Restated Bylaws, as amended through May 5, 2016 (Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 9, 2016)
4.1	Specimen Common Stock Certificate (Incorporated by reference to Exhibit 4.2 to the Registrant’s Form 8-A filed on March 6, 2007)
4.2	Description of Registrant’s Securities (Incorporated by reference to Exhibit 4.2 to the Registrant’s Annual Report on Form 10-K filed on March 18, 2020)
10.1	Registration Rights Agreement by and among the Registrant, Jason Macari and Steven Gibree (Incorporated by reference to Exhibit 10.9 to the Registrant’s Current Report on Form 8-K filed on September 5, 2006)
10.2*	2006 Performance Equity Plan (Incorporated by reference to Appendix A to the Registrant’s Definitive Proxy Statement on Schedule 14A filed on April 29, 2008, SEC File No. 001-33346)

32

10.3	Third Amended and Restated Loan and Security Agreement, dated as of October 15, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Bank of America, N.A., as agent and security trustee for the lenders (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on October 16, 2020)
10.4	Letter Agreement, dated April 16, 2021, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, and Bank of America, N.A., as agent and lender (Incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on May 18, 2021)
10.5	Letter Agreement, dated August 27, 2021, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, and Bank of America, N.A., as agent and lender (Incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on November 10, 2021)
10.6	Letter Agreement, dated September 22, 2021, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, and Bank of America, N.A., as agent and lender (Incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on November 10, 2021)
10.7+	Letter Agreement, dated December 15, 2021, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, and Bank of America, N.A., as agent and lender
10.8*	2012 Incentive Compensation Plan, as amended (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on August 5, 2015)
10.9*	Amended and Restated Incentive Compensation Plan (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on May 20, 2021)
10.10*	Summer Infant, Inc. Form of Indemnification Agreement (for officers and directors) (Incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed on January 17, 2014, SEC File No. 001-33346)
10.11	Amendment to Lease, dated May 13, 2015, by and between Faith Realty II, LLC and Summer Infant (USA), Inc. (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on May 19, 2015)
10.12	Second Amendment to Lease, dated January 22, 2018, by and between Faith Realty II, LLC and Summer Infant (USA), Inc. (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on January 26, 2018)
10.13	Third Amendment to Lease, dated April 24, 2020, by and between Faith Realty II, LLC and Summer Infant (USA), Inc. (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on April 30, 2020)
10.14*	Summer Infant, Inc. Change in Control Plan (as amended through May 11, 2020) (Incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q filed on August 11, 2020)
10.15	Engagement Letter, effective as of December 9, 2019, between Summer Infant, Inc. and Winter Harbor LLC (Incorporated by reference to Exhibit 10.16 to the Registrant’s Annual Report on Form 10-K filed on March 18, 2020
10.16**	Amendment to Engagement Letter, dated February 28, 2020, between Summer Infant, Inc. and Winter Harbor LLC (Incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on May 12, 2020)
10.17	Second Amendment to Engagement Letter, effective as of November 30, 2020, between Summer Infant, Inc. and Winter Harbor LLC (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on December 1, 2020)
10.18	Third Amendment to Engagement Letter, effective as of January 3, 2022, between Summer Infant, Inc. and Riveron RTS, LLC (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on January 7, 2022)
10.19	Letter Agreement, dated May 12, 2020, among Edmund J. Schwartz, Summer Infant, Inc. and Summer Infant (USA), Inc. (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on October 1, 2020)
10.20	Amendment, dated September 29, 2020, to Letter Agreement among Edmund J. Schwartz, Summer Infant, Inc. and Summer Infant (USA), Inc. dated May 12, 2020 (Incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on October 1, 2020)
21.1	List of Subsidiaries (Incorporated by reference to Exhibit 21.1 to the Registrant’s Annual Report on Form 10-K filed on March 16, 2021)
23.1+	Consent of Independent Registered Public Accounting Firm

33

31.1+	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2+	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1+	Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002)
32.2+	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002)
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101

*Management contract or compensatory plan or arrangement.

**Portions of this Exhibit have been omitted pursuant to a grant of confidential treatment.

+Filed herewith.

34

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 16^th day of March, 2022.

SUMMER INFANT, INC.
By:	/s/ BRUCE MEIER Bruce Meier Interim Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name	Title	Date
/s/ STUART NOYES Stuart Noyes	Chief Executive Officer (Principal Executive Officer) and Director	March 16, 2022
/s/ BRUCE MEIER Bruce Meier	Interim Chief Financial Officer (Principal Financial and Accounting Officer)	March 16, 2022
/s/ ROBIN MARINO Robin Marino	Chairwoman of the Board	March 16, 2022
/s/ EVELYN D’AN Evelyn D’An	Director	March 16, 2022
/s/ ALAN MUSTACCHI Alan Mustacchi	Director	March 16, 2022
/s/ ANDREW M. TRAIN Andrew M. Train	Director	March 16, 2022
/s/ STEPHEN ZELKOWICZ Stephen Zelkowicz	Director	March 16, 2022

35

Summer Infant, Inc. and Subsidiaries

Index to Financial Statements

Report of Independent Registered Public Accounting Firm [PCAOB ID 49]	F-2
Consolidated Balance Sheets	F-4
Consolidated Statements of Operations	F-5
Consolidated Statements of Comprehensive Loss	F-6
Consolidated Statements of Cash Flows	F-7
Consolidated Statements of Stockholders’ Equity	F-8
Notes to Consolidated Financial Statements	F-9- F-28

F-1

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of Summer Infant Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Summer Infant, Inc. and its subsidiaries (the Company) as of January 1, 2022 and January 2, 2021, the related consolidated statements of operations, comprehensive loss, stockholders’ equity and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of January 1, 2022 and January 2, 2021, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Emphasis of Matter Regarding Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has suffered recent losses from operations and negative operating cash flows. This raises substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters also are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

F-2

Indefinite-lived Trade Name Impairment Assessment

As described in Notes 1 and 4 to the consolidated financial statements, the Company’s indefinite-lived trade name balance was $8,400,000 as of January 1, 2022. Indefinite-lived intangible assets are tested for impairment annually during the fourth fiscal quarter and whenever events or circumstances may indicate that an impairment has occurred. The fair value of the indefinite-lived trade name is generally estimated using discounted cash flow methodologies. The discounted cash flow methodology requires significant judgment, including estimation of future revenue, which is dependent on internal forecasts, the estimation of the long-term revenue growth rate of the Company’s business, the determination of the Company’s weighted average cost of capital, and royalty rates.

We identified the Company’s indefinite-lived trade name impairment assessment as a critical audit matter because of the significant assumptions and judgments made by management when estimating the fair value of the indefinite-lived trade name. Auditing management’s assumptions and judgments regarding future revenues, the weighted average cost of capital, and the royalty rate involved a high degree of auditor judgment and an increased effort, including the use of our valuation specialists.

Our audit procedures related to future revenues, royalty rate, and the weighted average cost of capital utilized in the valuation of the Company’s indefinite-lived trade name included the following, among others:

- With the assistance of our valuation specialists, we evaluated the reasonableness of the weighted average cost of capital and tested the relevance and reliability of source information underlying the determination of the rates, tested the mathematical accuracy of the calculation, and evaluated the reasonableness of the royalty rate selected by management.

- We evaluated the reasonableness of future revenues by:

o Comparing management’s forecasts to historical results for the Company.

o Comparing management’s forecasts to third-party industry data.

- We evaluated the impact of changes to revenue forecasts and revenue growth rates on the fair value of the indefinite-lived trade name.

Deferred Tax Asset Valuation Allowance

As described in Note 6 to the consolidated financial statements, the Company’s gross deferred tax asset and valuation allowance was $5,800,000 and $5,800,000, respectively, as of January 2, 2021. The Company recognizes deferred income taxes for differences between the financial reporting and tax basis of assets and liabilities. Deferred tax assets include loss and credit carryforwards and are reduced by a valuation allowance if, based on available evidence, it is more likely than not that some portion of the deferred tax assets will not be realized. The Company regularly reviews the deferred tax assets for recoverability considering historical profitability, projected taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies.

The principal considerations for our determination that performing procedures relating to management’s determination of the value of deferred tax assets is a critical audit matter are that there is significant judgment by management in the determination that it is not more likely than not that sufficient taxable income will be generated to realize deferred tax assets and therefore a valuation allowance was recorded, and auditing the valuation of deferred tax assets involved especially subjective judgment.

Our audit procedures related to the determination that it is not more likely than not that sufficient taxable income will be generated to realize deferred tax assets included the following, among others:

- We evaluated the reasonableness of management’s estimates of future taxable income by considering the weight applied to negative evidence and positive evidence that is objectively verifiable.

- We evaluated the Company’s “more likely than not” conclusion with regard to deferred tax assets that are not considered realizable and recomputed the valuation allowance for those that were not considered realizable.

/s/ RSM US LLP

We have served as the Company's auditor since 2010.

Boston, Massachusetts

March 16, 2022

F-3

Summer Infant, Inc. and Subsidiaries

Consolidated Balance Sheets

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share amounts and par value per share.

	January 1,		January 2,
	2022		2021
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	535	$	510
Trade receivables, net of allowance for doubtful accounts of $14 and $197 at January 1, 2022 and January 2, 2021, respectively		30,934		25,995
Inventory, net		28,621		25,123
Prepaids and other current assets		1,143		1,850
TOTAL CURRENT ASSETS		61,233		53,478
Property and equipment, net		4,128		4,789
Intangible assets, net		11,382		11,739
Right of use assets		14,383		3,625
Deferred tax assets, net		—		1,001
Other assets		104		105
TOTAL ASSETS	$	91,230	$	74,737
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable	$	27,985	$	27,986
Accrued expenses		5,698		6,064
Lease liabilities, current		3,133		2,349
Current portion of long-term debt		2,125		2,125
TOTAL CURRENT LIABILITIES		38,941		38,524
Long-term debt, less current portion and unamortized debt issuance costs		37,420		27,536
Deferred tax liability		152		—
Lease liabilities, noncurrent		12,034		1,493
Other liabilities		108		2,064
TOTAL LIABILITIES		88,655		69,617
STOCKHOLDERS’ EQUITY
Preferred Stock, $0.0001 par value, 1,000,000 authorized, none issued or outstanding at January 1, 2022 and January 2, 2021		—		—
Common Stock $0.0001 par value, authorized, issued and outstanding of 49,000,000, 2,194,892, and 2,164,708 at January 1, 2022 and 49,000,000, 2,162,459, and 2,132,275 at January 2, 2021, respectively		2		2
Treasury Stock at cost (30,184 shares at January 1, 2022 and January 2, 2021)		(1,283)		(1,283)
Additional paid-in capital		78,370		77,979
Accumulated deficit		(73,088)		(70,190)
Accumulated other comprehensive loss		(1,426)		(1,388)
TOTAL STOCKHOLDERS’ EQUITY		2,575		5,120
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	91,230	$	74,737

See notes to consolidated financial statements.

F-4

Summer Infant, Inc. and Subsidiaries

Consolidated Statements of Operations

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and per share amounts.

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
Net sales	$	143,665	$	155,299
Cost of goods sold		104,286		104,448
Gross profit		39,379		50,851
General and administrative expenses		28,662		29,360
Selling expenses		10,785		12,574
Depreciation and amortization		2,239		3,348
Impairment of intangible asset		—		676
Operating (loss) income		(2,307)		4,893
Interest expense, net		1,386		4,078
(Gain) loss from extinguishment of debt		(1,972)		1,800
Loss before provision for income taxes		(1,721)		(985)
Provision for income taxes		1,177		117
Net loss	$	(2,898)	$	(1,102)
Net loss per share:
BASIC	$	(1.35)	$	(0.52)
DILUTED	$	(1.35)	$	(0.52)
Weighted average shares outstanding:
BASIC		2,152,926		2,119,499
DILUTED		2,152,926		2,119,499

See notes to consolidated financial statements.

F-5

Summer Infant, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Loss

Note that all amounts presented in the table below are in thousands of U.S. dollars.

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
Net loss	$	(2,898)	$	(1,102)
Other comprehensive loss:
Foreign currency translation adjustments		(38)		375
Comprehensive loss	$	(2,936)	$	(727)

See notes to consolidated financial statements.

F-6

Summer Infant, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

Note that all amounts presented in the table below are in thousands of U.S. dollars.

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
Cash flows from operating activities:
Net loss	$	(2,898)	$	(1,102)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization		2,239		3,348
Impairment of intangible assets		—		676
Stock-based compensation		327		253
(Gain) loss from extinguishment of debt		(1,972)		1,800
Amortization of deferred financing costs		294		651
Deferred income taxes		1,143		5
Amortization of right to use asset		2,999		2,431
Changes in assets and liabilities
(Increase) decrease in accounts receivable		(4,995)		6,763
(Increase) decrease in inventory		(3,571)		2,926
Decrease in lease liabilities		(2,431)		(2,678)
Decrease in prepaids and other assets		721		1,118
Increase in accounts payable and accrued expenses		(247)		1,416
Net cash (used in) provided by operating activities		(8,391)		17,607
Cash flows from investing activities:
Acquisitions of property and equipment		(1,160)		(1,258)
Acquisitions of intangible assets		(87)		(20)
Net cash used in investing activities		(1,247)		(1,278)
Cash flows from financing activities:
Repayment of Prior Term Loan Facility		—		(16,406)
Payment of financing fees and other costs		—		(1,522)
Proceeds from New Term Loan Facility		—		7,500
Proceeds from FILO Loan Facility		—		2,500
Repayment of New Term Loan Facility		(1,500)		(375)
Repayment of FILO Loan Facility		(625)		(156)
Net borrowings (repayments) on revolving facilities		11,714		(10,152)
Proceeds from PPP Loan		—		1,956
Issuance of common stock upon exercise of stock options		64		11
Net cash provided by (used in) financing activities		9,653		(16,644)
Effect of exchange rate changes on cash and cash equivalents		10		430
Net increase in cash and cash equivalents		25		115
Cash and cash equivalents at beginning of year		510		395
Cash and cash equivalents at end of year	$	535	$	510
Supplemental disclosure of cash flow information:
Cash paid during the year for interest	$	1,131	$	2,777
Cash paid (refunded) during the year for income taxes	$	8	$	(199)
Supplemental disclosure of non-cash investing and financing activities:
Derecognition of a building sale-leaseback fixed asset, net of depreciation	$	—		2,357
Derecognition of a building sale-leaseback financial obligation	$	—		(2,390)
Right-of-use asset acquired through new operating lease	$	13,802		(1,457)
Lease liability acquired through new operating lease	$	(13,802)		1,457

See notes to consolidated financial statements.

F-7

Consolidated Statements of Stockholders’ Equity

For the Fiscal Years Ended January 1, 2022 and January 2, 2021

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and per share data.

	Common Stock			Additional						Accumulated
				Paid in		Treasury		Accumulated		Comprehensive		Total
	Shares	Amount		Capital		Stock		Deficit		Loss		Equity
Balance at December 28, 2019	2,108,743	$	2	$	77,715	$	(1,283)	$	(69,088)	$	(1,763)	$	5,583
Issuance of common stock upon vesting of restricted shares	20,438		—		—		—		—		—		—
Issuance of common stock upon exercise of stock options	1,474		—		11		—		—		—		11
Stock-based compensation	—		—		253		—		—		—		253
Fractional share issuance upon reverse stock split	1,620		—		—		—		—		—		—
Net loss for the year	—		—		—		—		(1,102)		—		(1,102)
Foreign currency translation adjustment	—		—		—		—		—		375		375
Balance at January 2, 2021	2,132,275	$	2	$	77,979	$	(1,283)	$	(70,190)	$	(1,388)	$	5,120
Issuance of common stock upon vesting of restricted shares	24,468		—		—		—		—		—		—
Issuance of common stock upon exercise of stock options	7,965		—		64		—		—		—		64
Stock-based compensation	—		—		327		—		—		—		327
Net loss for the year	—		—		—		—		(2,898)		—		(2,898)
Foreign currency translation adjustment	—		—		—		—		—		(38)		(38)
Balance at January 1, 2022	2,164,708	$	2	$	78,370	$	(1,283)	$	(73,088)	$	(1,426)	$	2,575

See notes to consolidated financial statements.

F-8

SUMMER INFANT, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Company designs, markets and distributes branded juvenile safety and convenience products that are sold globally to national retailers as well as independent retailers, primarily in North America. The Company currently markets its products in several product categories including gates, potty, bath, entertainers, specialty blankets, strollers, car seats and travel systems. Most products are sold under our core brand names of Summer™ and SwaddleMe^®. When used herein, the terms the “Company,” “we,” “us,” and “our” mean Summer Infant, Inc. and its consolidated subsidiaries.

2022 Plan and COVID-19 Pandemic

The accompanying consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will continue to operate as a going concern and contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. For the year ended January 1, 2022, the Company incurred a net loss $2,898 and used cash in operating activities of $8,391, primarily a result of the growth of accounts receivable and inventory. As of January 1, 2022, the Company had $535 of cash, $40,572 of outstanding indebtedness and borrowing availability of $2,949 under its asset-based lending agreement.

Since January 1, 2022, the Company entered into a term loan agreement with Wynnefield Capital to provide additional availability to the Company.  While the Company’s asset-based loan agreement with Bank of America and term loan agreement with Wynnefield Capital do not expire until October 15, 2025, both agreements have adjusted EBITDA and liquidity covenants.  While these covenants provide room for the Company to conduct its business in the ordinary course, the Company currently faces a challenging supply chain environment that may impact its ability to execute on its operating plan and consequently, the Company amended its financial covenants with Bank of America and Wynnefield Capital on March 16, 2022.

Due to continuing losses, the Company’s financial position and the challenging supply chain environment, there is no assurance that Company will be able to maintain compliance with the financial covenants under its loan agreements, which would impair its ability to meet its financial obligations as they become due without future amendments to its loan agreements.  In addition, the COVID-19 pandemic has significantly increased economic and demand uncertainty across the globe, and while demand for the Company’s products has remained steady, if these challenges continue, the Company may not be able to meet demands of its customers which could result in lost or cancelled orders from our customers and could materially and adversely affect our business, financial condition, and results of operations.

Based on its known cash needs as of March 16, 2022, and the anticipated availability under its loan agreements, the Company has developed plans to extend its liquidity to support its working capital requirements and our ability to meet our financial obligations. The Company’s plans with regard to these matters include the following: (1) continuing to explore price increases where possible, (2) enhancing certain supply chain processes to obtain lower cost containers for its products and reduce demurrage and detention charges through additional new procedures, (3) reducing warehouse costs through new processes as it relates to pallets, (4) reducing product costs through re-engineering of certain products, (5) reducing discretionary marketing to the extent that it does not impact revenue performance, and (6)  considering additional financing and/or strategic alternatives.

However, there can be no assurance the Company’s plans will be achieved and that the Company will be able to meet its financial obligations as they become due without obtaining additional financing or sources of capital. Therefore, in accordance with applicable accounting guidance, and based on the Company’s current financial condition and availability of funds, there is substantial doubt about the Company’s ability to continue as a going concern through twelve months from the date these financial statements were issued.

F-9

Reverse Stock Split

On March 13, 2020, the Company completed a reverse stock split and reduced its common stock outstanding by a ratio of one for nine. Per ASC 505-10, if a reverse stock split occurs after the date of the latest reported balance sheet but before the release of the financial statements, then such changes in the capital structure must be given retroactive effect in the balance sheet. As such, the reverse stock split has been retroactively applied to all years reported in these financial statements.

Basis of Presentation and Principles of Consolidation

It is the Company’s policy to prepare its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America. The consolidated financial statements include the accounts of its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the consolidation.

All dollar amounts included in the Notes to Consolidated Financial Statements are in thousands of U.S. dollars except share and per share amounts.

Fiscal Year

The Company’s fiscal year ends on the Saturday closest to December 31 of each calendar year. There were fifty-two weeks in the fiscal year ended January 1, 2022, and fifty-three weeks in the fiscal year ended January 2, 2021.

Summary of Significant Accounting Policies

Revenue Recognition

The Company applies FASB ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The guidance sets forth a five-step revenue recognition model and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying principle of the standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in the prior accounting guidance.

The Company’s principal activities from which it generates its revenue is product sales. The Company has one reportable segment of business.

Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation in a contract by transferring control over a product to a customer when product delivery occurs. Consideration is typically paid approximately 60 days from the time control is transferred. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in selling costs.

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for the Company is transfer of primarily juvenile products to its customers. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation.

A transaction price is the amount of consideration the Company expects to receive under the arrangement. The Company is required to estimate variable consideration (if any) and to factor that estimation into the determination of the transaction price. The Company conducts its business with customers through valid purchase or sales orders each of which is considered a separate contract because individual orders are not interdependent on one another. Product transaction prices on a purchase or sale order are discrete and stand-alone. Purchase or sales orders may be issued under either a customer master service agreement or a reseller allowance agreement. Purchase or sales orders, master service agreements, and reseller allowance agreements which are specific and unique to each customer, may include product price discounts, markdown allowances, return allowances, and/or volume rebates which reduce the consideration due from customers. Variable consideration is estimated using the most likely amount method, which is based on our historical experience as well as current information such as sales forecasts.

F-10

Contracts may also include cooperative advertising arrangements where the Company allows a discount from invoiced product amounts in exchange for customer purchased advertising that features the Company’s products. These allowances are generally based upon product purchases or specific advertising campaigns. Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct benefit and fair value and are accounted for as direct selling expenses.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Accordingly, actual results could differ from those estimates.

Cash and Cash Equivalents

Cash flows, cash and cash equivalents include money market accounts and investments with an original maturity of three months or less. At times, the Company possesses cash balances in excess of federally-insured limits.

Trade Receivables

Trade receivables are carried at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based upon historical experience and management’s evaluation of outstanding accounts receivable.

Changes in the allowance for doubtful accounts are as follows:

	For the
	fiscal year ended
	January 1,		January 2,
	2022		2021
Allowance for doubtful accounts, beginning of period	$	197	$	542
Charges to (recovery of) costs and expenses		8		(27)
Account write-offs and other		(191)		(318)
Allowance for doubtful accounts, end of period	$	14	$	197

Inventory Valuation

Inventory is comprised mostly of finished goods and some component parts and is stated at the lower of cost using the first-in, first-out (FIFO) method, or net realizable value. The Company regularly reviews slow-moving and excess inventories and writes down inventories to net realizable value if the ultimate expected net proceeds from the disposals of excess inventory are less than the carrying cost of the merchandise.

Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and lease liabilities in the Company’s consolidated balance sheets.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company’s uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

F-11

The components of a lease should be split into three categories: lease components (e.g., land, building, etc.), non-lease components (e.g., common area maintenance, maintenance, consumables, etc.), and non-components (e.g., property taxes, insurance, etc.). Then the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on fair values to the lease components and non-lease components. Although separation of lease and non-lease components is required, certain practical expedients are available to entities. Entities electing the practical expedient would not separate lease and non-lease components. Rather, they would account for each lease component and the related non-lease component together as a single component. The Company’s facilities operating leases have lease and non-lease components to which the Company has elected to apply the practical expedient and account for each lease component and related non-lease component as one single component. The lease component results in a ROU asset being recorded on the balance sheet. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Property and Equipment

Property and equipment are recorded at cost. The Company owns the tools and molds used in the production of its products by third party manufacturers. Capitalized mold costs include costs incurred for the pre-production design and development of the molds.

Depreciation is provided over the estimated useful lives of the respective assets using the straight-line method.

Long-Lived Assets with Finite Lives

The Company reviews long-lived assets with finite lives for impairment on an asset group level whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered to be impaired when its carrying amount exceeds both the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition and the assets’ fair value. Long-lived assets include property and equipment and finite-lived intangible assets. The amount of impairment loss, if any, is charged by the Company to current operations.

Indefinite-Lived Intangible Assets

The Company accounts for intangible assets in accordance with accounting guidance that requires that intangible assets with indefinite useful lives be tested annually for impairment and more frequently if events or changes in circumstances indicate that the asset might be impaired. The Company’s annual impairment testing is conducted in the fourth quarter of every year.

The Company tests indefinite-lived intangible assets for impairment by comparing the asset’s fair value to its carrying amount. If the fair value is less than the carrying amount, the excess of the carrying amount over fair value is recognized as an impairment charge and the adjusted carrying amount becomes the assets’ new cost basis.

Management also evaluates the remaining useful life of an intangible asset that is not being amortized each reporting period to determine whether events and circumstances continue to support an indefinite useful life. If an intangible asset that is not being amortized is subsequently determined to have a finite useful life, it is amortized prospectively over its estimated remaining useful life.

Fair Value Measurements

The Company follows ASC 820, “Fair Value Measurements and Disclosures” which includes a framework for measuring fair value and expanded related disclosures. Broadly, the framework requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The standard established a three-level valuation hierarchy based upon observable and non-observable inputs.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy:

Level 1—Quoted prices for identical instruments in active markets.

Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

F-12

Level 3—Significant inputs to the valuation model are unobservable.

The Company maintains policies and procedures to value instruments using the best and most relevant data available. In addition, the Company utilizes third party specialists that review valuation, including independent price validation.

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and short and long-term borrowings. Because of their short maturity, the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value. The carrying value of the Company’s debt approximates fair value since the stated rate is similar to rates currently available to the Company for debt with similar terms and remaining maturities.

The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets and finite-lived intangibles. The Company tests its indefinite-lived assets for impairment at least annually and whenever events or changes in circumstances indicate that the carrying value may not be recoverable or that the carrying value may exceed its fair value. The resulting fair value measurements are considered to be Level 3 inputs. The Company did not record an impairment charge in fiscal 2021. During the fourth quarter of fiscal 2020, the Company determined that the estimated fair value of a definite-lived asset was non-recoverable, and the Company recorded a non-cash impairment charge of $676 which reduced the value of the intangible asset to $0, as more fully described in “Note 4 to the Consolidated Financial Statements-Intangible Assets.”

Income taxes

Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carryforwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence, it is more likely than not that such benefits will be realized. Deferred income tax assets are recorded on a net basis as a long term asset.

The Company follows the applicable guidance relative to uncertain tax positions. This standard provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Uncertain tax positions must meet a recognition threshold of more-likely-than-not in order for those tax positions to be recognized in the financial statements.

Translation of Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is its local currency, are translated into U.S. dollars at the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been translated at average rates prevailing during each respective quarter. Resulting translation adjustments are made to a separate component of stockholders’ equity within accumulated other comprehensive loss. Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is the U.S. dollar are remeasured into U.S. dollars at their historical rates or the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been remeasured at average rates prevailing during each respective quarter. Resulting remeasurement adjustments are made to the consolidated statement of operations. Foreign exchange transaction gains and losses are included in the accompanying consolidated statement of operations.

Shipping Costs

Shipping costs to customers are included in selling expenses and amounted to approximately $2,206 and $2,485 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

Advertising Costs

The Company charges advertising costs to selling expense as incurred. Advertising expense, which consists primarily of promotional and cooperative advertising allowances provided to customers, was approximately $7,881 and $9,215 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

F-13

Segment Information

Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision-maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company views its operations and manages its business as one operating segment utilizing an omni-channel distribution strategy.

Net Loss Per Share

Basic loss per share for the Company is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted income or loss per share includes the dilutive impact of outstanding stock options and unvested restricted shares.

Diluted loss per share for the Company is computed by dividing net loss by the dilutive weighted average shares outstanding which includes: the dilutive impact (using the “treasury stock” method) of “in the money” stock options and unvested restricted shares issued to employees. Options to purchase 70,635 and 60,639 shares of the Company’s common stock and 6,072 and 14,967 of restricted shares were not included in the calculation, due to the fact that these instruments were anti-dilutive for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

New Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and a subsequent amendment to the initial guidance, ASU 2018-19 Codification Improvements to Topic 325, Financial Instruments-Credit Losses (collectively, Topic 326). Topic 326 requires measurement and recognition of expected credit losses for financial assets held, which include, but are not limited to, trade and other receivables. The new standard is effective for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

2. REVENUE

Disaggregation of Revenue

The Company’s revenue is primarily from distinct fixed-price product sales in the juvenile product market, to similar customers and channels utilizing similar types of contracts that are short term in nature (less than one year). The Company does not sell service agreements or goods over a period of time and does not sell or utilize customer financing arrangements or time-and-material contracts.

The following is a table that presents net sales by geographical area:

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
United States	$	132,153	$	140,173
All Other		11,512		15,126
	$	143,665	$	155,299

All Other consists of Canada, Europe, South America, Mexico, Asia, and the Middle East.

Contract Balances

The Company does not have any contract assets such as work-in-process or contract liabilities such as customer advances. All trade receivables on the Company’s consolidated balance sheet are from contracts with customers.

F-14

Contract Costs

Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. All contract costs incurred in 2021 and 2020 fall under the provisions of the practical expedient and have therefore been expensed.

F-15

3. PROPERTY AND EQUIPMENT

Property and equipment, at cost, consisted of the following:

	For the
	fiscal year ended
	January 1,			January 2,	Depreciation/
	2022		2021		Amortization Period
Computer-related	$	4,577	$	4,560	5 years
Tools, dies, prototypes, and molds		28,826		27,849	1 - 5 years
Other		7,777		7,671	1 - 15 years
		41,180		40,080
Less: accumulated depreciation		37,052		35,291
Property and equipment, net	$	4,128	$	4,789

Total depreciation expense was $1,795 and $2,847 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

In May 2020, the Company entered into a lease agreement amendment related to our headquarters in Woonsocket, Rhode Island. The agreement decreased the leased premises square footage and extended the current term, which was set to end in March 2021 prior to the amendment to June 2025. It additionally granted two 5-year term extension options. The Company was accounting for the lease in Woonsocket as a sale-leaseback with the building on the balance sheet as property and equipment, net and a corresponding financing obligation in long-term liabilities. Upon the execution of the lease amendment, the Company re-assessed the classification of the lease and determined it to be an operating lease, as the criteria for a sale-leaseback had not been met. This resulted in the de-recognition of the building, from property and equipment, of $2,357, net of accumulated depreciation and the addition of a right-of-use asset and corresponding liability of $1,457.

4. INTANGIBLE ASSETS

Intangible assets consisted of the following:

	For the
	fiscal year ended
	January 1,		January 2,
	2022		2021
Brand names	$	10,900	$	10,900
Patents and licenses		4,208		4,125
Customer relationships		6,946		6,946
Other intangibles		1,886		1,882
		23,940		23,853
Less: accumulated amortization		(12,558)		(12,114)
Intangible assets, net	$	11,382	$	11,739

The amortization period for the majority of the intangible assets ranges from 5 to 18 years for those assets that have an estimated life; certain assets have indefinite lives (a brand name). Total of intangibles not subject to amortization amounted to $8,400 for the fiscal years ended January 1, 2022 and January 2, 2021.

F-16

Amortization expense amounted to $444 and $501 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively. In the fourth quarter of 2020, the Company recorded an asset impairment charge of $676 representing the remaining unamortized balance of the definite long-lived asset related to the Company’s Born Free Holdings Limited (BFH) trademarks. This intangible asset was determined to have a carrying value that was non-recoverable. The determination resulted from the Company’s decision to dissolve the BFH entity which was completed in December 2020.

The Company performed its annual indefinite-lived intangible asset impairment analysis in the fourth fiscal quarter. No asset impairment was recorded for the fiscal years ended January 1, 2022 and January 2, 2021.

Estimated amortization expense for the remaining definite-lived assets for the next five years is as follows:

Fiscal Year ending
2022	440
2023	440
2024	440
2025	437
2026	207

5. DEBT

Loan Agreement with Bank of America.

On October 15, 2020, the Company and its wholly owned subsidiary, Summer Infant (USA), Inc., became parties to a Third Amended and Restated Loan and Security Agreement (the “Loan Agreement”) with Bank of America, N.A., as agent, that provides for (i) a $40,000 asset-based revolving credit facility, with a $5,000 unused letter of credit sub-line facility as of January 1, 2022, (ii) a $7,500 term loan and (iii) a $2,500 FILO (first-in, last-out) loan. The Loan Agreement replaced the Company’s prior agreement with BofA and term loan with Pathlight Capital.

Pursuant to the Loan Agreement, total borrowing capacity under the revolving credit facility is based on a borrowing base, which is generally defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory (subject to certain limitations) or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of the loans under the revolving credit facility is October 15, 2025 (subject to customary early termination provisions). Loans under the revolving credit facility bear interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability. Interest payments are due monthly, payable in arrears. The Company is also required to pay an annual non-use fee on unused amounts under the revolving credit facility, as well as other customary fees as are set forth in the Loan Agreement. As of January 1, 2022, the interest rate on LIBOR based revolver loans and on base rate revolver loans was 2.625% and 4.500%, respectively. The amount outstanding on the revolving credit facility Agreement on January 1, 2022 was $33,228. As of January 2, 2021, the interest rate was 2.625% on LIBOR based revolver loans. The amount outstanding on the Restated BofA Agreement at January 2, 2021 was $21,467. Total borrowing base at January 1, 2022 was $36,177 and borrowing availability was $2,949.

The principal of the term loan is to be repaid, on a quarterly basis, in installments of $375, until paid in full on termination and subject to mandatory repayment in certain circumstances. The scheduled maturity date of the term loan is October 15, 2025 or earlier, if the revolving credit facility is terminated. The term loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of January 1, 2022, the interest rate on LIBOR based term loans and on base rate term loans was 3.875% and 5.750%, respectively. The amount outstanding on the term loan under the Restated BofA Agreement was $5,625 as of January 1, 2022. The amount outstanding on the term loan under the Restated BofA Agreement was $7,125 as of January 2, 2021.

F-17

The total borrowing capacity under the FILO loan is the lesser of (i) the then applicable aggregate FILO commitment amount and (ii) a borrowing base, generally defined as a specific percentage of the value of eligible accounts, plus a specified percentage of the value of eligible inventory. The aggregate FILO commitment amount as of January 1, 2022 was $1,719 with no further availability, and such amount will be proportionately reduced each quarter until the FILO loan is terminated at maturity on October 15, 2024. There can be no voluntary repayment on the FILO loan as long as there are loans outstanding under the revolving credit facility, unless (i) there is an overadvance under the FILO loan, or (ii) such prepayment is accompanied by a permanent dollar for dollar reduction in the aggregate FILO commitment amount such that, after giving effect to such prepayment and reduction, the outstanding principal amount of the FILO loan is equal to but does not exceed the lesser of (A) the aggregate FILO commitment amount and (B) the FILO borrowing base. The FILO loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of January 1, 2022, the interest rate on the LIBOR based FILO loans and on base rate FILO loans was 3.625% and 5.500%, respectively. The aggregate FILO commitment amount of as of January 2, 2021 was $2,344.

All obligations under the Loan Agreement are secured by substantially all the assets of the Company, and the Company’s subsidiaries, Summer Infant Canada Limited and Summer Infant Europe Limited, are guarantors under the Loan Agreement. The Loan Agreement contains customary affirmative and negative covenants. Among other restrictions, the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. Until the term loan and FILO loan have been repaid in full, the Company must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.00 to 1.00 for the twelve-month period then ended. After the term loan and FILO loan have been repaid in full, the Company will be required to maintain the fixed charge coverage ratio if availability falls below $5,000.

The Loan Agreement also contains customary events of default, including if the Company fails to comply with any required financial covenants, if there is an event of default under the PPP Loan (described below) and the occurrence of a change of control. In the event of a default, all of the obligations under the Loan Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations become due and payable.

Subsequent to fiscal year end, on January 28, 2022 and March 16, 2022, the Company (i) entered into a loan and security agreement with Wynnefield Capital, Inc., as agent, providing for a second lien, subordinated term loan in an amount up to $5,000 and (ii) amended the Loan Agreement to provide additional flexibility to the Company under its covenant requirements and to permit the second-lien term, subordinated term loan. See Note 13 for additional information regarding the new second lien, subordinated term loan and Loan Agreement amendment.

Prior Bank of America Credit Facility. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Second Amended and Restated Loan and Security Agreement with Bank of America, N.A., as agent, the financial institutions party to the agreement from time to time as lenders, and certain subsidiaries of the Company as guarantors (as amended, the “Restated BofA Agreement”). The Restated BofA Agreement replaced the Company’s prior credit facility with Bank of America, and provided for an asset-based revolving credit facility, with a $5,000 letter of credit sub-line facility. The total borrowing capacity was based on a borrowing base, which was defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of loans under the Restated BofA Agreement was June 28, 2023 (subject to customary early termination provisions). On October 15, 2020, the Restated BofA Agreement was replaced by the Loan Agreement described above. Loans under the Restated BofA Agreement bore interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability under the Restated BofA Agreement. Interest payments were due monthly, payable in arrears.

Prior Term Loan Agreement. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Term Loan and Security Agreement (as amended, the “Term Loan Agreement”) with Pathlight Capital LLC, as agent, each lender from time to time a party to the Term Loan Agreement, and certain subsidiaries of the Company as guarantors, providing for a $17,500 term loan (the “Term Loan”).

The principal of the Term Loan was being repaid, on a quarterly basis, in installments of $219, with the first installment having been paid on December 1, 2018, until paid in full on termination, provided that, in connection with the amendments to the Term Loan Agreement, principal payments for March, June and September 2020 were suspended. The Term Loan was repaid in full on October 15, 2020. The refinancing transaction was evaluated to determine the proper accounting treatment for the transaction. Accordingly, debt extinguishment accounting was used to account for the prepayment of the prior term loan facility with Pathlight Capital, LLC, resulting in a loss from the extinguishment of debt of $1,800 for the twelve months ended January 2, 2021.

F-18

PPP Loan

On August 3, 2020, the Company received loan proceeds of $1,956 (the “PPP Loan”) pursuant to the Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration (“SBA”) under the U.S. CARES Act. The PPP Loan, which was in the form of a promissory note (the “PPP Note”), between the Company and BofA, as the lender, had a maturity date of July 27, 2025 and would bear interest at a fixed rate of 1% per annum. Monthly principal and interest payments were deferred until (i) the date on which the amount of forgiveness was remitted to the Company’s lender, (ii) the date on which the Company’s lender provided notice that the Company was not entitled to loan forgiveness, and (iii) if a borrower did not apply for loan forgiveness, 10 months after the date of the loan forgiveness covered period. The Company was permitted to voluntarily prepay the borrowings in full with no associated penalty or premium. Under the terms of the PPP, the principal and interest could be forgiven if the PPP Loan proceeds were used for qualifying expenses, including payroll costs, rent and utility costs. The PPP Note contained customary representations, warranties, and covenants for this type of transaction, including customary events of default relating to, among other things, payment defaults and breaches of representations and warranties or other provisions of the PPP Note. The occurrence of an event of default could have resulted in, among other things, the Company becoming obligated to repay all amounts outstanding under the PPP Note. On February 18, 2021, the Company applied for full forgiveness of the PPP loan through Bank of America. In May 2021, the SBA determined that the PPP Loan was fully approved for forgiveness and on May 23, 2021, the PPP Loan was repaid in full by the SBA to BofA. The forgiveness amount remitted was $1,956 in principal and $16 in interest and is included as a gain from the extinguishment of debt in the statement of operations.

Aggregate maturities of bank debt related to the Loan Agreement are as follows:

Fiscal Year ending:
2022		1,594
2023		2,125
2024		2,125
2025		34,728
2026 and beyond		—
Total	$	40,572

Unamortized debt issuance costs were $1,027 at January 1, 2022 and $1,275 at January 2, 2021, and are presented as a direct deduction of long-term debt on the consolidated balance sheets.

Sale-Leaseback

On March 24, 2009, Summer Infant (USA), Inc., (“Summer USA”) the Company’s wholly owned subsidiary, entered into a definitive agreement with Faith Realty II, LLC, a Rhode Island limited liability company (“Faith Realty”) (the owner of which is Jason Macari, the former Chief Executive Officer, former director of the Company, and current investor), pursuant to which Faith Realty purchased the corporate headquarters of the Company located at 1275 Park East Drive, Woonsocket, Rhode Island (the “Headquarters”), for $4,052 and subsequently leased the Headquarters back to Summer USA for an annual rent of $390 during the initial seven year term of the lease, payable monthly and in advance. The original lease was to expire on the seventh anniversary of its commencement. Mr. Macari had given a personal guarantee to secure the Faith Realty debt on its mortgage; therefore, due to his continuing involvement in the building transaction, the transaction had been recorded as a financing lease, with no gain recognition.

On February 25, 2009, the Company’s Board of Directors (with Mr. Macari abstaining from such action) approved the sale leaseback transaction. In connection therewith, the Board of Directors granted a potential waiver, to the extent necessary, if at all, of the conflict of interest provisions of the Company’s Code of Ethics, effective upon execution of definitive agreements within the parameters approved by the Board. In connection with granting such potential waiver, the Board of Directors engaged independent counsel to review the sale leaseback transaction and an independent appraiser to ascertain (i) the value of the Headquarters and (ii) the market rent for the Headquarters. In reaching its conclusion that the sale leaseback transaction is fair to the Company, the Board of Directors considered a number of factors, including Summer USA’s ability to repurchase the headquarters at 110% of the initial sale price at the end of the initial term. The Company’s Audit Committee approved the sale leaseback transaction (as a related party transaction) and the potential waiver and recommended the matter to a vote of the entire Board of Directors (which approved the transaction).

F-19

On May 13, 2015, Summer USA entered into an amendment (the “Amendment”) to its lease dated March 24, 2009 (the “Lease”) with Faith Realty (the “Landlord”). Pursuant to the Amendment, (i) the initial term of the Lease was extended for two additional years, such that the initial term would end on March 31, 2018, and the term of the Lease could be extended at Summer USA’s election for one additional term of three years (rather than five years) upon twelve months’ prior notice, (ii) the annual rent for the last two years of the newly amended initial term was set at $429 and the annual rent for the extension period, if elected, was set at $468 and (iii) the Landlord agreed to provide an aggregate improvement allowance of not more than $78 for the newly amended initial term, to be applied against Summer USA’s monthly rent, and an additional improvement allowance of $234 for the extension term, if elected, to be applied against Summer USA’s monthly rent during such extension term. The Amendment was reviewed and approved by the audit committee because it was a related party transaction.

On January 22, 2018, Summer USA entered into a second amendment (the “Second Amendment”) to the Lease. Pursuant to the Second Amendment, (i) the term of the Lease was extended to March 31, 2021, with no further rights of extension, (ii) the annual rent for the last three years of the newly amended term was set at $468, (iii) Summer USA no longer has the option to purchase the property subject to the Lease and (iv) the Landlord and Summer USA agreed to certain expenses, repairs and modifications to the property that is subject to the Lease. The Second Amendment was reviewed and approved by the audit committee because it was a related party transaction.

On May 1, 2020, Summer USA entered into a third amendment (the “Third Amendment”) to the Lease. The agreement decreased the leased premises square footage and extended the current term, which was set to end in March 2021 prior to the amendment, to June 2025. It additionally granted two 5-year term extension options. Upon the execution of the lease amendment, the Company re-assessed the classification of the lease and determined it to be an operating lease, as the criteria for a sale-leaseback had not been met. This resulted in the de-recognition of the building of $2,357, net of depreciation and the addition of a right-of-use of $1,457 along with a short-term lease liability and a long-term lease liability for $264 and $1,193, respectively.

6. INCOME TAXES

In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”) that significantly revised the U.S. tax code effective January 1, 2018 by, among other things, lowering the corporate income tax rate from a top marginal rate of 35% to a flat 21%, limiting deductibility of interest expense and performance based incentive compensation and implementing a territorial tax system. As a result of the Tax Act in the fiscal years ending January 1, 2022 and January 2, 2021 the Company had non-deductible interest for tax purposes resulting in a deferred tax asset in the amount of $1,919 and $1,643, respectively. The Company recorded a valuation allowance on the value of this deferred tax asset until such time as it becomes more likely than not that this asset will be recognized.

The provision for income taxes is summarized as follows:

	Fiscal 2021		Fiscal 2020
Current:
Federal	$	—	$	108
Foreign		—		2
State and local		22		2
Total current		22		112
Deferred:
Federal		718	$	(5)
Foreign		237		6
State and local		200		4
Total deferred		1,155		5
Total provision	$	1,177	$	117

F-20

The tax effects of temporary differences that comprise the deferred tax liabilities and assets are as follows:

	January 1,		January 2,
	2022		2021
Deferred tax assets:
Accounts receivable	$	4	$	51
Inventory and Uniform Capitalization reserve		467		475
Interest deduction limitation		1,919		1,643
Lease Liability and accrued expenses		3,912		806
Research and development credit		2,030		2,292
Foreign tax credit		795		795
Net operating loss carry-forward		2,735		2,565
Total deferred tax assets		11,862		8,627
Deferred tax liabilities:
Intangible assets and other		(2,271)		(2,132)
ROU Assets and deferred rent		(3,745)		(833)
Property, plant and equipment		(83)		28
Total deferred tax liabilities		(6,099)		(2,937)
Valuation allowance		(5,915)		(4,689)
Deferred tax liabilities and valuation allowance		(12,014)		(7,626)
Net deferred income tax asset	$	(152)	$	1,001

The following reconciles the benefit for income taxes at the U.S. federal income tax statutory rate to the benefit in the consolidated financial statements:

	Fiscal 2021		Fiscal 2020
Tax benefit at statutory rate	$	(361)	$	(207)
State income taxes, net of U.S. federal income tax benefit		176		5
Adjustment to uncertain tax position		—		7,543
Stock options		16		5
Foreign tax rate differential		(49)		2
Tax credits		262		258
Worthless stock deduction		—		(7,435)
Non-deductible expenses/Non-taxable income including PPP		(428)		149
Expiration of unexercised stock options		24		90
Increase/(Decrease) in valuation allowance		1,512		(255)
Other		25		(38)
Total provision	$	1,177	$	117

The income tax provision for the year ended January 1, 2022 was primarily the result of an increase in valuation allowance on US and foreign net operating losses, offset by federal non-taxability of PPP loan forgiveness.

The income tax provision for the year ended January 2, 2021 was primarily the result of a deduction related to a worthless stock loss in the Company’s investment in its wholly owned subsidiary, Born Free Holdings Limited (“BFH”), net of reserve for uncertain tax positions. The Company, after analyzing the facts and circumstances, determined to no longer invest in BFH and liquidated the entity. The Company has maintained a permanent investment position and, therefore, has not previously recorded a deferred tax asset for the basis difference in this entity. The original acquisition and financial results of this entity had created an excess of tax basis over the book basis in which the worthless stock was deducted for income tax purposes of approximately $26,933, resulting in an estimated net tax benefit of $7,435. The Company analyzed this transaction and determined that this worthless stock deduction qualifies as an ordinary loss. While the Company believes this is a valid income tax deduction, due to the uncertain nature of worthless stock deductions, the Company has determined this tax benefit to be an uncertain tax position. Accordingly, the Company fully reserved for the tax benefit associated with the worthless stock deduction.

As of January 1, 2022, the Company had approximately $6,563 of US federal and state net operating loss carry forwards (or “NOLs”) to offset future federal taxable income. The federal NOL will begin to expire in 2031 and the state NOL began to expire in 2021. As of January 1, 2022, the Company had approximately $1,832, $543, and $2,028 of NOLs in Canada, Asia, and the United Kingdom, respectively, which can be carried forward indefinitely.

F-21

Authoritative guidance requires a valuation allowance to reduce the deferred tax assets reported, if based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all evidence, including the Company’s past earnings history and future earnings forecast, management determined that a valuation allowance in the amount of $3,201 at January 1, 2022 and $2,251 at January 2, 2021 relating to certain federal and state tax credits and foreign NOLs was necessary. Due to the Tax Act, the Company determined a valuation allowance in the amount of $2,714 at January 1, 2022 and $2,438 at January 2, 2021 relating to interest deduction limitations and foreign tax credits was necessary.

We apply the accounting guidance in ASC 740 related to accounting for uncertainty in income taxes. Our reserves related to taxes are based on a determination of whether, and how much of, a tax benefit taken by us in our tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit.

A summary of the Company’s adjustment to its uncertain tax positions in fiscal years ended January 1, 2022 and January 2, 2021 is set forth below:

	January 1,		January 2,
	2022		2021
Balance, at beginning of the year	$	7,543	$	—
Increase for tax positions related to the current year		—		7,543
Balance, at end of year	$	7,543	$	7,543

The unrecognized tax benefits mentioned above included an aggregate of $0 of accrued interest and penalty balances related to uncertain tax positions. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. The Company does not anticipate that its accrual for uncertain tax positions will be reduced by a material amount over the next twelve-month period, as it does not expect to settle any potential disputed items with the appropriate taxing authorities, nor does it expect the statute of limitations to expire for any items.

The Company is subject to U.S. federal income tax, as well as to income tax of multiple state and foreign tax jurisdictions. On a global basis, the open tax years subject to examination by major taxing jurisdictions in which the Company operates is between two to six years.

7. SHARE BASED COMPENSATION

The Company is currently authorized to issue up to 374,889 shares for equity awards under the Company’s Amended and Restated 2012 Incentive Compensation Plan (“2012 Plan”). In May 2021, the Company’s stockholders approved an increase in the number of shares available for issuance under the 2012 Plan from 188,889 to 374,889. Periodically, the Company may also grant equity awards outside of its 2012 Plan as inducement grants for new hires.

Under the 2012 Plan, awards may be granted to participants in the form of non-qualified stock options, incentive stock options, restricted stock, deferred stock, restricted stock units and other stock-based awards. Subject to the provisions of the plans, awards may be granted to employees, officers, directors, advisors and consultants who are deemed to have rendered or are able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the Company’s success. The Company accounts for options under the fair value recognition standard. The application of this standard resulted in share-based compensation expense for the twelve months ended January 1, 2022 and January 2, 2021 of $327 and $253, respectively. Share based compensation expense is included in selling, general and administrative expenses.

As of January 1, 2022, there are 202,576 shares available to grant under the 2012 Plan.

Stock Options

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the table below. The Company uses the simplified method to estimate the expected term of the options for grants of “plain vanilla” stock options as prescribed by the Securities and Exchange Commission. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Share-based compensation expense recognized in the consolidated financial statements in fiscal 2021 and 2020 is based on awards that are ultimately expected to vest.

F-22

The following table summarizes the weighted average assumptions used for options granted during the fiscal years ended January 1, 2022 and January 2, 2021.

	Fiscal		Fiscal
	2021		2020
Expected life (in years)	4.6		4.7
Risk-free interest rate	0.7	%	0.3	%
Volatility	105.3	%	98.9	%
Dividend yield	0.0	%	0.0	%
Forfeiture rate	50.6	%	51.9	%

The weighted-average grant date fair value of options granted during the year ended January 1, 2022 was $9.95 per share. The weighted-average grant date fair value of options granted during the year ended January 2, 2021 was $2.61 per share.

A summary of the status of the Company’s options as of January 1, 2022 and changes during the year then ended is presented below:

		Weighted-
	Number	Average
	Of	Exercise
	Shares	Price
Outstanding at beginning of year	60,639	$	10.63
Granted	52,000	$	13.41
Exercised or released	(7,965)	$	8.03
Canceled or forfeited	(33,705)	$	13.77
Expired	(334)	$	66.96
Outstanding at end of year	70,635	$	11.20
Options exercisable at January 1, 2022	13,425	$	11.14

Outstanding stock options vested and expected to vest as of January 1, 2022 is 49,179. The intrinsic value of options exercised was $69 and $13 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

The following table summarizes information about stock options at January 1, 2022:

	Options Outstanding				Options Exercisable
			Weighted				Weighted
		Remaining	Average			Remaining	Average
Range of	Number	Contractual	Exercise		Number	Contractual	Exercise
Exercise Prices	Outstanding	Life (years)	Price		Exercisable	Life	Price
$3.51 - $6.00	13,056	7.4	$	3.64	3,291	7.4	$	3.64
$6.01 - $12.00	19,840	8.3	$	9.26	5,895	6.7	$	7.71
$12.01 - $20.00	36,396	8.9	$	14.21	2,896	4.3	$	17.11
$20.01 - $30.00	336	3.2	$	23.76	336	3.2	$	23.76
$30.01 - $48.51	1,007	1.1	$	34.43	1,007	1.1	$	34.43
	70,635	8.3	$	11.20	13,425	5.9	$	11.14

The aggregate intrinsic value of options outstanding and exercisable at January 1, 2022 and January 2, 2021 are $39 and $73, respectively. As of January 1, 2022, there was approximately $204 of unrecognized compensation cost related to non-vested stock option awards, which is expected to be recognized over a remaining weighted-average vesting period of 3.2 years.

F-23

Restricted Stock Awards

Restricted stock awards require no payment from the grantee. The related compensation cost of each award is calculated using the market price on the grant date and is expensed equally over the vesting period. A summary of restricted stock awards made in the year ended January 1, 2022, is as follows:

	Number of	Grant Date
	Shares	Fair Value
Non-vested restricted stock awards as of January 2, 2021	14,967	$	8.68
Granted	20,960	$	11.45
Vested and released	(24,539)	$	11.13
Forfeited	(5,316)	$	9.73
Non-vested restricted stock awards as of January 1, 2022	6,072	$	7.44

As of January 1, 2022, there was approximately $21 of unrecognized compensation cost related to non-vested stock compensation arrangements granted under the Company’s stock incentive plan for restricted stock awards. That cost is expected to be recognized over the next 2.0 years.

On March 13, 2020, the Company completed a 1-for-9 reverse stock split reducing the outstanding common shares to 2,108,743. Transactions that occurred prior to the completion of the reverse stock split had the effect of being divided by nine.

8. WEIGHTED AVERAGE COMMON SHARES

Basic and diluted earnings or loss per share (“EPS”) is based upon the weighted average number of common shares outstanding during the period. Diluted weighted average number of common shares outstanding also included common stock equivalents such as stock options and restricted shares. The Company does not include the anti-dilutive effect of common stock equivalents in the calculation of dilutive common shares outstanding.

A reconciliation of basic and diluted net income attributable to common stockholders is as follows:

	For the Twelve		For the Twelve
	Months Ended		Months Ended
Calculation of Basic and Diluted EPS	January 1, 2022		January 2, 2021
Weighted-average common shares outstanding – basic		2,152,926		2,119,499
Dilutive effect of restricted shares		—		—
Dilutive effect of stock options		—		—
Weighted-average common shares outstanding – diluted		2,152,926		2,119,499
Earnings per share – basic	$	(1.35)	$	(0.52)
Earnings per share – diluted	$	(1.35)	$	(0.52)

The computation of diluted common shares for the twelve months January 1, 2022 excluded 70,635 and stock options and 6,072 shares of restricted stock outstanding, respectively because to include them would have been anti-dilutive. The computation of diluted common shares for the twelve months ended January 2, 2021 excluded 60,639 of stock options outstanding and excluded 14,967 shares of restricted stock outstanding, respectively because to include them would have been anti-dilutive.

9. PROFIT SHARING PLAN

Summer Infant (USA), Inc. maintains a defined contribution salary deferral plan under Section 401(k) of the Internal Revenue Code. All employees who meet the plan’s eligibility requirements can participate. Employees may elect to make contributions up to federal limitations. In 2007, the Company adopted a matching plan which was further amended in 2013, and which was funded throughout the year. For the years ended January 1, 2022 and January 2, 2021, the Company recorded 401(k) matching expense of $235 and $278, respectively.

F-24

10. MAJOR CUSTOMERS

Sales to the Company’s top seven customers together comprised approximately 88% of our sales in fiscal 2021 and 87% of our sales in fiscal 2021. Of these customers, three generated more than 10% of sales for fiscal 2021: Amazon.com (38%), Walmart (24%), and Target (18%). In fiscal 2020, three customers generated more than 10% of sales: Amazon.com (33%), Walmart (28%), and Target (17%).

11. COMMITMENTS AND CONTINGENCIES

Leases

The Company leases office space and distribution centers primarily related to its United States, Canada, United Kingdom, and Hong Kong operations. In connection with these leases, there were no cash incentives from the landlord to be used for the construction of leasehold improvements within the facility.

In May 2020, the Company entered into a lease agreement amendment related to our headquarters in Woonsocket, Rhode Island. The agreement decreased the leased premises square footage and extended the current term, which was set to end in March 2021 prior to the amendment to June 2025. It additionally granted two 5-year term extension options. The Company was accounting for the lease in Woonsocket as a sale-leaseback with the building on the balance sheet as property and equipment, net and a corresponding financing obligation in long-term liabilities. Upon the execution of the lease amendment, the Company re-assessed the classification of the lease and determined it to be an operating lease, as the criteria for a sale had been met. As part of this re-classification, the Company derecognized the financing obligation of $2,390 from long-term liabilities and the amount related to the property and equipment, net of $2,357 from the balance sheet and recorded a ROU asset and lease liability of $1,457 respectively. The Company did not include either of the term extension options in the calculation of the ROU asset and lease liability.

In April 2020, the Company entered into a twelve-month sublease agreement for a portion of its main leased warehouse and distribution center located in Riverside, California.

In February 2021, Summer USA extended its lease at its Riverside, California distribution center. The existing lease was set to expire on September 30, 2021 and has been extended for 61 months through October 31, 2026. In addition, the amended lease grants a 60-month extension option. The Company concluded that this is a modification to the existing lease and continues to be classified as operating. Upon the execution of the lease extension, the Company recorded an increase in ROU asset and lease liability of $13,583, respectively. The Company did not include the extension option in the calculation of the ROU asset and lease liability. Fixed sublease payments received are recognized on a straight-line basis over the sublease term in general and administrative expenses.

In October 2021, the Company renewed its lease in Hong Kong for an additional two years beginning in November 2021 and terminating in November 2023. No options to renew were stipulated in the lease. Upon execution of the lease, the Company recorded an ROU asset and lease liability of $291.

The Company identified and assessed the following significant assumptions in recognizing the right-of-use asset and corresponding liabilities:

● Expected lease term—The expected lease term includes both contractual lease periods and, when applicable, cancelable option periods when it is reasonably certain that the Company would exercise such options. These leases have remaining lease terms between 0.17 and 4.83 years. The Woonsocket lease has two 5-year extension options, and the Canada lease has one 5-year extension option that have not been included in the lease term.

● Incremental borrowing rate—The Company’s lease agreements do not provide an implicit rate. As the Company does not have any external borrowings for comparable terms of its leases, the Company estimated the incremental borrowing rate based on secured borrowings available to the Company for the next 5 years. This is the rate the Company would have to pay if borrowing on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

F-25

● Lease and non-lease components—In certain cases the Company is required to pay for certain additional charges for operating costs, including insurance, maintenance, taxes, and other costs incurred, which are billed based on both usage and as a percentage of the Company’s share of total square footage. The Company determined that these costs are non-lease components, and they are not included in the calculation of the lease liabilities because they are variable. Payments for these variable, non-lease components are considered variable lease costs and are recognized in the period in which the costs are incurred.

The components of the Company’s lease expense for the years ended January 1, 2022 and January 2, 2021 were as follows:

	Year Ended			Year Ended
	January 1, 2022			January 2, 2021
Operating lease cost	$	3,553		$	2,710
Variable lease cost		909			1,057
Less: sublease income		(1,199)			(749)
Total lease expense	$	3,263		$	3,018
Weighted-average remaining lease term		4.6 years			1.2 years
Weighted-average discount rate:		3.35	%		5.00	%

Cash paid for amounts included in the measurement of the Company’s lease liabilities were $2,969 and $2,911 for the years ended January 1, 2022 and January 2, 2021, respectively.

As of January 1, 2022, the present value of maturities of the Company’s operating lease liabilities were as follows:

Fiscal Year Ending:
2022	$	3,592
2023		3,498
2024		3,347
2025		3,284
2026		2,672
Less imputed interest		(1,226)
Total	$	15,167

The future fixed sublease receipts under non-cancelable operating lease agreements as of January 1, 2022 are as follows:

Fiscal Year Ending:
2022	$	1,348
Thereafter		—
Total	$	1,348

Employment Contracts

In accordance with applicable local law, Summer Infant Europe Limited is required to have employment contracts with all of its employees. In connection with these contracts, Summer Infant Europe Limited makes individual pension contributions to certain employees at varying rates from 1-7% of the employee’s annual salary, as part of their total compensation package. These pension contributions are expensed as incurred. There are no termination benefit provisions in these contracts.

Litigation

The Company is a party to routine litigation and administrative complaints incidental to its business. The Company does not believe that the resolution of any or all of such current routine litigation and administrative complaints is likely to have a material adverse effect on the Company’s financial condition or results of operations.

12. GEOGRAPHICAL INFORMATION

The Company sells products throughout the United States, Canada, and the United Kingdom, and various other parts of the world. The Company does not disclose product line revenues as it is not practicable for the Company to do so.

F-26

The following is a table that presents net revenue by geographic area:

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
United States	$	132,153	$	140,173
All Other		11,512		15,126
	$	143,665	$	155,299

The following is a table that presents total assets by geographic area:

	January 1,		January 2,
	2022		2021
United States	$	88,836	$	70,689
All Other		2,394		4,048
	$	91,230	$	74,737

The following is a table that presents total long-lived assets by geographic area:

	January 1,		January 2,
	2022		2021
United States	$	29,224	$	19,983
All Other		773		1,276
	$	29,997	$	21,259

13. SUBSEQUENT EVENTS

The Company has evaluated all events or transactions that occurred after January 1, 2022 through the date of this Annual Report on Form 10-K and determined that no subsequent events occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto except as follows:

Loan and Security Agreement. On January 28, 2022, the Company and its subsidiary, Summer Infant (USA), Inc. (“Summer USA”), as borrowers, entered into a Loan and Security Agreement among the Company and Summer USA. as borrowers, the guarantors from time to time party thereto, certain financial institutions as lenders, and Wynnefield Capital, Inc., as agent for the lenders, which was amended on March 16, 2022 (as amended, the “New Term Loan Agreement”). The lenders, Wynnefield Partners Small Cap Value, L.P. and Wynnefield Partners Small Cap Value, L.P. I, are existing stockholders of the Company and, together with affiliates, beneficially own approximately 35% of the Company’s outstanding common stock, and an employee of Wynnefield Capital, Inc., Stephen Zelkowicz, serves on the Company’s Board of Directors.

The New Term Loan Agreement provides for a second lien, subordinated term loan in an amount up to $5,000, with requests for the funding of tranches limited to every 30 days (the “New Term Loan”), subject to certain limitations.

Borrowings under the New Term Loan Agreement will bear interest at a rate of 5.0% per annum until January 27, 2024, and thereafter at a rate of 9.0% per annum, payable in arrears on a quarterly basis. The principal amount of any borrowing will be repaid quarterly in installments equal to 2.5% of the highest amount of borrowings outstanding under the New Term Loan Agreement during the applicable quarter, commencing on July 1, 2022 and continuing until the maturity date of April 19, 2026.

Borrowings under the New Loan Term Agreement are secured by a second lien on substantially all of the assets of the Company and are subordinated to the Company’s obligations under the BofA Agreement. The New Term Loan Agreement as amended contains customary affirmative and negative covenants and events of default substantially the same as the BofA Agreement.

F-27

Amendments to BofA Agreement. On January 28, 2022 and March 16, 2022, the Company and Summer USA, as borrowers, entered into amendments to the Third Amended and Restated Loan and Security Agreement among the Company and Summer Infant (USA), Inc. as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Bank of America, N.A., as agent for the lenders. The amendments, among other things, (1) revised the definition of EBITDA to allow the add-back of costs and expenses associated with the New Term Loan and permits the Company to addback of costs of legal advisors and independent consultants incurred during the period from January 1, 2022 through July 2, 2022 in an aggregate amount not to exceed $1,000, (2) modified the fixed charge coverage ratio covenant to provide that the ratio shall be at least 1.00 to 1.00 as of the last day of each fiscal month commencing January 28, 2023, (3) reflected temporary increase through April 2, 2022 in (i) the maximum percentage of accounts owing from Amazon that may be included as eligible accounts in the borrowing based from 45% to 55%, and (ii) the maximum portion of the borrowing base that is attributable to eligible in-transit inventory from $7,000 to $11,000, (4) removed references to LIBOR and replaces them with the Bloomberg Short-Term Bank Yield (“BSBY”) Index rate administered by Bloomberg, (5) added a new minimum availability requirement of $3,500 at all times, and (6) added a new minimum EBITDA requirement to be maintained on a rolling monthly basis beginning on April 2, 2022.

Proposed Merger with Kids2, Inc. On March 16, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Kids2, Inc., a Georgia corporation (“Parent”), and Project Abacus Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides, subject to its terms and conditions, for the acquisition of the Company by Parent through the merger of Merger Sub with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Parent (the “Proposed Merger”). Under the terms of the Proposed Merger, each share of common stock of the Company issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (other than shares of common stock (i) owned by Parent, Merger Sub, the Company or any subsidiary of Parent, Merger Sub or Company, or (ii) held by a stockholder who is entitled to, and who has perfected, appraisal rights for such shares under Delaware law) automatically will be converted into the right to receive cash in an amount of $12.00 per share (the “Merger Consideration”), without interest, subject to any required withholding of taxes. The completion of the Proposed Merger is subject to closing conditions, including: (i) the approval of the Merger Agreement by the Company’s stockholders; (ii) the absence of any laws or court orders making the Proposed Merger illegal or otherwise prohibiting the Proposed Merger; (iii) other customary closing conditions, including the accuracy of the representations and warranties of each party (subject to certain materiality exceptions) and material compliance by each party with its covenants under the Merger Agreement; and (iv) the closing of a debt financing by Parent to fund the Merger Consideration.

F-28

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Nos. 333-156725, 333-191405, 333-206682, 333-206683, 333-212947, 333-256461) on Form S-8 of Summer Infant, Inc. of our report dated March 16 2022, relating to the consolidated financial statements of Summer Infant, Inc. and its subsidiaries, appearing in this Annual Report on Form 10-K of Summer Infant, Inc. for the year ended January 1, 2022.

/s/ RSM US LLP

Boston, MA

March 16, 2022

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Stuart Noyes, certify that:

1.I have reviewed this Annual Report on Form 10-K of Summer Infant, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

6
Date: March 16, 2022	/s/ STUART NOYES
	Stuart Noyes
	Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Bruce Meier, certify that:

1.I have reviewed this Annual Report on Form 10-K of Summer Infant, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

6
Date: March 16, 2022	/s/ BRUCE MEIER
	Bruce Meier
	Interim Chief Financial Officer

EX-32.1

Exhibit 32.1

SECTION 1350 CERTIFICATION

In connection with the Annual Report on Form 10-K of Summer Infant, Inc. (the “Company”) for the year ended January 1, 2022 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Stuart Noyes, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 16, 2022	/s/ STUART NOYES
	Stuart Noyes
	Chief Executive Officer

EX-32.2

Exhibit 32.2

SECTION 1350 CERTIFICATION

In connection with the Annual Report on Form 10-K of Summer Infant, Inc. (the “Company”) for the year ended January 1, 2022 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Bruce Meier, Interim Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

6
Date: March 16, 2022	/s/ BRUCE MEIER
	Bruce Meier
	Interim Chief Financial Officer

EX-10.7

Exhibit 10.7

December 15, 2021

Summer Infant, Inc.

1275 Park East Drive

Woonsocket, RI 02895

Attn:Bruce Meier

Chief Financial Officer

Re: Third Amended and Restated Loan and Security Agreement

Dear Mr. Meier:

Reference is hereby made to the Third Amended and Restated Loan and Security Agreement dated as of October 15, 2020 (as amended, restated, supplemented or otherwise modified from time to time, the “Loan Agreement”), by and among Summer Infant, Inc. and Summer Infant (USA), Inc., as “Borrowers” (the “Borrowers”), the guarantors from time to time party thereto (the “Guarantors”, and together with the Borrowers, the “Obligors”), Bank of America, N.A., as the sole lender (the “Lender”), and Bank of America in its capacity as “Agent” for the Lenders from time to time party to Loan Agreement (in such capacity, the “Agent”).  Capitalized terms used herein without definition that are defined in the Loan Agreement shall have the meanings ascribed to such terms in the Loan Agreement.

Reference is also made to (i) that certain letter agreement dated August 27, 2021 among the Agent, the Lender and the Obligors pursuant to which the Agent and the Lender agreed to temporarily increase the maximum percentage of Accounts owing from the Amazon Companies that may be included as Eligible Accounts in the Borrowing Base from 45% to 55% through December 31, 2021 (the “Amazon Account Concentration Temporary Increase”), and (ii) that certain letter agreement dated September 22, 2021 among the Agent, the Lender and the Obligors pursuant to which the Agent and the Lender agreed to temporarily increase the maximum portion of the Borrowing Base that is attributable to Eligible In-Transit Inventory from $7,000,000 to $11,000,000 through December 31, 2021 (the “Eligible In-Transit Inventory Cap Temporary Increase”).

The Borrowers have requested, and the Agent and the Lender hereby agree, that the Amazon Account Concentration Temporary Increase and the Eligible In-Transit Inventory Cap Temporary Increase be extended through April 2, 2022.  Accordingly, the Agent, the Lender and the Obligors hereby agree as follows:

During the period from the date of this letter agreement through April 2, 2022:

(a)the maximum percentage of Accounts owing from the Amazon Companies that may be included as “Eligible Accounts” under the Loan Agreement shall not exceed 55%; provided that on April 3, 2022, the maximum percentage of Accounts owing from the Amazon Companies that may be included as “Eligible Accounts” under the Loan Agreement shall automatically be reduced back to 45%; and

Summer Infant, Inc.

December 15, 2021

Page 2

(b)the maximum portion of the Revolver Borrowing Base that is attributable to Eligible In-Transit Inventory (after giving effect to the Inventory Formula Amount) shall not exceed $11,000,000; provided that on April 3, 2022, the maximum portion of the Revolver Borrowing Base that is attributable to Eligible In-Transit Inventory (after giving effect to the Inventory Formula Amount) shall automatically be reduced back to $7,000,000.  For the avoidance of doubt, the maximum portion of the FILO Borrowing Base that is attributable to Eligible In-Transit Inventory (after giving effect to the Applicable FILO Inventory Advance Percentage) shall remain at $1,000,000.

By their acknowledgment below, the Obligors (a) hereby represent, warrant and confirm that (i) all representations and warranties of the Obligors in the Loan Agreement and the other Loan Documents are true and correct in all material respects (without duplication of any materiality qualifier contained therein) on and as of the date hereof as if made on such date (except to the extent that such representations and warranties expressly relate to or are stated to have been made as of an earlier date, in which case, such representations and warranties shall be true and correct in all material respects (without duplication of any materiality qualifier contained therein) as of such earlier date), and (ii) no Default or Event of Default has occurred and is continuing, and (b) hereby ratify and confirm all of the terms and provisions of the Loan Agreement and the other Loan Documents, and agree that all of such terms and provisions remain in full force and effect.

In consideration of the accommodations reflected in this letter agreement, Borrowers shall pay to Agent, for the benefit of itself and the Lender, a one-time fee in an amount equal to $5,000 (the “December  2021 Letter Agreement Fee”).  Borrowers agree that the December 2021 Letter Agreement Fee shall be fully earned by the Agent and the Lender on the date hereof and shall be payable by Borrowers to the Agent and the Lender on the date hereof.  The December 2021 Letter Agreement Fee is in addition to any other fee set forth in the Loan Documents and shall not be refundable for any reason whatsoever.

Please confirm your agreement to the foregoing matters by counter-signing a copy of this letter agreement in the space provided therefor below and thereafter returning a fully executed copy hereof to the undersigned at your earliest opportunity.

Yours etc.,
BANK OF AMERICA, N.A.,
as Agent and Lender
By	/s/ Cynthia G. Stannard
	Name:	Cynthia G. Stannard
	Title:	Senior Vice President

Summer Infant, Inc.

December 15, 2021

Page 3

ACKNOWLEDGED AND AGREED
AS OF DECEMBER 15, 2021
BORROWERS:
SUMMER INFANT, INC.
By:	/s/ Bruce Meier
	Name:	Bruce Meier
	Title:	Interim Chief Financial Officer
SUMMER INFANT (USA), INC.
By:	/s/ Bruce Meier
	Name:	Bruce Meier
	Title:	Chief Financial Officer
GUARANTORS:
SUMMER INFANT CANADA, LIMITED
By:	/s/ Bruce Meier
	Name:	Bruce Meier
	Title:	Chief Financial Officer
SUMMER INFANT EUROPE LIMITED
By:	/s/ Bruce Meier
	Name:	Bruce Meier
	Title:	Chief Financial Officer

XML

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Jan. 01, 2022	Mar. 11, 2022	Jul. 02, 2021
Document and Entity Information
Entity Registrant Name	SUMMER INFANT, INC.
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--01-01
Document Period End Date	Jan. 01, 2022
Document Transition Report	false
Entity File Number	001-33346
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-1994619
Entity Address, Address Line One	1275 Park East Drive
Entity Address, City or Town	Woonsocket
Entity Address, State or Province	RI
Entity Address, Postal Zip Code	02895
City Area Code	401
Local Phone Number	671-6550
Title of 12(b) Security	Common Stock, Par Value $0.0001
Trading Symbol	SUMR
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 10.9
Entity Common Stock, Shares Outstanding		2,164,708
Entity Central Index Key	0001314772
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Amendment Flag	false
Auditor Firm ID	49
Auditor Name	RSM US LLP
Auditor Location	Boston, Massachusetts

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
CURRENT ASSETS
Cash and cash equivalents	$ 535	$ 510
Trade receivables, net of allowance for doubtful accounts of $14 and $197 at January 1, 2022 and January 2, 2021, respectively	30,934	25,995
Inventory, net	28,621	25,123
Prepaids and other current assets	1,143	1,850
TOTAL CURRENT ASSETS	61,233	53,478
Property and equipment, net	4,128	4,789
Intangible assets, net	11,382	11,739
Right of use assets	14,383	3,625
Deferred tax assets, net		1,001
Other assets	104	105
TOTAL ASSETS	91,230	74,737
CURRENT LIABILITIES
Accounts payable	27,985	27,986
Accrued expenses	5,698	6,064
Lease liabilities, current	3,133	2,349
Current portion of long-term debt	2,125	2,125
TOTAL CURRENT LIABILITIES	38,941	38,524
Long-term debt, less current portion and unamortized debt issuance costs	37,420	27,536
Deferred tax liability	152
Lease liabilities, noncurrent	12,034	1,493
Other liabilities	108	2,064
TOTAL LIABILITIES	88,655	69,617
STOCKHOLDERS' EQUITY
Preferred Stock, $0.0001 par value, 1,000,000 authorized, none issued or outstanding at January 1, 2022 and January 2, 2021
Common Stock $0.0001 par value, authorized, issued and outstanding of 49,000,000, 2,194,892, and 2,164,708 at January 1, 2022 and 49,000,000, 2,162,459, and 2,132,275 at January 2, 2021, respectively	2	2
Treasury Stock at cost (30,184 shares at January 1, 2022 and January 2, 2021)	(1,283)	(1,283)
Additional paid-in capital	78,370	77,979
Accumulated deficit	(73,088)	(70,190)
Accumulated other comprehensive loss	(1,426)	(1,388)
TOTAL STOCKHOLDERS' EQUITY	2,575	5,120
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 91,230	$ 74,737

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Consolidated Balance Sheets
Trade receivables, allowance for doubtful accounts	$ 14	$ 197
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, authorized	1,000,000	1,000,000
Preferred Stock, issued	0	0
Preferred Stock, outstanding	0	0
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common Stock, authorized	49,000,000	49,000,000
Common Stock, issued	2,194,892	2,162,459
Common Stock, outstanding	2,164,708	2,132,275
Treasury Stock at cost, shares	30,184	30,184

XML

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Consolidated Statements of Operations
Net sales	$ 143,665	$ 155,299
Cost of goods sold	104,286	104,448
Gross profit	39,379	50,851
General and administrative expenses	28,662	29,360
Selling expenses	10,785	12,574
Depreciation and amortization	2,239	3,348
Impairment of intangible asset		676
Operating (loss) income	(2,307)	4,893
Interest expense, net	1,386	4,078
(Gain) loss from extinguishment of debt	(1,972)	1,800
Loss before provision for income taxes	(1,721)	(985)
Provision for income taxes	1,177	117
Net loss	$ (2,898)	$ (1,102)
Net loss per share:
BASIC	$ (1.35)	$ (0.52)
DILUTED	$ (1.35)	$ (0.52)
Weighted average shares outstanding:
BASIC	2,152,926	2,119,499
DILUTED	2,152,926	2,119,499

XML

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Consolidated Statements of Comprehensive Loss
Net loss	$ (2,898)	$ (1,102)
Other comprehensive loss:
Foreign currency translation adjustments	(38)	375
Comprehensive loss	$ (2,936)	$ (727)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Cash flows from operating activities:
Net loss	$ (2,898)	$ (1,102)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	2,239	3,348
Impairment of intangible asset		676
Stock-based compensation	327	253
(Gain) loss from extinguishment of debt	(1,972)	1,800
Amortization of deferred financing costs	294	651
Deferred income taxes	1,143	5
Amortization of right to use asset	2,999	2,431
Changes in assets and liabilities
(Increase) decrease in accounts receivable	(4,995)	6,763
(Increase) decrease in inventory	(3,571)	2,926
Decrease in lease liabilities	(2,431)	(2,678)
Decrease in prepaids and other assets	721	1,118
Increase in accounts payable and accrued expenses	(247)	1,416
Net cash (used in) provided by operating activities	(8,391)	17,607
Cash flows from investing activities:
Acquisitions of property and equipment	(1,160)	(1,258)
Acquisitions of intangible assets	(87)	(20)
Net cash used in investing activities	(1,247)	(1,278)
Cash flows from financing activities:
Repayment of Prior Term Loan Facility		(16,406)
Payment of financing fees and other costs		(1,522)
Proceeds from New Term Loan Facility		7,500
Proceeds from FILO Loan Facility		2,500
Repayment of New Term Loan Facility	(1,500)	(375)
Repayment of FILO Loan Facility	(625)	(156)
Net borrowings (repayment) on revolving facilities	11,714	(10,152)
Issuance of common stock upon exercise of stock options	64	11
Proceeds from PPP loan		1,956
Net cash provided by (used in) financing activities	9,653	(16,644)
Effect of exchange rate changes on cash and cash equivalents	10	430
Net increase in cash and cash equivalents	25	115
Cash and cash equivalents, beginning of year	510	395
Cash and cash equivalents, end of year	535	510
Supplemental disclosure of cash flow information:
Cash paid during the year for interest	1,131	2,777
Cash paid (refunded) during the year for income taxes	8	(199)
Supplemental disclosure of non-cash investing and financing activities:
Derecognition of a building sale-leaseback fixed asset, net of depreciation		2,357
Derecognition of a building sale-leaseback financial obligation		(2,390)
Right-of-use asset acquired through new operating lease	13,802	(1,457)
Lease liability acquired through new operating lease	$ (13,802)	$ 1,457

XML

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid in Capital	Treasury Stock	Accumulated Deficit	Accumulated Comprehensive Loss	Total
Balance, beginning of year at Dec. 28, 2019	$ 2	$ 77,715	$ (1,283)	$ (69,088)	$ (1,763)	$ 5,583
Balance, beginning of year (in shares) at Dec. 28, 2019	2,108,743
Increase (Decrease) in Shareholders' Equity
Issuance of common stock upon vesting of restricted shares (in shares)	20,438
Issuance of common stock upon exercise of stock options		11				11
Issuance of common stock upon exercise of stock options (in shares)	1,474
Stock-based compensation		253				253
Fractional share issuance upon reverse stock split	1,620
Net loss for the year				(1,102)		(1,102)
Foreign currency translation adjustment					375	375
Balance, end of year at Jan. 02, 2021	$ 2	77,979	(1,283)	(70,190)	(1,388)	5,120
Balance, end of year (in shares) at Jan. 02, 2021	2,132,275
Increase (Decrease) in Shareholders' Equity
Issuance of common stock upon vesting of restricted shares (in shares)	24,468
Issuance of common stock upon exercise of stock options		64				64
Issuance of common stock upon exercise of stock options (in shares)	7,965
Stock-based compensation		327				327
Net loss for the year				(2,898)		(2,898)
Foreign currency translation adjustment					(38)	(38)
Balance, end of year at Jan. 01, 2022	$ 2	$ 78,370	$ (1,283)	$ (73,088)	$ (1,426)	$ 2,575
Balance, end of year (in shares) at Jan. 01, 2022	2,164,708

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Jan. 01, 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Company designs, markets and distributes branded juvenile safety and convenience products that are sold globally to national retailers as well as independent retailers, primarily in North America. The Company currently markets its products in several product categories including gates, potty, bath, entertainers, specialty blankets, strollers, car seats and travel systems. Most products are sold under our core brand names of Summer™ and SwaddleMe^®. When used herein, the terms the “Company,” “we,” “us,” and “our” mean Summer Infant, Inc. and its consolidated subsidiaries.

2022 Plan and COVID-19 Pandemic

The accompanying consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will continue to operate as a going concern and contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. For the year ended January 1, 2022, the Company incurred a net loss $2,898 and used cash in operating activities of $8,391, primarily a result of the growth of accounts receivable and inventory. As of January 1, 2022, the Company had $535 of cash, $40,572 of outstanding indebtedness and borrowing availability of $2,949 under its asset-based lending agreement.

Since January 1, 2022, the Company entered into a term loan agreement with Wynnefield Capital to provide additional availability to the Company.  While the Company’s asset-based loan agreement with Bank of America and term loan agreement with Wynnefield Capital do not expire until October 15, 2025, both agreements have adjusted EBITDA and liquidity covenants.  While these covenants provide room for the Company to conduct its business in the ordinary course, the Company currently faces a challenging supply chain environment that may impact its ability to execute on its operating plan and consequently, the Company amended its financial covenants with Bank of America and Wynnefield Capital on March 16, 2022.

Due to continuing losses, the Company’s financial position and the challenging supply chain environment, there is no assurance that Company will be able to maintain compliance with the financial covenants under its loan agreements, which would impair its ability to meet its financial obligations as they become due without future amendments to its loan agreements.  In addition, the COVID-19 pandemic has significantly increased economic and demand uncertainty across the globe, and while demand for the Company’s products has remained steady, if these challenges continue, the Company may not be able to meet demands of its customers which could result in lost or cancelled orders from our customers and could materially and adversely affect our business, financial condition, and results of operations.

Based on its known cash needs as of March 16, 2022, and the anticipated availability under its loan agreements, the Company has developed plans to extend its liquidity to support its working capital requirements and our ability to meet our financial obligations. The Company’s plans with regard to these matters include the following: (1) continuing to explore price increases where possible, (2) enhancing certain supply chain processes to obtain lower cost containers for its products and reduce demurrage and detention charges through additional new procedures, (3) reducing warehouse costs through new processes as it relates to pallets, (4) reducing product costs through re-engineering of certain products, (5) reducing discretionary marketing to the extent that it does not impact revenue performance, and (6)  considering additional financing and/or strategic alternatives.

However, there can be no assurance the Company’s plans will be achieved and that the Company will be able to meet its financial obligations as they become due without obtaining additional financing or sources of capital. Therefore, in accordance with applicable accounting guidance, and based on the Company’s current financial condition and availability of funds, there is substantial doubt about the Company’s ability to continue as a going concern through twelve months from the date these financial statements were issued.

Reverse Stock Split

On March 13, 2020, the Company completed a reverse stock split and reduced its common stock outstanding by a ratio of one for nine. Per ASC 505-10, if a reverse stock split occurs after the date of the latest reported balance sheet but before the release of the financial statements, then such changes in the capital structure must be given retroactive effect in the balance sheet. As such, the reverse stock split has been retroactively applied to all years reported in these financial statements.

Basis of Presentation and Principles of Consolidation

It is the Company’s policy to prepare its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America. The consolidated financial statements include the accounts of its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the consolidation.

All dollar amounts included in the Notes to Consolidated Financial Statements are in thousands of U.S. dollars except share and per share amounts.

Fiscal Year

The Company’s fiscal year ends on the Saturday closest to December 31 of each calendar year. There were fifty-two weeks in the fiscal year ended January 1, 2022, and fifty-three weeks in the fiscal year ended January 2, 2021.

Summary of Significant Accounting Policies

Revenue Recognition

The Company applies FASB ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The guidance sets forth a five-step revenue recognition model and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying principle of the standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in the prior accounting guidance.

The Company’s principal activities from which it generates its revenue is product sales. The Company has one reportable segment of business.

Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation in a contract by transferring control over a product to a customer when product delivery occurs. Consideration is typically paid approximately 60 days from the time control is transferred. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in selling costs.

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for the Company is transfer of primarily juvenile products to its customers. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation.

A transaction price is the amount of consideration the Company expects to receive under the arrangement. The Company is required to estimate variable consideration (if any) and to factor that estimation into the determination of the transaction price. The Company conducts its business with customers through valid purchase or sales orders each of which is considered a separate contract because individual orders are not interdependent on one another. Product transaction prices on a purchase or sale order are discrete and stand-alone. Purchase or sales orders may be issued under either a customer master service agreement or a reseller allowance agreement. Purchase or sales orders, master service agreements, and reseller allowance agreements which are specific and unique to each customer, may include product price discounts, markdown allowances, return allowances, and/or volume rebates which reduce the consideration due from customers. Variable consideration is estimated using the most likely amount method, which is based on our historical experience as well as current information such as sales forecasts.

Contracts may also include cooperative advertising arrangements where the Company allows a discount from invoiced product amounts in exchange for customer purchased advertising that features the Company’s products. These allowances are generally based upon product purchases or specific advertising campaigns. Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct benefit and fair value and are accounted for as direct selling expenses.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Accordingly, actual results could differ from those estimates.

Cash and Cash Equivalents

Cash flows, cash and cash equivalents include money market accounts and investments with an original maturity of three months or less. At times, the Company possesses cash balances in excess of federally-insured limits.

Trade Receivables

Trade receivables are carried at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based upon historical experience and management’s evaluation of outstanding accounts receivable.

Changes in the allowance for doubtful accounts are as follows:

	For the
	fiscal year ended
	January 1,		January 2,
	2022		2021
Allowance for doubtful accounts, beginning of period	$	197	$	542
Charges to (recovery of) costs and expenses		8		(27)
Account write-offs and other		(191)		(318)
Allowance for doubtful accounts, end of period	$	14	$	197

Inventory Valuation

Inventory is comprised mostly of finished goods and some component parts and is stated at the lower of cost using the first-in, first-out (FIFO) method, or net realizable value. The Company regularly reviews slow-moving and excess inventories and writes down inventories to net realizable value if the ultimate expected net proceeds from the disposals of excess inventory are less than the carrying cost of the merchandise.

Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and lease liabilities in the Company’s consolidated balance sheets.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company’s uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

The components of a lease should be split into three categories: lease components (e.g., land, building, etc.), non-lease components (e.g., common area maintenance, maintenance, consumables, etc.), and non-components (e.g., property taxes, insurance, etc.). Then the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on fair values to the lease components and non-lease components. Although separation of lease and non-lease components is required, certain practical expedients are available to entities. Entities electing the practical expedient would not separate lease and non-lease components. Rather, they would account for each lease component and the related non-lease component together as a single component. The Company’s facilities operating leases have lease and non-lease components to which the Company has elected to apply the practical expedient and account for each lease component and related non-lease component as one single component. The lease component results in a ROU asset being recorded on the balance sheet. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Property and Equipment

Property and equipment are recorded at cost. The Company owns the tools and molds used in the production of its products by third party manufacturers. Capitalized mold costs include costs incurred for the pre-production design and development of the molds.

Depreciation is provided over the estimated useful lives of the respective assets using the straight-line method.

Long-Lived Assets with Finite Lives

The Company reviews long-lived assets with finite lives for impairment on an asset group level whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered to be impaired when its carrying amount exceeds both the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition and the assets’ fair value. Long-lived assets include property and equipment and finite-lived intangible assets. The amount of impairment loss, if any, is charged by the Company to current operations.

Indefinite-Lived Intangible Assets

The Company accounts for intangible assets in accordance with accounting guidance that requires that intangible assets with indefinite useful lives be tested annually for impairment and more frequently if events or changes in circumstances indicate that the asset might be impaired. The Company’s annual impairment testing is conducted in the fourth quarter of every year.

The Company tests indefinite-lived intangible assets for impairment by comparing the asset’s fair value to its carrying amount. If the fair value is less than the carrying amount, the excess of the carrying amount over fair value is recognized as an impairment charge and the adjusted carrying amount becomes the assets’ new cost basis.

Management also evaluates the remaining useful life of an intangible asset that is not being amortized each reporting period to determine whether events and circumstances continue to support an indefinite useful life. If an intangible asset that is not being amortized is subsequently determined to have a finite useful life, it is amortized prospectively over its estimated remaining useful life.

Fair Value Measurements

The Company follows ASC 820, “Fair Value Measurements and Disclosures” which includes a framework for measuring fair value and expanded related disclosures. Broadly, the framework requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The standard established a three-level valuation hierarchy based upon observable and non-observable inputs.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy:

Level 1—Quoted prices for identical instruments in active markets.

Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

Level 3—Significant inputs to the valuation model are unobservable.

The Company maintains policies and procedures to value instruments using the best and most relevant data available. In addition, the Company utilizes third party specialists that review valuation, including independent price validation.

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and short and long-term borrowings. Because of their short maturity, the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value. The carrying value of the Company’s debt approximates fair value since the stated rate is similar to rates currently available to the Company for debt with similar terms and remaining maturities.

The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets and finite-lived intangibles. The Company tests its indefinite-lived assets for impairment at least annually and whenever events or changes in circumstances indicate that the carrying value may not be recoverable or that the carrying value may exceed its fair value. The resulting fair value measurements are considered to be Level 3 inputs. The Company did not record an impairment charge in fiscal 2021. During the fourth quarter of fiscal 2020, the Company determined that the estimated fair value of a definite-lived asset was non-recoverable, and the Company recorded a non-cash impairment charge of $676 which reduced the value of the intangible asset to $0, as more fully described in “Note 4 to the Consolidated Financial Statements-Intangible Assets.”

Income taxes

Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carryforwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence, it is more likely than not that such benefits will be realized. Deferred income tax assets are recorded on a net basis as a long term asset.

The Company follows the applicable guidance relative to uncertain tax positions. This standard provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Uncertain tax positions must meet a recognition threshold of more-likely-than-not in order for those tax positions to be recognized in the financial statements.

Translation of Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is its local currency, are translated into U.S. dollars at the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been translated at average rates prevailing during each respective quarter. Resulting translation adjustments are made to a separate component of stockholders’ equity within accumulated other comprehensive loss. Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is the U.S. dollar are remeasured into U.S. dollars at their historical rates or the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been remeasured at average rates prevailing during each respective quarter. Resulting remeasurement adjustments are made to the consolidated statement of operations. Foreign exchange transaction gains and losses are included in the accompanying consolidated statement of operations.

Shipping Costs

Shipping costs to customers are included in selling expenses and amounted to approximately $2,206 and $2,485 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

Advertising Costs

The Company charges advertising costs to selling expense as incurred. Advertising expense, which consists primarily of promotional and cooperative advertising allowances provided to customers, was approximately $7,881 and $9,215 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

Segment Information

Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision-maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company views its operations and manages its business as one operating segment utilizing an omni-channel distribution strategy.

Net Loss Per Share

Basic loss per share for the Company is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted income or loss per share includes the dilutive impact of outstanding stock options and unvested restricted shares.

Diluted loss per share for the Company is computed by dividing net loss by the dilutive weighted average shares outstanding which includes: the dilutive impact (using the “treasury stock” method) of “in the money” stock options and unvested restricted shares issued to employees. Options to purchase 70,635 and 60,639 shares of the Company’s common stock and 6,072 and 14,967 of restricted shares were not included in the calculation, due to the fact that these instruments were anti-dilutive for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

New Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and a subsequent amendment to the initial guidance, ASU 2018-19 Codification Improvements to Topic 325, Financial Instruments-Credit Losses (collectively, Topic 326). Topic 326 requires measurement and recognition of expected credit losses for financial assets held, which include, but are not limited to, trade and other receivables. The new standard is effective for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

XML

REVENUE

12 Months Ended

Jan. 01, 2022

REVENUE

REVENUE

2. REVENUE

Disaggregation of Revenue

The Company’s revenue is primarily from distinct fixed-price product sales in the juvenile product market, to similar customers and channels utilizing similar types of contracts that are short term in nature (less than one year). The Company does not sell service agreements or goods over a period of time and does not sell or utilize customer financing arrangements or time-and-material contracts.

The following is a table that presents net sales by geographical area:

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
United States	$	132,153	$	140,173
All Other		11,512		15,126
	$	143,665	$	155,299

All Other consists of Canada, Europe, South America, Mexico, Asia, and the Middle East.

Contract Balances

The Company does not have any contract assets such as work-in-process or contract liabilities such as customer advances. All trade receivables on the Company’s consolidated balance sheet are from contracts with customers.

Contract Costs

Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. All contract costs incurred in 2021 and 2020 fall under the provisions of the practical expedient and have therefore been expensed.

XML

PROPERTY AND EQUIPMENT

12 Months Ended

Jan. 01, 2022

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT

3. PROPERTY AND EQUIPMENT

Property and equipment, at cost, consisted of the following:

	For the
	fiscal year ended
	January 1,			January 2,	Depreciation/
	2022		2021		Amortization Period
Computer-related	$	4,577	$	4,560	5 years
Tools, dies, prototypes, and molds		28,826		27,849	1 - 5 years
Other		7,777		7,671	1 - 15 years
		41,180		40,080
Less: accumulated depreciation		37,052		35,291
Property and equipment, net	$	4,128	$	4,789

Total depreciation expense was $1,795 and $2,847 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

In May 2020, the Company entered into a lease agreement amendment related to our headquarters in Woonsocket, Rhode Island. The agreement decreased the leased premises square footage and extended the current term, which was set to end in March 2021 prior to the amendment to June 2025. It additionally granted two 5-year term extension options. The Company was accounting for the lease in Woonsocket as a sale-leaseback with the building on the balance sheet as property and equipment, net and a corresponding financing obligation in long-term liabilities. Upon the execution of the lease amendment, the Company re-assessed the classification of the lease and determined it to be an operating lease, as the criteria for a sale-leaseback had not been met. This resulted in the de-recognition of the building, from property and equipment, of $2,357, net of accumulated depreciation and the addition of a right-of-use asset and corresponding liability of $1,457.

XML

INTANGIBLE ASSETS

12 Months Ended

Jan. 01, 2022

INTANGIBLE ASSETS

INTANGIBLE ASSETS

4. INTANGIBLE ASSETS

Intangible assets consisted of the following:

	For the
	fiscal year ended
	January 1,		January 2,
	2022		2021
Brand names	$	10,900	$	10,900
Patents and licenses		4,208		4,125
Customer relationships		6,946		6,946
Other intangibles		1,886		1,882
		23,940		23,853
Less: accumulated amortization		(12,558)		(12,114)
Intangible assets, net	$	11,382	$	11,739

The amortization period for the majority of the intangible assets ranges from 5 to 18 years for those assets that have an estimated life; certain assets have indefinite lives (a brand name). Total of intangibles not subject to amortization amounted to $8,400 for the fiscal years ended January 1, 2022 and January 2, 2021.

Amortization expense amounted to $444 and $501 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively. In the fourth quarter of 2020, the Company recorded an asset impairment charge of $676 representing the remaining unamortized balance of the definite long-lived asset related to the Company’s Born Free Holdings Limited (BFH) trademarks. This intangible asset was determined to have a carrying value that was non-recoverable. The determination resulted from the Company’s decision to dissolve the BFH entity which was completed in December 2020.

The Company performed its annual indefinite-lived intangible asset impairment analysis in the fourth fiscal quarter. No asset impairment was recorded for the fiscal years ended January 1, 2022 and January 2, 2021.

Estimated amortization expense for the remaining definite-lived assets for the next five years is as follows:

Fiscal Year ending
2022	440
2023	440
2024	440
2025	437
2026	207

XML

DEBT

12 Months Ended

Jan. 01, 2022

DEBT

DEBT

5. DEBT

Loan Agreement with Bank of America.

On October 15, 2020, the Company and its wholly owned subsidiary, Summer Infant (USA), Inc., became parties to a Third Amended and Restated Loan and Security Agreement (the “Loan Agreement”) with Bank of America, N.A., as agent, that provides for (i) a $40,000 asset-based revolving credit facility, with a $5,000 unused letter of credit sub-line facility as of January 1, 2022, (ii) a $7,500 term loan and (iii) a $2,500 FILO (first-in, last-out) loan. The Loan Agreement replaced the Company’s prior agreement with BofA and term loan with Pathlight Capital.

Pursuant to the Loan Agreement, total borrowing capacity under the revolving credit facility is based on a borrowing base, which is generally defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory (subject to certain limitations) or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of the loans under the revolving credit facility is October 15, 2025 (subject to customary early termination provisions). Loans under the revolving credit facility bear interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability. Interest payments are due monthly, payable in arrears. The Company is also required to pay an annual non-use fee on unused amounts under the revolving credit facility, as well as other customary fees as are set forth in the Loan Agreement. As of January 1, 2022, the interest rate on LIBOR based revolver loans and on base rate revolver loans was 2.625% and 4.500%, respectively. The amount outstanding on the revolving credit facility Agreement on January 1, 2022 was $33,228. As of January 2, 2021, the interest rate was 2.625% on LIBOR based revolver loans. The amount outstanding on the Restated BofA Agreement at January 2, 2021 was $21,467. Total borrowing base at January 1, 2022 was $36,177 and borrowing availability was $2,949.

The principal of the term loan is to be repaid, on a quarterly basis, in installments of $375, until paid in full on termination and subject to mandatory repayment in certain circumstances. The scheduled maturity date of the term loan is October 15, 2025 or earlier, if the revolving credit facility is terminated. The term loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of January 1, 2022, the interest rate on LIBOR based term loans and on base rate term loans was 3.875% and 5.750%, respectively. The amount outstanding on the term loan under the Restated BofA Agreement was $5,625 as of January 1, 2022. The amount outstanding on the term loan under the Restated BofA Agreement was $7,125 as of January 2, 2021.

The total borrowing capacity under the FILO loan is the lesser of (i) the then applicable aggregate FILO commitment amount and (ii) a borrowing base, generally defined as a specific percentage of the value of eligible accounts, plus a specified percentage of the value of eligible inventory. The aggregate FILO commitment amount as of January 1, 2022 was $1,719 with no further availability, and such amount will be proportionately reduced each quarter until the FILO loan is terminated at maturity on October 15, 2024. There can be no voluntary repayment on the FILO loan as long as there are loans outstanding under the revolving credit facility, unless (i) there is an overadvance under the FILO loan, or (ii) such prepayment is accompanied by a permanent dollar for dollar reduction in the aggregate FILO commitment amount such that, after giving effect to such prepayment and reduction, the outstanding principal amount of the FILO loan is equal to but does not exceed the lesser of (A) the aggregate FILO commitment amount and (B) the FILO borrowing base. The FILO loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of January 1, 2022, the interest rate on the LIBOR based FILO loans and on base rate FILO loans was 3.625% and 5.500%, respectively. The aggregate FILO commitment amount of as of January 2, 2021 was $2,344.

All obligations under the Loan Agreement are secured by substantially all the assets of the Company, and the Company’s subsidiaries, Summer Infant Canada Limited and Summer Infant Europe Limited, are guarantors under the Loan Agreement. The Loan Agreement contains customary affirmative and negative covenants. Among other restrictions, the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. Until the term loan and FILO loan have been repaid in full, the Company must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.00 to 1.00 for the twelve-month period then ended. After the term loan and FILO loan have been repaid in full, the Company will be required to maintain the fixed charge coverage ratio if availability falls below $5,000.

The Loan Agreement also contains customary events of default, including if the Company fails to comply with any required financial covenants, if there is an event of default under the PPP Loan (described below) and the occurrence of a change of control. In the event of a default, all of the obligations under the Loan Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations become due and payable.

Subsequent to fiscal year end, on January 28, 2022 and March 16, 2022, the Company (i) entered into a loan and security agreement with Wynnefield Capital, Inc., as agent, providing for a second lien, subordinated term loan in an amount up to $5,000 and (ii) amended the Loan Agreement to provide additional flexibility to the Company under its covenant requirements and to permit the second-lien term, subordinated term loan. See Note 13 for additional information regarding the new second lien, subordinated term loan and Loan Agreement amendment.

Prior Bank of America Credit Facility. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Second Amended and Restated Loan and Security Agreement with Bank of America, N.A., as agent, the financial institutions party to the agreement from time to time as lenders, and certain subsidiaries of the Company as guarantors (as amended, the “Restated BofA Agreement”). The Restated BofA Agreement replaced the Company’s prior credit facility with Bank of America, and provided for an asset-based revolving credit facility, with a $5,000 letter of credit sub-line facility. The total borrowing capacity was based on a borrowing base, which was defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of loans under the Restated BofA Agreement was June 28, 2023 (subject to customary early termination provisions). On October 15, 2020, the Restated BofA Agreement was replaced by the Loan Agreement described above. Loans under the Restated BofA Agreement bore interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability under the Restated BofA Agreement. Interest payments were due monthly, payable in arrears.

Prior Term Loan Agreement. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Term Loan and Security Agreement (as amended, the “Term Loan Agreement”) with Pathlight Capital LLC, as agent, each lender from time to time a party to the Term Loan Agreement, and certain subsidiaries of the Company as guarantors, providing for a $17,500 term loan (the “Term Loan”).

The principal of the Term Loan was being repaid, on a quarterly basis, in installments of $219, with the first installment having been paid on December 1, 2018, until paid in full on termination, provided that, in connection with the amendments to the Term Loan Agreement, principal payments for March, June and September 2020 were suspended. The Term Loan was repaid in full on October 15, 2020. The refinancing transaction was evaluated to determine the proper accounting treatment for the transaction. Accordingly, debt extinguishment accounting was used to account for the prepayment of the prior term loan facility with Pathlight Capital, LLC, resulting in a loss from the extinguishment of debt of $1,800 for the twelve months ended January 2, 2021.

PPP Loan

On August 3, 2020, the Company received loan proceeds of $1,956 (the “PPP Loan”) pursuant to the Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration (“SBA”) under the U.S. CARES Act. The PPP Loan, which was in the form of a promissory note (the “PPP Note”), between the Company and BofA, as the lender, had a maturity date of July 27, 2025 and would bear interest at a fixed rate of 1% per annum. Monthly principal and interest payments were deferred until (i) the date on which the amount of forgiveness was remitted to the Company’s lender, (ii) the date on which the Company’s lender provided notice that the Company was not entitled to loan forgiveness, and (iii) if a borrower did not apply for loan forgiveness, 10 months after the date of the loan forgiveness covered period. The Company was permitted to voluntarily prepay the borrowings in full with no associated penalty or premium. Under the terms of the PPP, the principal and interest could be forgiven if the PPP Loan proceeds were used for qualifying expenses, including payroll costs, rent and utility costs. The PPP Note contained customary representations, warranties, and covenants for this type of transaction, including customary events of default relating to, among other things, payment defaults and breaches of representations and warranties or other provisions of the PPP Note. The occurrence of an event of default could have resulted in, among other things, the Company becoming obligated to repay all amounts outstanding under the PPP Note. On February 18, 2021, the Company applied for full forgiveness of the PPP loan through Bank of America. In May 2021, the SBA determined that the PPP Loan was fully approved for forgiveness and on May 23, 2021, the PPP Loan was repaid in full by the SBA to BofA. The forgiveness amount remitted was $1,956 in principal and $16 in interest and is included as a gain from the extinguishment of debt in the statement of operations.

Aggregate maturities of bank debt related to the Loan Agreement are as follows:

Fiscal Year ending:
2022		1,594
2023		2,125
2024		2,125
2025		34,728
2026 and beyond		—
Total	$	40,572

Unamortized debt issuance costs were $1,027 at January 1, 2022 and $1,275 at January 2, 2021, and are presented as a direct deduction of long-term debt on the consolidated balance sheets.

Sale-Leaseback

On March 24, 2009, Summer Infant (USA), Inc., (“Summer USA”) the Company’s wholly owned subsidiary, entered into a definitive agreement with Faith Realty II, LLC, a Rhode Island limited liability company (“Faith Realty”) (the owner of which is Jason Macari, the former Chief Executive Officer, former director of the Company, and current investor), pursuant to which Faith Realty purchased the corporate headquarters of the Company located at 1275 Park East Drive, Woonsocket, Rhode Island (the “Headquarters”), for $4,052 and subsequently leased the Headquarters back to Summer USA for an annual rent of $390 during the initial seven year term of the lease, payable monthly and in advance. The original lease was to expire on the seventh anniversary of its commencement. Mr. Macari had given a personal guarantee to secure the Faith Realty debt on its mortgage; therefore, due to his continuing involvement in the building transaction, the transaction had been recorded as a financing lease, with no gain recognition.

On February 25, 2009, the Company’s Board of Directors (with Mr. Macari abstaining from such action) approved the sale leaseback transaction. In connection therewith, the Board of Directors granted a potential waiver, to the extent necessary, if at all, of the conflict of interest provisions of the Company’s Code of Ethics, effective upon execution of definitive agreements within the parameters approved by the Board. In connection with granting such potential waiver, the Board of Directors engaged independent counsel to review the sale leaseback transaction and an independent appraiser to ascertain (i) the value of the Headquarters and (ii) the market rent for the Headquarters. In reaching its conclusion that the sale leaseback transaction is fair to the Company, the Board of Directors considered a number of factors, including Summer USA’s ability to repurchase the headquarters at 110% of the initial sale price at the end of the initial term. The Company’s Audit Committee approved the sale leaseback transaction (as a related party transaction) and the potential waiver and recommended the matter to a vote of the entire Board of Directors (which approved the transaction).

On May 13, 2015, Summer USA entered into an amendment (the “Amendment”) to its lease dated March 24, 2009 (the “Lease”) with Faith Realty (the “Landlord”). Pursuant to the Amendment, (i) the initial term of the Lease was extended for two additional years, such that the initial term would end on March 31, 2018, and the term of the Lease could be extended at Summer USA’s election for one additional term of three years (rather than five years) upon twelve months’ prior notice, (ii) the annual rent for the last two years of the newly amended initial term was set at $429 and the annual rent for the extension period, if elected, was set at $468 and (iii) the Landlord agreed to provide an aggregate improvement allowance of not more than $78 for the newly amended initial term, to be applied against Summer USA’s monthly rent, and an additional improvement allowance of $234 for the extension term, if elected, to be applied against Summer USA’s monthly rent during such extension term. The Amendment was reviewed and approved by the audit committee because it was a related party transaction.

On January 22, 2018, Summer USA entered into a second amendment (the “Second Amendment”) to the Lease. Pursuant to the Second Amendment, (i) the term of the Lease was extended to March 31, 2021, with no further rights of extension, (ii) the annual rent for the last three years of the newly amended term was set at $468, (iii) Summer USA no longer has the option to purchase the property subject to the Lease and (iv) the Landlord and Summer USA agreed to certain expenses, repairs and modifications to the property that is subject to the Lease. The Second Amendment was reviewed and approved by the audit committee because it was a related party transaction.

On May 1, 2020, Summer USA entered into a third amendment (the “Third Amendment”) to the Lease. The agreement decreased the leased premises square footage and extended the current term, which was set to end in March 2021 prior to the amendment, to June 2025. It additionally granted two 5-year term extension options. Upon the execution of the lease amendment, the Company re-assessed the classification of the lease and determined it to be an operating lease, as the criteria for a sale-leaseback had not been met. This resulted in the de-recognition of the building of $2,357, net of depreciation and the addition of a right-of-use of $1,457 along with a short-term lease liability and a long-term lease liability for $264 and $1,193, respectively.

XML

INCOME TAXES

12 Months Ended

Jan. 01, 2022

INCOME TAXES

INCOME TAXES

6. INCOME TAXES

In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”) that significantly revised the U.S. tax code effective January 1, 2018 by, among other things, lowering the corporate income tax rate from a top marginal rate of 35% to a flat 21%, limiting deductibility of interest expense and performance based incentive compensation and implementing a territorial tax system. As a result of the Tax Act in the fiscal years ending January 1, 2022 and January 2, 2021 the Company had non-deductible interest for tax purposes resulting in a deferred tax asset in the amount of $1,919 and $1,643, respectively. The Company recorded a valuation allowance on the value of this deferred tax asset until such time as it becomes more likely than not that this asset will be recognized.

The provision for income taxes is summarized as follows:

	Fiscal 2021		Fiscal 2020
Current:
Federal	$	—	$	108
Foreign		—		2
State and local		22		2
Total current		22		112
Deferred:
Federal		718	$	(5)
Foreign		237		6
State and local		200		4
Total deferred		1,155		5
Total provision	$	1,177	$	117

The tax effects of temporary differences that comprise the deferred tax liabilities and assets are as follows:

	January 1,		January 2,
	2022		2021
Deferred tax assets:
Accounts receivable	$	4	$	51
Inventory and Uniform Capitalization reserve		467		475
Interest deduction limitation		1,919		1,643
Lease Liability and accrued expenses		3,912		806
Research and development credit		2,030		2,292
Foreign tax credit		795		795
Net operating loss carry-forward		2,735		2,565
Total deferred tax assets		11,862		8,627
Deferred tax liabilities:
Intangible assets and other		(2,271)		(2,132)
ROU Assets and deferred rent		(3,745)		(833)
Property, plant and equipment		(83)		28
Total deferred tax liabilities		(6,099)		(2,937)
Valuation allowance		(5,915)		(4,689)
Deferred tax liabilities and valuation allowance		(12,014)		(7,626)
Net deferred income tax asset	$	(152)	$	1,001

The following reconciles the benefit for income taxes at the U.S. federal income tax statutory rate to the benefit in the consolidated financial statements:

	Fiscal 2021		Fiscal 2020
Tax benefit at statutory rate	$	(361)	$	(207)
State income taxes, net of U.S. federal income tax benefit		176		5
Adjustment to uncertain tax position		—		7,543
Stock options		16		5
Foreign tax rate differential		(49)		2
Tax credits		262		258
Worthless stock deduction		—		(7,435)
Non-deductible expenses/Non-taxable income including PPP		(428)		149
Expiration of unexercised stock options		24		90
Increase/(Decrease) in valuation allowance		1,512		(255)
Other		25		(38)
Total provision	$	1,177	$	117

The income tax provision for the year ended January 1, 2022 was primarily the result of an increase in valuation allowance on US and foreign net operating losses, offset by federal non-taxability of PPP loan forgiveness.

The income tax provision for the year ended January 2, 2021 was primarily the result of a deduction related to a worthless stock loss in the Company’s investment in its wholly owned subsidiary, Born Free Holdings Limited (“BFH”), net of reserve for uncertain tax positions. The Company, after analyzing the facts and circumstances, determined to no longer invest in BFH and liquidated the entity. The Company has maintained a permanent investment position and, therefore, has not previously recorded a deferred tax asset for the basis difference in this entity. The original acquisition and financial results of this entity had created an excess of tax basis over the book basis in which the worthless stock was deducted for income tax purposes of approximately $26,933, resulting in an estimated net tax benefit of $7,435. The Company analyzed this transaction and determined that this worthless stock deduction qualifies as an ordinary loss. While the Company believes this is a valid income tax deduction, due to the uncertain nature of worthless stock deductions, the Company has determined this tax benefit to be an uncertain tax position. Accordingly, the Company fully reserved for the tax benefit associated with the worthless stock deduction.

As of January 1, 2022, the Company had approximately $6,563 of US federal and state net operating loss carry forwards (or “NOLs”) to offset future federal taxable income. The federal NOL will begin to expire in 2031 and the state NOL began to expire in 2021. As of January 1, 2022, the Company had approximately $1,832, $543, and $2,028 of NOLs in Canada, Asia, and the United Kingdom, respectively, which can be carried forward indefinitely.

Authoritative guidance requires a valuation allowance to reduce the deferred tax assets reported, if based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all evidence, including the Company’s past earnings history and future earnings forecast, management determined that a valuation allowance in the amount of $3,201 at January 1, 2022 and $2,251 at January 2, 2021 relating to certain federal and state tax credits and foreign NOLs was necessary. Due to the Tax Act, the Company determined a valuation allowance in the amount of $2,714 at January 1, 2022 and $2,438 at January 2, 2021 relating to interest deduction limitations and foreign tax credits was necessary.

We apply the accounting guidance in ASC 740 related to accounting for uncertainty in income taxes. Our reserves related to taxes are based on a determination of whether, and how much of, a tax benefit taken by us in our tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit.

A summary of the Company’s adjustment to its uncertain tax positions in fiscal years ended January 1, 2022 and January 2, 2021 is set forth below:

	January 1,		January 2,
	2022		2021
Balance, at beginning of the year	$	7,543	$	—
Increase for tax positions related to the current year		—		7,543
Balance, at end of year	$	7,543	$	7,543

The unrecognized tax benefits mentioned above included an aggregate of $0 of accrued interest and penalty balances related to uncertain tax positions. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. The Company does not anticipate that its accrual for uncertain tax positions will be reduced by a material amount over the next twelve-month period, as it does not expect to settle any potential disputed items with the appropriate taxing authorities, nor does it expect the statute of limitations to expire for any items.

The Company is subject to U.S. federal income tax, as well as to income tax of multiple state and foreign tax jurisdictions. On a global basis, the open tax years subject to examination by major taxing jurisdictions in which the Company operates is between two to six years.

XML

SHARE BASED COMPENSATION

12 Months Ended

Jan. 01, 2022

SHARE BASED COMPENSATION

SHARE BASED COMPENSATION

7. SHARE BASED COMPENSATION

The Company is currently authorized to issue up to 374,889 shares for equity awards under the Company’s Amended and Restated 2012 Incentive Compensation Plan (“2012 Plan”). In May 2021, the Company’s stockholders approved an increase in the number of shares available for issuance under the 2012 Plan from 188,889 to 374,889. Periodically, the Company may also grant equity awards outside of its 2012 Plan as inducement grants for new hires.

Under the 2012 Plan, awards may be granted to participants in the form of non-qualified stock options, incentive stock options, restricted stock, deferred stock, restricted stock units and other stock-based awards. Subject to the provisions of the plans, awards may be granted to employees, officers, directors, advisors and consultants who are deemed to have rendered or are able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the Company’s success. The Company accounts for options under the fair value recognition standard. The application of this standard resulted in share-based compensation expense for the twelve months ended January 1, 2022 and January 2, 2021 of $327 and $253, respectively. Share based compensation expense is included in selling, general and administrative expenses.

As of January 1, 2022, there are 202,576 shares available to grant under the 2012 Plan.

Stock Options

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the table below. The Company uses the simplified method to estimate the expected term of the options for grants of “plain vanilla” stock options as prescribed by the Securities and Exchange Commission. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Share-based compensation expense recognized in the consolidated financial statements in fiscal 2021 and 2020 is based on awards that are ultimately expected to vest.

The following table summarizes the weighted average assumptions used for options granted during the fiscal years ended January 1, 2022 and January 2, 2021.

	Fiscal		Fiscal
	2021		2020
Expected life (in years)	4.6		4.7
Risk-free interest rate	0.7	%	0.3	%
Volatility	105.3	%	98.9	%
Dividend yield	0.0	%	0.0	%
Forfeiture rate	50.6	%	51.9	%

The weighted-average grant date fair value of options granted during the year ended January 1, 2022 was $9.95 per share. The weighted-average grant date fair value of options granted during the year ended January 2, 2021 was $2.61 per share.

A summary of the status of the Company’s options as of January 1, 2022 and changes during the year then ended is presented below:

		Weighted-
	Number	Average
	Of	Exercise
	Shares	Price
Outstanding at beginning of year	60,639	$	10.63
Granted	52,000	$	13.41
Exercised or released	(7,965)	$	8.03
Canceled or forfeited	(33,705)	$	13.77
Expired	(334)	$	66.96
Outstanding at end of year	70,635	$	11.20
Options exercisable at January 1, 2022	13,425	$	11.14

Outstanding stock options vested and expected to vest as of January 1, 2022 is 49,179. The intrinsic value of options exercised was $69 and $13 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

The following table summarizes information about stock options at January 1, 2022:

	Options Outstanding				Options Exercisable
			Weighted				Weighted
		Remaining	Average			Remaining	Average
Range of	Number	Contractual	Exercise		Number	Contractual	Exercise
Exercise Prices	Outstanding	Life (years)	Price		Exercisable	Life	Price
$3.51 - $6.00	13,056	7.4	$	3.64	3,291	7.4	$	3.64
$6.01 - $12.00	19,840	8.3	$	9.26	5,895	6.7	$	7.71
$12.01 - $20.00	36,396	8.9	$	14.21	2,896	4.3	$	17.11
$20.01 - $30.00	336	3.2	$	23.76	336	3.2	$	23.76
$30.01 - $48.51	1,007	1.1	$	34.43	1,007	1.1	$	34.43
	70,635	8.3	$	11.20	13,425	5.9	$	11.14

The aggregate intrinsic value of options outstanding and exercisable at January 1, 2022 and January 2, 2021 are $39 and $73, respectively. As of January 1, 2022, there was approximately $204 of unrecognized compensation cost related to non-vested stock option awards, which is expected to be recognized over a remaining weighted-average vesting period of 3.2 years.

Restricted Stock Awards

Restricted stock awards require no payment from the grantee. The related compensation cost of each award is calculated using the market price on the grant date and is expensed equally over the vesting period. A summary of restricted stock awards made in the year ended January 1, 2022, is as follows:

	Number of	Grant Date
	Shares	Fair Value
Non-vested restricted stock awards as of January 2, 2021	14,967	$	8.68
Granted	20,960	$	11.45
Vested and released	(24,539)	$	11.13
Forfeited	(5,316)	$	9.73
Non-vested restricted stock awards as of January 1, 2022	6,072	$	7.44

As of January 1, 2022, there was approximately $21 of unrecognized compensation cost related to non-vested stock compensation arrangements granted under the Company’s stock incentive plan for restricted stock awards. That cost is expected to be recognized over the next 2.0 years.

On March 13, 2020, the Company completed a 1-for-9 reverse stock split reducing the outstanding common shares to 2,108,743. Transactions that occurred prior to the completion of the reverse stock split had the effect of being divided by nine.

XML

WEIGHTED AVERAGE COMMON SHARES

12 Months Ended

Jan. 01, 2022

WEIGHTED AVERAGE COMMON SHARES

WEIGHTED AVERAGE COMMON SHARES

8. WEIGHTED AVERAGE COMMON SHARES

Basic and diluted earnings or loss per share (“EPS”) is based upon the weighted average number of common shares outstanding during the period. Diluted weighted average number of common shares outstanding also included common stock equivalents such as stock options and restricted shares. The Company does not include the anti-dilutive effect of common stock equivalents in the calculation of dilutive common shares outstanding.

A reconciliation of basic and diluted net income attributable to common stockholders is as follows:

	For the Twelve		For the Twelve
	Months Ended		Months Ended
Calculation of Basic and Diluted EPS	January 1, 2022		January 2, 2021
Weighted-average common shares outstanding – basic		2,152,926		2,119,499
Dilutive effect of restricted shares		—		—
Dilutive effect of stock options		—		—
Weighted-average common shares outstanding – diluted		2,152,926		2,119,499
Earnings per share – basic	$	(1.35)	$	(0.52)
Earnings per share – diluted	$	(1.35)	$	(0.52)

The computation of diluted common shares for the twelve months January 1, 2022 excluded 70,635 and stock options and 6,072 shares of restricted stock outstanding, respectively because to include them would have been anti-dilutive. The computation of diluted common shares for the twelve months ended January 2, 2021 excluded 60,639 of stock options outstanding and excluded 14,967 shares of restricted stock outstanding, respectively because to include them would have been anti-dilutive.

XML

PROFIT SHARING PLAN

12 Months Ended

Jan. 01, 2022

PROFIT SHARING PLAN

PROFIT SHARING PLAN

9. PROFIT SHARING PLAN

Summer Infant (USA), Inc. maintains a defined contribution salary deferral plan under Section 401(k) of the Internal Revenue Code. All employees who meet the plan’s eligibility requirements can participate. Employees may elect to make contributions up to federal limitations. In 2007, the Company adopted a matching plan which was further amended in 2013, and which was funded throughout the year. For the years ended January 1, 2022 and January 2, 2021, the Company recorded 401(k) matching expense of $235 and $278, respectively.

XML

MAJOR CUSTOMERS

12 Months Ended

Jan. 01, 2022

MAJOR CUSTOMERS

MAJOR CUSTOMERS

10. MAJOR CUSTOMERS

Sales to the Company’s top seven customers together comprised approximately 88% of our sales in fiscal 2021 and 87% of our sales in fiscal 2021. Of these customers, three generated more than 10% of sales for fiscal 2021: Amazon.com (38%), Walmart (24%), and Target (18%). In fiscal 2020, three customers generated more than 10% of sales: Amazon.com (33%), Walmart (28%), and Target (17%).

XML

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Jan. 01, 2022

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

11. COMMITMENTS AND CONTINGENCIES

Leases

The Company leases office space and distribution centers primarily related to its United States, Canada, United Kingdom, and Hong Kong operations. In connection with these leases, there were no cash incentives from the landlord to be used for the construction of leasehold improvements within the facility.

In May 2020, the Company entered into a lease agreement amendment related to our headquarters in Woonsocket, Rhode Island. The agreement decreased the leased premises square footage and extended the current term, which was set to end in March 2021 prior to the amendment to June 2025. It additionally granted two 5-year term extension options. The Company was accounting for the lease in Woonsocket as a sale-leaseback with the building on the balance sheet as property and equipment, net and a corresponding financing obligation in long-term liabilities. Upon the execution of the lease amendment, the Company re-assessed the classification of the lease and determined it to be an operating lease, as the criteria for a sale had been met. As part of this re-classification, the Company derecognized the financing obligation of $2,390 from long-term liabilities and the amount related to the property and equipment, net of $2,357 from the balance sheet and recorded a ROU asset and lease liability of $1,457 respectively. The Company did not include either of the term extension options in the calculation of the ROU asset and lease liability.

In April 2020, the Company entered into a twelve-month sublease agreement for a portion of its main leased warehouse and distribution center located in Riverside, California.

In February 2021, Summer USA extended its lease at its Riverside, California distribution center. The existing lease was set to expire on September 30, 2021 and has been extended for 61 months through October 31, 2026. In addition, the amended lease grants a 60-month extension option. The Company concluded that this is a modification to the existing lease and continues to be classified as operating. Upon the execution of the lease extension, the Company recorded an increase in ROU asset and lease liability of $13,583, respectively. The Company did not include the extension option in the calculation of the ROU asset and lease liability. Fixed sublease payments received are recognized on a straight-line basis over the sublease term in general and administrative expenses.

In October 2021, the Company renewed its lease in Hong Kong for an additional two years beginning in November 2021 and terminating in November 2023. No options to renew were stipulated in the lease. Upon execution of the lease, the Company recorded an ROU asset and lease liability of $291.

The Company identified and assessed the following significant assumptions in recognizing the right-of-use asset and corresponding liabilities:

● Expected lease term—The expected lease term includes both contractual lease periods and, when applicable, cancelable option periods when it is reasonably certain that the Company would exercise such options. These leases have remaining lease terms between 0.17 and 4.83 years. The Woonsocket lease has two 5-year extension options, and the Canada lease has one 5-year extension option that have not been included in the lease term.

● Incremental borrowing rate—The Company’s lease agreements do not provide an implicit rate. As the Company does not have any external borrowings for comparable terms of its leases, the Company estimated the incremental borrowing rate based on secured borrowings available to the Company for the next 5 years. This is the rate the Company would have to pay if borrowing on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

● Lease and non-lease components—In certain cases the Company is required to pay for certain additional charges for operating costs, including insurance, maintenance, taxes, and other costs incurred, which are billed based on both usage and as a percentage of the Company’s share of total square footage. The Company determined that these costs are non-lease components, and they are not included in the calculation of the lease liabilities because they are variable. Payments for these variable, non-lease components are considered variable lease costs and are recognized in the period in which the costs are incurred.

The components of the Company’s lease expense for the years ended January 1, 2022 and January 2, 2021 were as follows:

	Year Ended			Year Ended
	January 1, 2022			January 2, 2021
Operating lease cost	$	3,553		$	2,710
Variable lease cost		909			1,057
Less: sublease income		(1,199)			(749)
Total lease expense	$	3,263		$	3,018
Weighted-average remaining lease term		4.6 years			1.2 years
Weighted-average discount rate:		3.35	%		5.00	%

Cash paid for amounts included in the measurement of the Company’s lease liabilities were $2,969 and $2,911 for the years ended January 1, 2022 and January 2, 2021, respectively.

As of January 1, 2022, the present value of maturities of the Company’s operating lease liabilities were as follows:

Fiscal Year Ending:
2022	$	3,592
2023		3,498
2024		3,347
2025		3,284
2026		2,672
Less imputed interest		(1,226)
Total	$	15,167

The future fixed sublease receipts under non-cancelable operating lease agreements as of January 1, 2022 are as follows:

Fiscal Year Ending:
2022	$	1,348
Thereafter		—
Total	$	1,348

Employment Contracts

In accordance with applicable local law, Summer Infant Europe Limited is required to have employment contracts with all of its employees. In connection with these contracts, Summer Infant Europe Limited makes individual pension contributions to certain employees at varying rates from 1-7% of the employee’s annual salary, as part of their total compensation package. These pension contributions are expensed as incurred. There are no termination benefit provisions in these contracts.

Litigation

The Company is a party to routine litigation and administrative complaints incidental to its business. The Company does not believe that the resolution of any or all of such current routine litigation and administrative complaints is likely to have a material adverse effect on the Company’s financial condition or results of operations.

XML

GEOGRAPHICAL INFORMATION

12 Months Ended

Jan. 01, 2022

GEOGRAPHICAL INFORMATION

GEOGRAPHICAL INFORMATION

12. GEOGRAPHICAL INFORMATION

The Company sells products throughout the United States, Canada, and the United Kingdom, and various other parts of the world. The Company does not disclose product line revenues as it is not practicable for the Company to do so.

The following is a table that presents net revenue by geographic area:

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
United States	$	132,153	$	140,173
All Other		11,512		15,126
	$	143,665	$	155,299

The following is a table that presents total assets by geographic area:

	January 1,		January 2,
	2022		2021
United States	$	88,836	$	70,689
All Other		2,394		4,048
	$	91,230	$	74,737

The following is a table that presents total long-lived assets by geographic area:

	January 1,		January 2,
	2022		2021
United States	$	29,224	$	19,983
All Other		773		1,276
	$	29,997	$	21,259

XML

SUBSEQUENT EVENTS

12 Months Ended

Jan. 01, 2022

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

13. SUBSEQUENT EVENTS

The Company has evaluated all events or transactions that occurred after January 1, 2022 through the date of this Annual Report on Form 10-K and determined that no subsequent events occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto except as follows:

Loan and Security Agreement. On January 28, 2022, the Company and its subsidiary, Summer Infant (USA), Inc. (“Summer USA”), as borrowers, entered into a Loan and Security Agreement among the Company and Summer USA. as borrowers, the guarantors from time to time party thereto, certain financial institutions as lenders, and Wynnefield Capital, Inc., as agent for the lenders, which was amended on March 16, 2022 (as amended, the “New Term Loan Agreement”). The lenders, Wynnefield Partners Small Cap Value, L.P. and Wynnefield Partners Small Cap Value, L.P. I, are existing stockholders of the Company and, together with affiliates, beneficially own approximately 35% of the Company’s outstanding common stock, and an employee of Wynnefield Capital, Inc., Stephen Zelkowicz, serves on the Company’s Board of Directors.

The New Term Loan Agreement provides for a second lien, subordinated term loan in an amount up to $5,000, with requests for the funding of tranches limited to every 30 days (the “New Term Loan”), subject to certain limitations.

Borrowings under the New Term Loan Agreement will bear interest at a rate of 5.0% per annum until January 27, 2024, and thereafter at a rate of 9.0% per annum, payable in arrears on a quarterly basis. The principal amount of any borrowing will be repaid quarterly in installments equal to 2.5% of the highest amount of borrowings outstanding under the New Term Loan Agreement during the applicable quarter, commencing on July 1, 2022 and continuing until the maturity date of April 19, 2026.

Borrowings under the New Loan Term Agreement are secured by a second lien on substantially all of the assets of the Company and are subordinated to the Company’s obligations under the BofA Agreement. The New Term Loan Agreement as amended contains customary affirmative and negative covenants and events of default substantially the same as the BofA Agreement.

Amendments to BofA Agreement. On January 28, 2022 and March 16, 2022, the Company and Summer USA, as borrowers, entered into amendments to the Third Amended and Restated Loan and Security Agreement among the Company and Summer Infant (USA), Inc. as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Bank of America, N.A., as agent for the lenders. The amendments, among other things, (1) revised the definition of EBITDA to allow the add-back of costs and expenses associated with the New Term Loan and permits the Company to addback of costs of legal advisors and independent consultants incurred during the period from January 1, 2022 through July 2, 2022 in an aggregate amount not to exceed $1,000, (2) modified the fixed charge coverage ratio covenant to provide that the ratio shall be at least 1.00 to 1.00 as of the last day of each fiscal month commencing January 28, 2023, (3) reflected temporary increase through April 2, 2022 in (i) the maximum percentage of accounts owing from Amazon that may be included as eligible accounts in the borrowing based from 45% to 55%, and (ii) the maximum portion of the borrowing base that is attributable to eligible in-transit inventory from $7,000 to $11,000, (4) removed references to LIBOR and replaces them with the Bloomberg Short-Term Bank Yield (“BSBY”) Index rate administered by Bloomberg, (5) added a new minimum availability requirement of $3,500 at all times, and (6) added a new minimum EBITDA requirement to be maintained on a rolling monthly basis beginning on April 2, 2022.

Proposed Merger with Kids2, Inc. On March 16, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Kids2, Inc., a Georgia corporation (“Parent”), and Project Abacus Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides, subject to its terms and conditions, for the acquisition of the Company by Parent through the merger of Merger Sub with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Parent (the “Proposed Merger”). Under the terms of the Proposed Merger, each share of common stock of the Company issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) (other than shares of common stock (i) owned by Parent, Merger Sub, the Company or any subsidiary of Parent, Merger Sub or Company, or (ii) held by a stockholder who is entitled to, and who has perfected, appraisal rights for such shares under Delaware law) automatically will be converted into the right to receive cash in an amount of $12.00 per share (the “Merger Consideration”), without interest, subject to any required withholding of taxes. The completion of the Proposed Merger is subject to closing conditions, including: (i) the approval of the Merger Agreement by the Company’s stockholders; (ii) the absence of any laws or court orders making the Proposed Merger illegal or otherwise prohibiting the Proposed Merger; (iii) other customary closing conditions, including the accuracy of the representations and warranties of each party (subject to certain materiality exceptions) and material compliance by each party with its covenants under the Merger Agreement; and (iv) the closing of a debt financing by Parent to fund the Merger Consideration.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Jan. 01, 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

Revenue Recognition

The Company applies FASB ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The guidance sets forth a five-step revenue recognition model and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying principle of the standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in the prior accounting guidance.

The Company’s principal activities from which it generates its revenue is product sales. The Company has one reportable segment of business.

Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation in a contract by transferring control over a product to a customer when product delivery occurs. Consideration is typically paid approximately 60 days from the time control is transferred. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in selling costs.

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for the Company is transfer of primarily juvenile products to its customers. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation.

A transaction price is the amount of consideration the Company expects to receive under the arrangement. The Company is required to estimate variable consideration (if any) and to factor that estimation into the determination of the transaction price. The Company conducts its business with customers through valid purchase or sales orders each of which is considered a separate contract because individual orders are not interdependent on one another. Product transaction prices on a purchase or sale order are discrete and stand-alone. Purchase or sales orders may be issued under either a customer master service agreement or a reseller allowance agreement. Purchase or sales orders, master service agreements, and reseller allowance agreements which are specific and unique to each customer, may include product price discounts, markdown allowances, return allowances, and/or volume rebates which reduce the consideration due from customers. Variable consideration is estimated using the most likely amount method, which is based on our historical experience as well as current information such as sales forecasts.

Contracts may also include cooperative advertising arrangements where the Company allows a discount from invoiced product amounts in exchange for customer purchased advertising that features the Company’s products. These allowances are generally based upon product purchases or specific advertising campaigns. Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct benefit and fair value and are accounted for as direct selling expenses.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Accordingly, actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash flows, cash and cash equivalents include money market accounts and investments with an original maturity of three months or less. At times, the Company possesses cash balances in excess of federally-insured limits.

Trade Receivables

Trade Receivables

Trade receivables are carried at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based upon historical experience and management’s evaluation of outstanding accounts receivable.

Changes in the allowance for doubtful accounts are as follows:

	For the
	fiscal year ended
	January 1,		January 2,
	2022		2021
Allowance for doubtful accounts, beginning of period	$	197	$	542
Charges to (recovery of) costs and expenses		8		(27)
Account write-offs and other		(191)		(318)
Allowance for doubtful accounts, end of period	$	14	$	197

Inventory Valuation

Inventory Valuation

Inventory is comprised mostly of finished goods and some component parts and is stated at the lower of cost using the first-in, first-out (FIFO) method, or net realizable value. The Company regularly reviews slow-moving and excess inventories and writes down inventories to net realizable value if the ultimate expected net proceeds from the disposals of excess inventory are less than the carrying cost of the merchandise.

Leases

Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and lease liabilities in the Company’s consolidated balance sheets.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company’s uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

The components of a lease should be split into three categories: lease components (e.g., land, building, etc.), non-lease components (e.g., common area maintenance, maintenance, consumables, etc.), and non-components (e.g., property taxes, insurance, etc.). Then the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on fair values to the lease components and non-lease components. Although separation of lease and non-lease components is required, certain practical expedients are available to entities. Entities electing the practical expedient would not separate lease and non-lease components. Rather, they would account for each lease component and the related non-lease component together as a single component. The Company’s facilities operating leases have lease and non-lease components to which the Company has elected to apply the practical expedient and account for each lease component and related non-lease component as one single component. The lease component results in a ROU asset being recorded on the balance sheet. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost. The Company owns the tools and molds used in the production of its products by third party manufacturers. Capitalized mold costs include costs incurred for the pre-production design and development of the molds.

Depreciation is provided over the estimated useful lives of the respective assets using the straight-line method.

Long-Lived Assets with Finite Lives

Long-Lived Assets with Finite Lives

The Company reviews long-lived assets with finite lives for impairment on an asset group level whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered to be impaired when its carrying amount exceeds both the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition and the assets’ fair value. Long-lived assets include property and equipment and finite-lived intangible assets. The amount of impairment loss, if any, is charged by the Company to current operations.

Indefinite-Lived Intangible Assets

Indefinite-Lived Intangible Assets

The Company accounts for intangible assets in accordance with accounting guidance that requires that intangible assets with indefinite useful lives be tested annually for impairment and more frequently if events or changes in circumstances indicate that the asset might be impaired. The Company’s annual impairment testing is conducted in the fourth quarter of every year.

The Company tests indefinite-lived intangible assets for impairment by comparing the asset’s fair value to its carrying amount. If the fair value is less than the carrying amount, the excess of the carrying amount over fair value is recognized as an impairment charge and the adjusted carrying amount becomes the assets’ new cost basis.

Management also evaluates the remaining useful life of an intangible asset that is not being amortized each reporting period to determine whether events and circumstances continue to support an indefinite useful life. If an intangible asset that is not being amortized is subsequently determined to have a finite useful life, it is amortized prospectively over its estimated remaining useful life.

Fair Value Measurements

Fair Value Measurements

The Company follows ASC 820, “Fair Value Measurements and Disclosures” which includes a framework for measuring fair value and expanded related disclosures. Broadly, the framework requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The standard established a three-level valuation hierarchy based upon observable and non-observable inputs.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy:

Level 1—Quoted prices for identical instruments in active markets.

Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

Level 3—Significant inputs to the valuation model are unobservable.

The Company maintains policies and procedures to value instruments using the best and most relevant data available. In addition, the Company utilizes third party specialists that review valuation, including independent price validation.

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and short and long-term borrowings. Because of their short maturity, the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value. The carrying value of the Company’s debt approximates fair value since the stated rate is similar to rates currently available to the Company for debt with similar terms and remaining maturities.

The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets and finite-lived intangibles. The Company tests its indefinite-lived assets for impairment at least annually and whenever events or changes in circumstances indicate that the carrying value may not be recoverable or that the carrying value may exceed its fair value. The resulting fair value measurements are considered to be Level 3 inputs. The Company did not record an impairment charge in fiscal 2021. During the fourth quarter of fiscal 2020, the Company determined that the estimated fair value of a definite-lived asset was non-recoverable, and the Company recorded a non-cash impairment charge of $676 which reduced the value of the intangible asset to $0, as more fully described in “Note 4 to the Consolidated Financial Statements-Intangible Assets.”

Income Taxes

Income taxes

Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carryforwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence, it is more likely than not that such benefits will be realized. Deferred income tax assets are recorded on a net basis as a long term asset.

The Company follows the applicable guidance relative to uncertain tax positions. This standard provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Uncertain tax positions must meet a recognition threshold of more-likely-than-not in order for those tax positions to be recognized in the financial statements.

Translation of Foreign Currencies

Translation of Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is its local currency, are translated into U.S. dollars at the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been translated at average rates prevailing during each respective quarter. Resulting translation adjustments are made to a separate component of stockholders’ equity within accumulated other comprehensive loss. Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is the U.S. dollar are remeasured into U.S. dollars at their historical rates or the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been remeasured at average rates prevailing during each respective quarter. Resulting remeasurement adjustments are made to the consolidated statement of operations. Foreign exchange transaction gains and losses are included in the accompanying consolidated statement of operations.

Shipping Costs

Shipping Costs

Shipping costs to customers are included in selling expenses and amounted to approximately $2,206 and $2,485 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

Advertising Costs

Advertising Costs

The Company charges advertising costs to selling expense as incurred. Advertising expense, which consists primarily of promotional and cooperative advertising allowances provided to customers, was approximately $7,881 and $9,215 for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

Segment Information

Segment Information

Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision-maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company views its operations and manages its business as one operating segment utilizing an omni-channel distribution strategy.

Net Loss Per Share

Net Loss Per Share

Basic loss per share for the Company is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted income or loss per share includes the dilutive impact of outstanding stock options and unvested restricted shares.

Diluted loss per share for the Company is computed by dividing net loss by the dilutive weighted average shares outstanding which includes: the dilutive impact (using the “treasury stock” method) of “in the money” stock options and unvested restricted shares issued to employees. Options to purchase 70,635 and 60,639 shares of the Company’s common stock and 6,072 and 14,967 of restricted shares were not included in the calculation, due to the fact that these instruments were anti-dilutive for the fiscal years ended January 1, 2022 and January 2, 2021, respectively.

New Accounting Pronouncements

New Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and a subsequent amendment to the initial guidance, ASU 2018-19 Codification Improvements to Topic 325, Financial Instruments-Credit Losses (collectively, Topic 326). Topic 326 requires measurement and recognition of expected credit losses for financial assets held, which include, but are not limited to, trade and other receivables. The new standard is effective for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jan. 01, 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Summary of changes in the allowance for doubtful accounts

	For the
	fiscal year ended
	January 1,		January 2,
	2022		2021
Allowance for doubtful accounts, beginning of period	$	197	$	542
Charges to (recovery of) costs and expenses		8		(27)
Account write-offs and other		(191)		(318)
Allowance for doubtful accounts, end of period	$	14	$	197

XML

REVENUE (Tables)

12 Months Ended

Jan. 01, 2022

REVENUE

Schedule of net sales by geographical area

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
United States	$	132,153	$	140,173
All Other		11,512		15,126
	$	143,665	$	155,299

XML

PROPERTY AND EQUIPMENT (Tables)

12 Months Ended

Jan. 01, 2022

PROPERTY AND EQUIPMENT

Schedule of property and equipment, at cost

	For the
	fiscal year ended
	January 1,			January 2,	Depreciation/
	2022		2021		Amortization Period
Computer-related	$	4,577	$	4,560	5 years
Tools, dies, prototypes, and molds		28,826		27,849	1 - 5 years
Other		7,777		7,671	1 - 15 years
		41,180		40,080
Less: accumulated depreciation		37,052		35,291
Property and equipment, net	$	4,128	$	4,789

XML

INTANGIBLE ASSETS (Tables)

12 Months Ended

Jan. 01, 2022

INTANGIBLE ASSETS

Schedule of intangible assets

	For the
	fiscal year ended
	January 1,		January 2,
	2022		2021
Brand names	$	10,900	$	10,900
Patents and licenses		4,208		4,125
Customer relationships		6,946		6,946
Other intangibles		1,886		1,882
		23,940		23,853
Less: accumulated amortization		(12,558)		(12,114)
Intangible assets, net	$	11,382	$	11,739

Estimated amortization expense for the remaining definite-lived assets for the next five years

Estimated amortization expense for the remaining definite-lived assets for the next five years is as follows:

Fiscal Year ending
2022	440
2023	440
2024	440
2025	437
2026	207

XML

DEBT (Tables)

12 Months Ended

Jan. 01, 2022

DEBT

Schedule of aggregate maturities of the Loan Agreement and the PPP Loan

Aggregate maturities of bank debt related to the Loan Agreement are as follows:

Fiscal Year ending:
2022		1,594
2023		2,125
2024		2,125
2025		34,728
2026 and beyond		—
Total	$	40,572

XML

INCOME TAXES (Tables)

12 Months Ended

Jan. 01, 2022

INCOME TAXES

Schedule of provision (benefit) for income taxes

	Fiscal 2021		Fiscal 2020
Current:
Federal	$	—	$	108
Foreign		—		2
State and local		22		2
Total current		22		112
Deferred:
Federal		718	$	(5)
Foreign		237		6
State and local		200		4
Total deferred		1,155		5
Total provision	$	1,177	$	117

Schedule of tax effects of temporary differences that comprise the deferred tax liabilities and assets

	January 1,		January 2,
	2022		2021
Deferred tax assets:
Accounts receivable	$	4	$	51
Inventory and Uniform Capitalization reserve		467		475
Interest deduction limitation		1,919		1,643
Lease Liability and accrued expenses		3,912		806
Research and development credit		2,030		2,292
Foreign tax credit		795		795
Net operating loss carry-forward		2,735		2,565
Total deferred tax assets		11,862		8,627
Deferred tax liabilities:
Intangible assets and other		(2,271)		(2,132)
ROU Assets and deferred rent		(3,745)		(833)
Property, plant and equipment		(83)		28
Total deferred tax liabilities		(6,099)		(2,937)
Valuation allowance		(5,915)		(4,689)
Deferred tax liabilities and valuation allowance		(12,014)		(7,626)
Net deferred income tax asset	$	(152)	$	1,001

Schedule of reconciliation of the benefit for income taxes at the U.S. federal income tax statutory rate to the benefit in the consolidated financial statements

	Fiscal 2021		Fiscal 2020
Tax benefit at statutory rate	$	(361)	$	(207)
State income taxes, net of U.S. federal income tax benefit		176		5
Adjustment to uncertain tax position		—		7,543
Stock options		16		5
Foreign tax rate differential		(49)		2
Tax credits		262		258
Worthless stock deduction		—		(7,435)
Non-deductible expenses/Non-taxable income including PPP		(428)		149
Expiration of unexercised stock options		24		90
Increase/(Decrease) in valuation allowance		1,512		(255)
Other		25		(38)
Total provision	$	1,177	$	117

Schedule of the Company's adjustment to its uncertain tax positions

	January 1,		January 2,
	2022		2021
Balance, at beginning of the year	$	7,543	$	—
Increase for tax positions related to the current year		—		7,543
Balance, at end of year	$	7,543	$	7,543

XML

SHARE BASED COMPENSATION (Tables)

12 Months Ended

Jan. 01, 2022

SHARE BASED COMPENSATION

Summary of weighted average assumptions used for stock options granted

	Fiscal		Fiscal
	2021		2020
Expected life (in years)	4.6		4.7
Risk-free interest rate	0.7	%	0.3	%
Volatility	105.3	%	98.9	%
Dividend yield	0.0	%	0.0	%
Forfeiture rate	50.6	%	51.9	%

Summary of status of the Company's options and changes during the period

		Weighted-
	Number	Average
	Of	Exercise
	Shares	Price
Outstanding at beginning of year	60,639	$	10.63
Granted	52,000	$	13.41
Exercised or released	(7,965)	$	8.03
Canceled or forfeited	(33,705)	$	13.77
Expired	(334)	$	66.96
Outstanding at end of year	70,635	$	11.20
Options exercisable at January 1, 2022	13,425	$	11.14

Summary of stock options, by range of exercise prices

The following table summarizes information about stock options at January 1, 2022:

	Options Outstanding				Options Exercisable
			Weighted				Weighted
		Remaining	Average			Remaining	Average
Range of	Number	Contractual	Exercise		Number	Contractual	Exercise
Exercise Prices	Outstanding	Life (years)	Price		Exercisable	Life	Price
$3.51 - $6.00	13,056	7.4	$	3.64	3,291	7.4	$	3.64
$6.01 - $12.00	19,840	8.3	$	9.26	5,895	6.7	$	7.71
$12.01 - $20.00	36,396	8.9	$	14.21	2,896	4.3	$	17.11
$20.01 - $30.00	336	3.2	$	23.76	336	3.2	$	23.76
$30.01 - $48.51	1,007	1.1	$	34.43	1,007	1.1	$	34.43
	70,635	8.3	$	11.20	13,425	5.9	$	11.14

Schedule of non-vested activity - Restricted Stock Awards

	Number of	Grant Date
	Shares	Fair Value
Non-vested restricted stock awards as of January 2, 2021	14,967	$	8.68
Granted	20,960	$	11.45
Vested and released	(24,539)	$	11.13
Forfeited	(5,316)	$	9.73
Non-vested restricted stock awards as of January 1, 2022	6,072	$	7.44

XML

WEIGHTED AVERAGE COMMON SHARES (Tables)

12 Months Ended

Jan. 01, 2022

WEIGHTED AVERAGE COMMON SHARES

Schedule of reconciliation of basic and diluted net income attributable to common stockholders

	For the Twelve		For the Twelve
	Months Ended		Months Ended
Calculation of Basic and Diluted EPS	January 1, 2022		January 2, 2021
Weighted-average common shares outstanding – basic		2,152,926		2,119,499
Dilutive effect of restricted shares		—		—
Dilutive effect of stock options		—		—
Weighted-average common shares outstanding – diluted		2,152,926		2,119,499
Earnings per share – basic	$	(1.35)	$	(0.52)
Earnings per share – diluted	$	(1.35)	$	(0.52)

XML

COMMITMENTS AND CONTINGENCIES (Tables)

12 Months Ended

Jan. 01, 2022

COMMITMENTS AND CONTINGENCIES

Schedule of lease expense

The components of the Company’s lease expense for the years ended January 1, 2022 and January 2, 2021 were as follows:

	Year Ended			Year Ended
	January 1, 2022			January 2, 2021
Operating lease cost	$	3,553		$	2,710
Variable lease cost		909			1,057
Less: sublease income		(1,199)			(749)
Total lease expense	$	3,263		$	3,018
Weighted-average remaining lease term		4.6 years			1.2 years
Weighted-average discount rate:		3.35	%		5.00	%

Schedule of present value of maturities of operating lease liabilities

As of January 1, 2022, the present value of maturities of the Company’s operating lease liabilities were as follows:

Fiscal Year Ending:
2022	$	3,592
2023		3,498
2024		3,347
2025		3,284
2026		2,672
Less imputed interest		(1,226)
Total	$	15,167

Schedule of future fixed sublease receipts under non-cancelable operating lease agreements

The future fixed sublease receipts under non-cancelable operating lease agreements as of January 1, 2022 are as follows:

Fiscal Year Ending:
2022	$	1,348
Thereafter		—
Total	$	1,348

XML

GEOGRAPHICAL INFORMATION (Tables)

12 Months Ended

Jan. 01, 2022

GEOGRAPHICAL INFORMATION

Schedule of net revenue by geographic area

The following is a table that presents net revenue by geographic area:

	For the fiscal year ended
	January 1,		January 2,
	2022		2021
United States	$	132,153	$	140,173
All Other		11,512		15,126
	$	143,665	$	155,299

Schedule of total assets by geographic area

The following is a table that presents total assets by geographic area:

	January 1,		January 2,
	2022		2021
United States	$	88,836	$	70,689
All Other		2,394		4,048
	$	91,230	$	74,737

Schedule of total long lived assets by geographic area

The following is a table that presents total long-lived assets by geographic area:

	January 1,		January 2,
	2022		2021
United States	$	29,224	$	19,983
All Other		773		1,276
	$	29,997	$	21,259

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) $ in Thousands		3 Months Ended	12 Months Ended
	Mar. 13, 2020	Jan. 02, 2021 USD ($)	Jan. 01, 2022 USD ($) segment shares	Jan. 02, 2021 USD ($) shares
2022 Plan and COVID-19 Pandemic
Cash		$ 510	$ 535	$ 510
Net loss			(2,898)	(1,102)
Cash in operating activities			(8,391)	17,607
Outstanding indebtedness			40,572
Borrowing availability			2,949
Reverse Stock Split
Reverse stock split	0.1111
Reclassification
Amortization of deferred financing costs			$ 294	$ 651
Fiscal Year
Fiscal Period Duration			364 days	371 days
Revenue Recognition
Number of reportable segments | segment			1
Days in accounts receivable			P60D
Changes in the allowance for doubtful accounts
Allowance for doubtful accounts, beginning of period			$ 197	$ 542
Charges to (recovery of) costs and expenses			8	(27)
Account write-offs and other			(191)	(318)
Allowance for doubtful accounts, end of period		197	$ 14	197
Fair Value Measurements
Amortization of definite-lived intangible assets		676		676
Adjusted value of definite-lived intangible asset		0		0
Segment Information
Number of operating segments | segment			1
New Accounting Pronouncements
ROU asset		$ 3,625	$ 14,383	$ 3,625
Operating Lease, Liability			$ 15,167
Stock Options
Net Income/Loss Per Share
Anti-dilutive securities excluded from the computation of diluted earnings per share (in shares) | shares			70,635	60,639
Restricted shares
Net Income/Loss Per Share
Anti-dilutive securities excluded from the computation of diluted earnings per share (in shares) | shares			6,072	14,967
Selling expenses
Shipping costs and Advertising costs
Shipping costs			$ 2,206	$ 2,485
Advertising costs			$ 7,881	$ 9,215

XML

REVENUE (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Net sales by geographical area
Net sales	$ 143,665	$ 155,299
Election of practical expedient, incremental cost of obtaining contracts	true	true
United States
Net sales by geographical area
Net sales	$ 132,153	$ 140,173
All Other
Net sales by geographical area
Net sales	$ 11,512	$ 15,126

XML

PROPERTY AND EQUIPMENT (Details) $ in Thousands	12 Months Ended
	Jan. 01, 2022 USD ($) item	Jan. 02, 2021 USD ($)	May 31, 2020 USD ($)	May 01, 2020 USD ($)
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 41,180	$ 40,080
Less: accumulated depreciation	37,052	35,291
Property and equipment, net	4,128	4,789
Total depreciation expense	1,795	2,847
ROU asset	$ 14,383	3,625
Woonsocket, RI
PROPERTY AND EQUIPMENT
Number of options to extend | item	2
Extension term	5 years
ROU asset			$ 1,457
Adjustments resulting from lease amendment agreement
PROPERTY AND EQUIPMENT
Property and equipment, net			(2,357)	$ (2,357)
ROU asset			$ 1,457	$ 1,457
Computer-related
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 4,577	$ 4,560
Depreciation/Amortization Period	5 years	5 years
Tools, dies, prototypes, and molds
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 28,826	$ 27,849
Tools, dies, prototypes, and molds | Minimum
PROPERTY AND EQUIPMENT
Depreciation/Amortization Period	1 year	1 year
Tools, dies, prototypes, and molds | Maximum
PROPERTY AND EQUIPMENT
Depreciation/Amortization Period	5 years	5 years
Other
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 7,777	$ 7,671
Other | Minimum
PROPERTY AND EQUIPMENT
Depreciation/Amortization Period	1 year	1 year
Other | Maximum
PROPERTY AND EQUIPMENT
Depreciation/Amortization Period	15 years	15 years

XML

INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jan. 02, 2021	Jan. 01, 2022	Jan. 02, 2021
INTANGIBLE ASSETS
Intangible assets, gross	$ 23,853	$ 23,940	$ 23,853
Less: Accumulated amortization	(12,114)	(12,558)	(12,114)
Intangible assets, net	11,739	11,382	11,739
Amortization expense		444	501
Amortization of definite-lived intangible assets	676		676
Intangibles not subject to amortization	8,400	8,400	8,400
Impairment of intangible asset		0	$ 0
Estimated future amortization expense
2022		440
2023		440
2024		440
2025		437
2026		$ 207
Minimum
INTANGIBLE ASSETS
Amortization period of intangible assets		5 years	5 years
Maximum
INTANGIBLE ASSETS
Amortization period of intangible assets		18 years	18 years
Patents and licenses
INTANGIBLE ASSETS
Intangible assets, gross	4,125	$ 4,208	$ 4,125
Customer relationships
INTANGIBLE ASSETS
Intangible assets, gross	6,946	6,946	6,946
Other intangibles
INTANGIBLE ASSETS
Intangible assets, gross	1,882	1,886	1,882
Brand names
INTANGIBLE ASSETS
Intangible assets, gross	$ 10,900	$ 10,900	$ 10,900

XML

DEBT - Loan Agreement with Bank of America (Details) $ in Thousands		12 Months Ended
	Jun. 28, 2018 USD ($)	Jan. 01, 2022 USD ($)	Jan. 02, 2021 USD ($)	Mar. 16, 2022 USD ($)	Jan. 28, 2022 USD ($)	Oct. 15, 2020 USD ($)
DEBT
Borrowing availability		$ 2,949
Prior Bank of America Credit Facility | Revolving credit facility | Financial Covenant
DEBT
Borrowing base as a percentage of eligible receivables	85.00%
Borrowing base as a percentage of eligible inventory	70.00%
Borrowing base as a percentage of net orderly liquidation value of eligible inventory and less reserves	85.00%
Prior Bank of America Credit Facility | Letter of credit sub-line facility
DEBT
Maximum borrowing capacity	$ 5,000
BofA Agreement | Minimum | Financial Covenant
DEBT
Fixed charge coverage ratio at the end of each fiscal month		1.00
BofA Agreement | Term Loan
DEBT
Maximum borrowing capacity						$ 7,500
Amount outstanding		$ 5,625	$ 7,125
Quarterly basis installment amount		375
BofA Agreement | Term Loan | Financial Covenant
DEBT
Threshold availability to maintain minimum fixed charge coverage ratio		$ 5,000
BofA Agreement | Term Loan | LIBOR
DEBT
Interest rate during the period		3.875%
BofA Agreement | Term Loan | Base rate
DEBT
Interest rate during the period		5.75%
BofA Agreement | FILO Loan
DEBT
Maximum borrowing capacity						2,500
Amount outstanding		$ 1,719	2,344
BofA Agreement | FILO Loan | LIBOR
DEBT
Interest rate during the period		3.625%
BofA Agreement | FILO Loan | Base rate
DEBT
Interest rate during the period		5.50%
BofA Agreement | Revolving credit facility
DEBT
Maximum borrowing capacity						$ 40,000
Amount outstanding		$ 33,228	$ 21,467
Borrowing capacity		36,177
Borrowing availability		$ 2,949
BofA Agreement | Revolving credit facility | Financial Covenant
DEBT
Borrowing base as a percentage of eligible receivables		85.00%
Borrowing base as a percentage of eligible inventory		70.00%
Borrowing base as a percentage of net orderly liquidation value of eligible inventory and less reserves		85.00%
BofA Agreement | Revolving credit facility | LIBOR
DEBT
Interest rate during the period		2.625%	2.625%
BofA Agreement | Revolving credit facility | Base rate
DEBT
Interest rate during the period		4.50%
BofA Agreement | Letter of credit sub-line facility
DEBT
Maximum borrowing capacity		$ 5,000
Term Loan and Security Agreement | New Term Loan Agreement
DEBT
Subordinated Debt				$ 5,000,000	$ 5,000,000
Term Loan and Security Agreement | Financial Covenant
DEBT
Interest rate basis	LIBOR
Prior Term Loan | Term Loan
DEBT
Quarterly basis installment amount		$ 219

XML

DEBT - Term Loan Agreement (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Jun. 28, 2018
DEBT
Loss from extinguishment of debt	$ 1,972	$ (1,800)
Prior Term Loan
DEBT
Loss from extinguishment of debt		$ (1,800)
Prior Term Loan | Term Loan
DEBT
Quarterly basis installment amount	$ 219
Face amount of loan			$ 17,500

XML

DEBT - PPP Loan and Aggregate maturities (Details) - USD ($) $ in Thousands	May 23, 2021	Aug. 03, 2020	Jan. 01, 2022	Jan. 02, 2021
Aggregate maturities of bank debt related to the Loan Agreement
2022			$ 1,594
2023			2,125
2024			2,125
2025			34,728
Total			40,572
Long-term Debt
Aggregate maturities of bank debt related to the Loan Agreement
Unamortized debt issuance costs			$ 1,027	$ 1,275
PPP Loan
DEBT
Amount of interest forgiven	$ 16
PPP Loan
DEBT
Loan proceeds		$ 1,956
Amount of principal forgiven	$ 1,956
Fixed rate interest		1.00%
Period for loan forgiveness		10 months

XML

DEBT - Sale Leaseback Transactions (Details) $ in Thousands	Jan. 22, 2018 USD ($)	May 13, 2015 USD ($) period	May 12, 2015	Mar. 24, 2009 USD ($)	Feb. 25, 2009	Jan. 01, 2022 USD ($)	Jan. 02, 2021 USD ($)	May 31, 2020 USD ($)	May 01, 2020 USD ($) item
Sale Leaseback Transaction [Line Items]
Property and equipment, net						$ 4,128	$ 4,789
ROU asset						14,383	3,625
Lease liabilities, current						3,133	2,349
Lease liabilities, noncurrent						$ 12,034	$ 1,493
Adjustments resulting from lease amendment agreement
Sale Leaseback Transaction [Line Items]
Property and equipment, net								$ (2,357)	$ (2,357)
ROU asset								$ 1,457	1,457
Lease liabilities, current									264
Lease liabilities, noncurrent									$ 1,193
Operating Lease, Third Amendment
Sale Leaseback Transaction [Line Items]
Number of options to extend | item									2
Extension term									5 years
Summer Infant (USA), Inc. | Faith Realty | Sale-leaseback definitive agreement
Sale Leaseback Transaction [Line Items]
Sale proceeds				$ 4,052
Repurchase price as a percentage of the initial sale price					110.00%
Summer Infant (USA), Inc. | Faith Realty | Original Lease
Sale Leaseback Transaction [Line Items]
Annual rent				$ 390
Lease term				7 years
Summer Infant (USA), Inc. | Faith Realty | Amended Lease
Sale Leaseback Transaction [Line Items]
Annual rent		$ 429
Lease term		2 years
Leasehold improvement allowance		$ 78
Summer Infant (USA), Inc. | Faith Realty | Amended Lease, Optional Extension
Sale Leaseback Transaction [Line Items]
Annual rent		$ 468
Number of extensions | period		1
Lease term		3 years	5 years
Prior notice required for extension		12 months
Leasehold improvement allowance		$ 234
Summer Infant (USA), Inc. | Faith Realty | Second Amendment
Sale Leaseback Transaction [Line Items]
Annual rent	$ 468
Lease term	3 years

XML

INCOME TAXES - Tax Act (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 29, 2018	Dec. 30, 2017
Tax Cuts and Jobs Act
Federal statutory income tax rate			21.00%	35.00%
Deferred tax asset, non-deductible interest	$ 1,919	$ 1,643

XML

INCOME TAXES - Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Current:
Federal		$ 108
Foreign		2
State and local	$ 22	2
Total current	22	112
Deferred:
Federal	718	(5)
Foreign	237	6
State and local	200	4
Total deferred	1,155	5
Total provision	$ 1,177	$ 117

XML

INCOME TAXES - Deferred Income Taxes (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Deferred tax assets:
Accounts receivable	$ 4	$ 51
Inventory and Uniform Capitalization reserve	467	475
Interest deduction limitation	1,919	1,643
Lease Liability and accrued expenses	3,912	806
Research and development credit	2,030	2,292
Foreign tax credit	795	795
Net operating loss carry-forward	2,735	2,565
Total deferred tax assets	11,862	8,627
Deferred tax liabilities:
Intangible assets and other	(2,271)	(2,132)
ROU Assets and deferred rent	(3,745)	(833)
Property, plant and equipment	(83)	28
Total deferred tax liabilities	(6,099)	(2,937)
Valuation allowance	(5,915)	(4,689)
Deferred tax liabilities and valuation allowance	(12,014)	(7,626)
Net deferred income tax asset	$ (152)	$ (1,001)

XML

INCOME TAXES - Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Effective Income Tax Rate Reconciliation
Tax benefit at statutory rate	$ (361)	$ (207)
State income taxes, net of U.S. federal income tax benefit	176	5
Adjustment to uncertain tax position		7,543
Stock options	16	5
Foreign tax rate differential	(49)	2
Tax credits	262	258
Worthless stock deduction		(7,435)
Non-deductible expenses/Non-taxable income including PPP	(428)	149
Expiration of unexercised stock options	24	90
Increase/(Decrease) in valuation allowance	1,512	(255)
Other	25	(38)
Total provision	$ 1,177	117
Worthless stock deducted for income tax purposes		$ 26,933

XML

INCOME TAXES - NOL Carryforwards and Uncertain Tax Positions (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Net operating loss carryforwards
Valuation Allowance	$ 5,915	$ 4,689
Writedown related to interest deduction limitations	2,714	2,438
Accrued interest and penalties relating to uncertain tax positions	0
Reconciliation of Unrecognized Tax positions
Balance, at beginning of the year	7,543	0
Increase for tax positions related to the current year		7,543
Balance, at end of year	$ 7,543	7,543
Minimum
Net operating loss carryforwards
Period subject to examination by major taxing jurisdictions	2 years
Maximum
Net operating loss carryforwards
Period subject to examination by major taxing jurisdictions	6 years
Federal and state
Net operating loss carryforwards
Net operating loss carryforwards	$ 6,563
Foreign | Canada
Net operating loss carryforwards
Net operating loss carryforwards	1,832
Foreign | Asia
Net operating loss carryforwards
Net operating loss carryforwards	543
Foreign | United Kingdom
Net operating loss carryforwards
Net operating loss carryforwards	2,028
State and foreign
Net operating loss carryforwards
Valuation Allowance	$ 3,201	$ 2,251

XML

SHARE BASED COMPENSATION - Summary of Plans (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Oct. 02, 2021	May 31, 2021	Apr. 30, 2021
Selling, general and administrative expenses
SHARE BASED COMPENSATION
Share-based compensation expense	$ 327	$ 253
2012 Plan
SHARE BASED COMPENSATION
Number of shares authorized under the plan			374,889	374,889	188,889
Shares available to grant	202,576

XML

SHARE BASED COMPENSATION - Stock Options (Details) - Stock Options - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Weighted average assumptions
Expected life (in years)	4 years 7 months 6 days	4 years 8 months 12 days
Risk-free interest rate	0.70%	0.30%
Volatility	105.30%	98.90%
Dividend yield	0.00%	0.00%
Forfeiture rate	50.60%	51.90%
Additional information
Weighted-average grant date fair value of options granted (in dollars per share)	$ 9.95	$ 2.61
Outstanding stock options expected to vest (in shares)	49,179
Intrinsic value of options exercised	$ 69	$ 13
Number Of Shares
Outstanding at beginning of year (in shares)	60,639
Granted (in shares)	52,000
Exercised or released (in shares)	(7,965)
Canceled or forfeited (in shares)	(33,705)
Expired (in shares)	(334)
Outstanding at end of year (in shares)	70,635	60,639
Options exercisable at end of year (in shares)	13,425
Weighted-Average Exercise Price
Outstanding at beginning of year (in dollars per share)	$ 10.63
Granted (in dollars per share)	13.41
Exercised or released (in dollars per share)	8.03
Canceled or forfeited (in dollars per share)	13.77
Expired (in dollars per share)	66.96
Outstanding at end of year (in dollars per share)	11.20	$ 10.63
Options exercisable at January 2, 2021 (in dollars per share)	$ 11.14

XML

SHARE BASED COMPENSATION - Stock Options by Exercise Price (Details) - Stock Options - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Options Outstanding
Number Outstanding (in shares)	70,635
Remaining Contractual Life (years)	8 years 3 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 11.20
Options Exercisable
Number Exercisable (in shares)	13,425
Remaining Contractual Life (in years)	5 years 10 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 11.14
Share based compensation, additional information
Aggregate intrinsic value of options outstanding	$ 39	$ 73
Aggregate intrinsic value of options exercisable	39	$ 73
Unrecognized compensation cost	$ 204
Weighted average vesting period for recognition of unrecognized cost	3 years 2 months 12 days
$3.51 - $6.00
Range of Exercise Prices
Exercise price, low end of range (in dollars per share)	$ 3.51
Exercise price, high end of range (in dollars per share)	$ 6.00
Options Outstanding
Number Outstanding (in shares)	13,056
Remaining Contractual Life (years)	7 years 4 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 3.64
Options Exercisable
Number Exercisable (in shares)	3,291
Remaining Contractual Life (in years)	7 years 4 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 3.64
$6.01 - $12.00
Range of Exercise Prices
Exercise price, low end of range (in dollars per share)	6.01
Exercise price, high end of range (in dollars per share)	$ 12.00
Options Outstanding
Number Outstanding (in shares)	19,840
Remaining Contractual Life (years)	8 years 3 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 9.26
Options Exercisable
Number Exercisable (in shares)	5,895
Remaining Contractual Life (in years)	6 years 8 months 12 days
Weighted Average Exercise Price (in dollars per share)	$ 7.71
$12.00 - $20.00
Range of Exercise Prices
Exercise price, low end of range (in dollars per share)	12.01
Exercise price, high end of range (in dollars per share)	$ 20.00
Options Outstanding
Number Outstanding (in shares)	36,396
Remaining Contractual Life (years)	8 years 10 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 14.21
Options Exercisable
Number Exercisable (in shares)	2,896
Remaining Contractual Life (in years)	4 years 3 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 17.11
$20.01 - $30.00
Range of Exercise Prices
Exercise price, low end of range (in dollars per share)	20.01
Exercise price, high end of range (in dollars per share)	$ 30.00
Options Outstanding
Number Outstanding (in shares)	336
Remaining Contractual Life (years)	3 years 2 months 12 days
Weighted Average Exercise Price (in dollars per share)	$ 23.76
Options Exercisable
Number Exercisable (in shares)	336
Remaining Contractual Life (in years)	3 years 2 months 12 days
Weighted Average Exercise Price (in dollars per share)	$ 23.76
$30.01 - $48.51
Range of Exercise Prices
Exercise price, low end of range (in dollars per share)	30.01
Exercise price, high end of range (in dollars per share)	$ 48.51
Options Outstanding
Number Outstanding (in shares)	1,007
Remaining Contractual Life (years)	1 year 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 34.43
Options Exercisable
Number Exercisable (in shares)	1,007
Remaining Contractual Life (in years)	1 year 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 34.43

XML

SHARE BASED COMPENSATION - Restricted Stock (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Mar. 13, 2020 shares	Jan. 01, 2022 USD ($) $ / shares shares
Additional disclosures
Reverse stock split	0.1111
Outstanding common shares	2,108,743
Restricted shares
SHARE BASED COMPENSATION
Required payment from grantee | $		$ 0
Number of Shares
Non-vested restricted stock awards, Beginning of year		14,967
Granted (in shares)		20,960
Vested and released (in shares)		(24,539)
Forfeited (in shares)		(5,316)
Non-vested restricted stock awards, End of year		6,072
Grant Date Fair Value
Non-vested restricted stock awards, Beginning of year (in dollars per share) | $ / shares		$ 8.68
Granted (in dollars per share) | $ / shares		11.45
Vested and released (in dollars per share) | $ / shares		11.13
Forfeited (in dollars per share) | $ / shares		9.73
Non-vested restricted stock awards, End of year (in dollars per share) | $ / shares		$ 7.44
Additional disclosures
Unrecognized compensation cost | $		$ 21
Weighted average vesting period for recognition of unrecognized cost		2 years

XML

WEIGHTED AVERAGE COMMON SHARES - Reconciliation of Basic and Diluted Net Income (Loss) Attributable to Common Stockholders (Details) - $ / shares	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Calculation of Basic and Diluted EPS
Weighted-average common shares outstanding - basic	2,152,926	2,119,499
Weighted-average common shares outstanding - diluted	2,152,926	2,119,499
Earnings per share - basic	$ (1.35)	$ (0.52)
Earnings per share - diluted	$ (1.35)	$ (0.52)

XML

WEIGHTED AVERAGE COMMON SHARES - Anti-dilutive securities (Details) - shares	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Stock Options
WEIGHTED AVERAGE COMMON SHARES
Anti-dilutive securities excluded from the computation of diluted earnings per share (in shares)	70,635	60,639
Restricted shares
WEIGHTED AVERAGE COMMON SHARES
Anti-dilutive securities excluded from the computation of diluted earnings per share (in shares)	6,072	14,967

XML

PROFIT SHARING PLAN (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
PROFIT SHARING PLAN
Matching expense	$ 235	$ 278

XML

MAJOR CUSTOMERS (Details) - Sales - Customer concentration risk - customer	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
MAJOR CUSTOMERS
Number of significant customers	7	7
Number of customers individually representing more than 10% of sales	3	3
Amazon.com
MAJOR CUSTOMERS
Percentage of concentration risk	38.00%	33.00%
Walmart
MAJOR CUSTOMERS
Percentage of concentration risk	24.00%	28.00%
Target
MAJOR CUSTOMERS
Percentage of concentration risk	18.00%	17.00%
Seven customers
MAJOR CUSTOMERS
Percentage of concentration risk	88.00%	87.00%

XML

COMMITMENTS AND CONTINGENCIES - Summary of Leases (Details) $ in Thousands		1 Months Ended		12 Months Ended
	Feb. 28, 2021 USD ($)	May 31, 2020 USD ($) item	Apr. 30, 2020	Jan. 01, 2022 USD ($) item	Jan. 02, 2021 USD ($)	Oct. 31, 2021 USD ($)
Leases
Derecognition of a building sale-leaseback financial obligation					$ 2,390
Derecognition of a building sale-leaseback fixed asset, net of depreciation					2,357
ROU asset				$ 14,383	3,625
Operating lease liability				$ 12,034	$ 1,493
Term of secured borrowings used to estimate incremental borrowing rate				5 years
Minimum
Leases
Remaining lease term				2 months 1 day
Maximum
Leases
Remaining lease term				4 years 9 months 29 days
Woonsocket, RI
Leases
Number of options to extend | item				2
Extension term				5 years
Derecognition of a building sale-leaseback financial obligation		$ 2,390
Derecognition of a building sale-leaseback fixed asset, net of depreciation		2,357
ROU asset		1,457
Operating lease liability		$ 1,457
Riverside, CA
Leases
Extension term	61 months
Sublease term			12 months
Canada
Leases
Number of options to extend | item				1
Extension term				5 years
Hong Kong
Leases
Extension term						2 years
ROU asset						$ 291
Operating lease liability						$ 291
Office space and distribution centers
Leases
Cash incentives from the landlord				$ 0
Lease Amendment | Woonsocket, RI
Leases
Number of options to extend | item		2
Extension term		5 years
Lease Amendment | Riverside, CA
Leases
Extension term	60 months
Increase to ROU Assets due to lease modification	$ 13,583
Increase to lease liabilities due to lease modification	$ 13,583

XML

COMMITMENTS AND CONTINGENCIES - Components of lease expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
COMMITMENTS AND CONTINGENCIES
Operating lease cost	$ 3,553	$ 2,710
Variable lease cost	909	1,057
Less: sublease income	(1,199)	(749)
Total lease expense	$ 3,263	$ 3,018
Weighted-average remaining lease term (in years)	4 years 7 months 6 days	1 year 2 months 12 days
Weighted-average discount rate:	3.35%	5.00%
Cash paid for amounts included in the measurement of the Company's lease liabilities	$ 2,969	$ 2,911

XML

COMMITMENTS AND CONTINGENCIES - Maturities of operating lease liabilities (Details) $ in Thousands	Jan. 01, 2022 USD ($)
Maturities of the operating lease liabilities
2022	$ 3,592
2023	3,498
2024	3,347
2025	3,284
2026	2,672
Less imputed interest	(1,226)
Total	$ 15,167

XML

COMMITMENTS AND CONTINGENCIES - Future fixed sublease receipts (Details) $ in Thousands	Jan. 01, 2022 USD ($)
Future fixed sublease receipts under non-cancelable operating lease agreements
2022	$ 1,348
Total	$ 1,348

XML

COMMITMENTS AND CONTINGENCIES - Employment contracts (Details) - Summer Infant Europe Limited $ in Thousands	12 Months Ended
	Jan. 01, 2022 USD ($)
COMMITMENTS AND CONTINGENCIES
Termination benefit provisions	$ 0
Minimum
COMMITMENTS AND CONTINGENCIES
Employer's contribution as a percentage of employee's annual salary	1.00%
Maximum
COMMITMENTS AND CONTINGENCIES
Employer's contribution as a percentage of employee's annual salary	7.00%

XML

GEOGRAPHICAL INFORMATION (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
GEOGRAPHICAL INFORMATION
Net revenue	$ 143,665	$ 155,299
Total assets	91,230	74,737
Total long-lived assets	29,997	21,259
United States
GEOGRAPHICAL INFORMATION
Net revenue	132,153	140,173
Total assets	88,836	70,689
Total long-lived assets	29,224	19,983
All Other
GEOGRAPHICAL INFORMATION
Net revenue	11,512	15,126
Total assets	2,394	4,048
Total long-lived assets	$ 773	$ 1,276

XML

SUBSEQUENT EVENTS (Details) $ / shares in Units, $ in Thousands	Mar. 16, 2022 USD ($) $ / shares	Jan. 28, 2022 USD ($)
New Term Loan Agreement | Term Loan and Security Agreement
Subsequent events
Subordinated Debt	$ 5,000,000	$ 5,000,000
Subsequent Event | New Term Loan Agreement
Subsequent events
Loan agreement, Interest percentage		5.00%
Percentage of highest amount of borrowings outstanding than Principal outstanding under New Loan Agreement		2.50%
Subsequent Event | New Term Loan Agreement | Forecast [Member]
Subsequent events
Loan agreement, Interest percentage		9.00%
Subsequent Event | New Term Loan Agreement | BofA Agreement
Subsequent events
Minimum Credit availability	3,500	$ 3,500
Aggregate amount not to exceed	$ 1,000	$ 1,000
Fixed charge coverage ratio	1.00	1.00
Subsequent Event | New Term Loan Agreement | BofA Agreement | Maximum
Subsequent events
Borrowing base of eligible accounts under loan agreements, Amount	$ 11,000	$ 11,000
Subsequent Event | New Term Loan Agreement | BofA Agreement | Amazon | Minimum
Subsequent events
Borrowing base as a percentage of eligible accounts under loan agreements	45.00%	45.00%
Subsequent Event | New Term Loan Agreement | BofA Agreement | Amazon | Maximum
Subsequent events
Borrowing base as a percentage of eligible accounts under loan agreements	55.00%	55.00%
Subsequent Event | New Term Loan Agreement | Term Loan and Security Agreement
Subsequent events
Subordinated Debt		$ 5,000
Period for funding of Tranches		30 days
Subsequent Event | Merger Agreement | BofA Agreement | Amazon | Minimum
Subsequent events
Borrowing base of eligible accounts under loan agreements, Amount	$ 7,000	$ 7,000
Subsequent Event | Merger Agreement | Kids 2
Subsequent events
Sale of Stock, Price Per Share | $ / shares	$ 12.00
Subsequent Event | Wynnefield Partners Small Cap Value, L.P. and Wynnefield Partners Small Cap Value, L.P. I | New Term Loan Agreement
Subsequent events
Ownership percentage		35.00%